id	sid	tid	token	lemma	pos
bjos-8666337	1	1	1	1	NUM
bjos-8666337	1	2	volume	volume	NOUN
bjos-8666337	1	3	21	21	NUM
bjos-8666337	1	4	2022	2022	NUM
bjos-8666337	1	5	e226337	e226337	NOUN
bjos-8666337	1	6	original	original	ADJ
bjos-8666337	1	7	article	article	NOUN
bjos-8666337	1	8	braz	braz	PROPN
bjos-8666337	1	9	j	j	PROPN
bjos-8666337	1	10	oral	oral	PROPN
bjos-8666337	1	11	sci	sci	PROPN
bjos-8666337	1	12	.	.	PUNCT
bjos-8666337	2	1	2022;21	2022;21	NUM
bjos-8666337	2	2	:	:	PUNCT
bjos-8666337	2	3	e226337http://dx.doi.org/10.20396	e226337http://dx.doi.org/10.20396	X
bjos-8666337	2	4	/	/	SYM
bjos-8666337	2	5	bjos.v21i00.8666337	bjos.v21i00.8666337	PROPN
bjos-8666337	2	6	1	1	NUM
bjos-8666337	2	7	department	department	NOUN
bjos-8666337	2	8	of	of	ADP
bjos-8666337	2	9	oral	oral	ADJ
bjos-8666337	2	10	medicine	medicine	NOUN
bjos-8666337	2	11	,	,	PUNCT
bjos-8666337	2	12	school	school	NOUN
bjos-8666337	2	13	of	of	ADP
bjos-8666337	2	14	dentistry	dentistry	NOUN
bjos-8666337	2	15	,	,	PUNCT
bjos-8666337	2	16	tehran	tehran	PROPN
bjos-8666337	2	17	university	university	PROPN
bjos-8666337	2	18	of	of	ADP
bjos-8666337	2	19	medical	medical	ADJ
bjos-8666337	2	20	sciences	sciences	PROPN
bjos-8666337	2	21	,	,	PUNCT
bjos-8666337	2	22	tehran	tehran	PROPN
bjos-8666337	2	23	,	,	PUNCT
bjos-8666337	2	24	iran	iran	PROPN
bjos-8666337	2	25	.	.	PUNCT
bjos-8666337	3	1	2	2	NUM
bjos-8666337	3	2	assistant	assistant	NOUN
bjos-8666337	3	3	professor	professor	NOUN
bjos-8666337	3	4	,	,	PUNCT
bjos-8666337	3	5	razi	razi	PROPN
bjos-8666337	3	6	vaccine	vaccine	NOUN
bjos-8666337	3	7	and	and	CCONJ
bjos-8666337	3	8	serum	serum	PROPN
bjos-8666337	3	9	research	research	PROPN
bjos-8666337	3	10	institute	institute	PROPN
bjos-8666337	3	11	,	,	PUNCT
bjos-8666337	3	12	agricultural	agricultural	ADJ
bjos-8666337	3	13	research	research	NOUN
bjos-8666337	3	14	,	,	PUNCT
bjos-8666337	3	15	education	education	NOUN
bjos-8666337	3	16	and	and	CCONJ
bjos-8666337	3	17	extension	extension	NOUN
bjos-8666337	3	18	organization	organization	NOUN
bjos-8666337	3	19	(	(	PUNCT
bjos-8666337	3	20	areeo	areeo	PROPN
bjos-8666337	3	21	)	)	PUNCT
bjos-8666337	3	22	,	,	PUNCT
bjos-8666337	3	23	karaj	karaj	PROPN
bjos-8666337	3	24	,	,	PUNCT
bjos-8666337	3	25	iran	iran	PROPN
bjos-8666337	3	26	.	.	PUNCT
bjos-8666337	4	1	3	3	NUM
bjos-8666337	4	2	associate	associate	NOUN
bjos-8666337	4	3	professor	professor	NOUN
bjos-8666337	4	4	,	,	PUNCT
bjos-8666337	4	5	department	department	NOUN
bjos-8666337	4	6	of	of	ADP
bjos-8666337	4	7	oral	oral	ADJ
bjos-8666337	4	8	medicine	medicine	NOUN
bjos-8666337	4	9	,	,	PUNCT
bjos-8666337	4	10	imam	imam	PROPN
bjos-8666337	4	11	khomeini	khomeini	PROPN
bjos-8666337	4	12	hospital	hospital	PROPN
bjos-8666337	4	13	,	,	PUNCT
bjos-8666337	4	14	tehran	tehran	PROPN
bjos-8666337	4	15	university	university	PROPN
bjos-8666337	4	16	of	of	ADP
bjos-8666337	4	17	medical	medical	ADJ
bjos-8666337	4	18	science	science	NOUN
bjos-8666337	4	19	,	,	PUNCT
bjos-8666337	4	20	tehran	tehran	PROPN
bjos-8666337	4	21	,	,	PUNCT
bjos-8666337	4	22	iran	iran	PROPN
bjos-8666337	4	23	.	.	PUNCT
bjos-8666337	5	1	corresponding	correspond	VERB
bjos-8666337	5	2	author	author	NOUN
bjos-8666337	5	3	:	:	PUNCT
bjos-8666337	5	4	soheila	soheila	PROPN
bjos-8666337	5	5	manifar	manifar	PROPN
bjos-8666337	5	6	,	,	PUNCT
bjos-8666337	5	7	associate	associate	NOUN
bjos-8666337	5	8	professor	professor	NOUN
bjos-8666337	5	9	,	,	PUNCT
bjos-8666337	5	10	department	department	NOUN
bjos-8666337	5	11	of	of	ADP
bjos-8666337	5	12	oral	oral	ADJ
bjos-8666337	5	13	medicine	medicine	NOUN
bjos-8666337	5	14	,	,	PUNCT
bjos-8666337	5	15	imam	imam	PROPN
bjos-8666337	5	16	khomeini	khomeini	PROPN
bjos-8666337	5	17	hospital	hospital	PROPN
bjos-8666337	5	18	,	,	PUNCT
bjos-8666337	5	19	tehran	tehran	PROPN
bjos-8666337	5	20	university	university	PROPN
bjos-8666337	5	21	of	of	ADP
bjos-8666337	5	22	medical	medical	ADJ
bjos-8666337	5	23	science	science	NOUN
bjos-8666337	5	24	,	,	PUNCT
bjos-8666337	5	25	tehran	tehran	PROPN
bjos-8666337	5	26	,	,	PUNCT
bjos-8666337	5	27	iran	iran	PROPN
bjos-8666337	5	28	.	.	PUNCT
bjos-8666337	6	1	tel	tel	ADP
bjos-8666337	6	2	:	:	PUNCT
bjos-8666337	6	3	+98	+98	PROPN
bjos-8666337	6	4	-	-	PUNCT
bjos-8666337	6	5	2188351150	2188351150	NUM
bjos-8666337	6	6	,	,	PUNCT
bjos-8666337	6	7	+98	+98	NOUN
bjos-8666337	6	8	-	-	PUNCT
bjos-8666337	6	9	912	912	NUM
bjos-8666337	6	10	-	-	PUNCT
bjos-8666337	6	11	033	033	NUM
bjos-8666337	6	12	-	-	PUNCT
bjos-8666337	6	13	0580	0580	NUM
bjos-8666337	6	14	e	e	NOUN
bjos-8666337	6	15	-	-	NOUN
bjos-8666337	6	16	mail	mail	NOUN
bjos-8666337	6	17	:	:	PUNCT
bjos-8666337	6	18	 	 	SPACE
bjos-8666337	6	19	mariakoopaie@gmail.com	mariakoopaie@gmail.com	X
bjos-8666337	7	1	address	address	NOUN
bjos-8666337	7	2	:	:	PUNCT
bjos-8666337	7	3	north	north	NOUN
bjos-8666337	7	4	kargar	kargar	PROPN
bjos-8666337	7	5	st	st	PROPN
bjos-8666337	7	6	,	,	PUNCT
bjos-8666337	7	7	tehran	tehran	PROPN
bjos-8666337	7	8	,	,	PUNCT
bjos-8666337	7	9	iran	iran	PROPN
bjos-8666337	7	10	po	po	PROPN
bjos-8666337	7	11	.	.	PUNCT
bjos-8666337	7	12	code	code	PROPN
bjos-8666337	7	13	:	:	PUNCT
bjos-8666337	7	14	14399	14399	NUM
bjos-8666337	7	15	-	-	SYM
bjos-8666337	7	16	55991	55991	NUM
bjos-8666337	7	17	p.o.box:14395	p.o.box:14395	PROPN
bjos-8666337	7	18	-	-	PUNCT
bjos-8666337	7	19	433	433	NUM
bjos-8666337	7	20	.	.	PUNCT
bjos-8666337	8	1	editor	editor	NOUN
bjos-8666337	8	2	:	:	PUNCT
bjos-8666337	8	3	dr	dr	PROPN
bjos-8666337	8	4	.	.	PROPN
bjos-8666337	8	5	altair	altair	PROPN
bjos-8666337	8	6	a.	a.	PROPN
bjos-8666337	8	7	del	del	PROPN
bjos-8666337	8	8	bel	bel	PROPN
bjos-8666337	8	9	cury	cury	PROPN
bjos-8666337	8	10	received	receive	VERB
bjos-8666337	8	11	:	:	PUNCT
bjos-8666337	8	12	july	july	PROPN
bjos-8666337	8	13	10	10	NUM
bjos-8666337	8	14	,	,	PUNCT
bjos-8666337	8	15	2021	2021	NUM
bjos-8666337	8	16	accepted	accept	VERB
bjos-8666337	8	17	:	:	PUNCT
bjos-8666337	8	18	april	april	PROPN
bjos-8666337	8	19	2	2	NUM
bjos-8666337	8	20	,	,	PUNCT
bjos-8666337	8	21	2022	2022	NUM
bjos-8666337	8	22	lineage	lineage	NOUN
bjos-8666337	8	23	and	and	CCONJ
bjos-8666337	8	24	phylogenetic	phylogenetic	ADJ
bjos-8666337	8	25	analysis	analysis	NOUN
bjos-8666337	8	26	of	of	ADP
bjos-8666337	8	27	hpv-16	hpv-16	NUM
bjos-8666337	8	28	,	,	PUNCT
bjos-8666337	8	29	-18	-18	PUNCT
bjos-8666337	8	30	in	in	ADP
bjos-8666337	8	31	saliva	saliva	NOUN
bjos-8666337	8	32	of	of	ADP
bjos-8666337	8	33	hnscc	hnscc	NOUN
bjos-8666337	8	34	patients	patient	NOUN
bjos-8666337	8	35	maryam	maryam	PROPN
bjos-8666337	8	36	koopaie1	koopaie1	PROPN
bjos-8666337	8	37	,	,	PUNCT
bjos-8666337	8	38	mohamad	mohamad	PROPN
bjos-8666337	8	39	amin	amin	PROPN
bjos-8666337	8	40	nematollahi1	nematollahi1	PROPN
bjos-8666337	8	41	,	,	PUNCT
bjos-8666337	8	42	maryam	maryam	PROPN
bjos-8666337	8	43	dadar2	dadar2	PROPN
bjos-8666337	8	44	,	,	PUNCT
bjos-8666337	8	45	soheila	soheila	PROPN
bjos-8666337	8	46	manifar3	manifar3	PROPN
bjos-8666337	8	47	,	,	PUNCT
bjos-8666337	8	48	*	*	PUNCT
bjos-8666337	9	1	aim	aim	NOUN
bjos-8666337	9	2	:	:	PUNCT
bjos-8666337	9	3	head	head	NOUN
bjos-8666337	9	4	and	and	CCONJ
bjos-8666337	9	5	neck	neck	VERB
bjos-8666337	9	6	squamous	squamous	ADJ
bjos-8666337	9	7	cell	cell	NOUN
bjos-8666337	9	8	carcinoma	carcinoma	NOUN
bjos-8666337	9	9	(	(	PUNCT
bjos-8666337	9	10	hnscc	hnscc	NOUN
bjos-8666337	9	11	)	)	PUNCT
bjos-8666337	9	12	is	be	AUX
bjos-8666337	9	13	a	a	DET
bjos-8666337	9	14	global	global	ADJ
bjos-8666337	9	15	health	health	NOUN
bjos-8666337	9	16	problem	problem	NOUN
bjos-8666337	9	17	whose	whose	DET
bjos-8666337	9	18	incidence	incidence	NOUN
bjos-8666337	9	19	varies	vary	VERB
bjos-8666337	9	20	by	by	ADP
bjos-8666337	9	21	geographic	geographic	ADJ
bjos-8666337	9	22	region	region	NOUN
bjos-8666337	9	23	and	and	CCONJ
bjos-8666337	9	24	race	race	NOUN
bjos-8666337	9	25	according	accord	VERB
bjos-8666337	9	26	to	to	ADP
bjos-8666337	9	27	risk	risk	NOUN
bjos-8666337	9	28	factors	factor	NOUN
bjos-8666337	9	29	.	.	PUNCT
bjos-8666337	10	1	human	human	ADJ
bjos-8666337	10	2	papillomavirus	papillomavirus	NOUN
bjos-8666337	10	3	(	(	PUNCT
bjos-8666337	10	4	hpv	hpv	NOUN
bjos-8666337	10	5	)	)	PUNCT
bjos-8666337	10	6	infection	infection	NOUN
bjos-8666337	10	7	is	be	AUX
bjos-8666337	10	8	a	a	DET
bjos-8666337	10	9	significant	significant	ADJ
bjos-8666337	10	10	risk	risk	NOUN
bjos-8666337	10	11	factor	factor	NOUN
bjos-8666337	10	12	for	for	ADP
bjos-8666337	10	13	hnscc	hnscc	NOUN
bjos-8666337	10	14	.	.	PUNCT
bjos-8666337	11	1	hpv-16	hpv-16	NUM
bjos-8666337	11	2	and	and	CCONJ
bjos-8666337	11	3	hpv-18	hpv-18	NOUN
bjos-8666337	11	4	are	be	AUX
bjos-8666337	11	5	two	two	NUM
bjos-8666337	11	6	forms	form	NOUN
bjos-8666337	11	7	of	of	ADP
bjos-8666337	11	8	hpv	hpv	NOUN
bjos-8666337	11	9	that	that	PRON
bjos-8666337	11	10	are	be	AUX
bjos-8666337	11	11	carcinogenic	carcinogenic	ADJ
bjos-8666337	11	12	.	.	PUNCT
bjos-8666337	12	1	hnsccs	hnsccs	NOUN
bjos-8666337	12	2	that	that	PRON
bjos-8666337	12	3	are	be	AUX
bjos-8666337	12	4	hpv	hpv	ADJ
bjos-8666337	12	5	positive	positive	ADJ
bjos-8666337	12	6	have	have	VERB
bjos-8666337	12	7	a	a	DET
bjos-8666337	12	8	better	well	ADJ
bjos-8666337	12	9	prognosis	prognosis	NOUN
bjos-8666337	12	10	rather	rather	ADV
bjos-8666337	12	11	than	than	ADP
bjos-8666337	12	12	hpv	hpv	NOUN
bjos-8666337	12	13	negative	negative	ADJ
bjos-8666337	12	14	.	.	PUNCT
bjos-8666337	13	1	the	the	DET
bjos-8666337	13	2	purpose	purpose	NOUN
bjos-8666337	13	3	of	of	ADP
bjos-8666337	13	4	this	this	DET
bjos-8666337	13	5	research	research	NOUN
bjos-8666337	13	6	was	be	AUX
bjos-8666337	13	7	to	to	PART
bjos-8666337	13	8	characterize	characterize	VERB
bjos-8666337	13	9	hpv-16	hpv-16	PRON
bjos-8666337	13	10	,	,	PUNCT
bjos-8666337	13	11	-18	-18	PUNCT
bjos-8666337	13	12	variations	variation	NOUN
bjos-8666337	13	13	in	in	ADP
bjos-8666337	13	14	the	the	DET
bjos-8666337	13	15	saliva	saliva	NOUN
bjos-8666337	13	16	of	of	ADP
bjos-8666337	13	17	hnscc	hnscc	NOUN
bjos-8666337	13	18	patients	patient	NOUN
bjos-8666337	13	19	by	by	ADP
bjos-8666337	13	20	examining	examine	VERB
bjos-8666337	13	21	the	the	DET
bjos-8666337	13	22	genetic	genetic	ADJ
bjos-8666337	13	23	diversity	diversity	NOUN
bjos-8666337	13	24	of	of	ADP
bjos-8666337	13	25	hpv-16	hpv-16	PROPN
bjos-8666337	13	26	,	,	PUNCT
bjos-8666337	13	27	-18	-18	PUNCT
bjos-8666337	13	28	utilizing	utilize	VERB
bjos-8666337	13	29	the	the	DET
bjos-8666337	13	30	full	full	ADJ
bjos-8666337	13	31	e6	e6	NOUN
bjos-8666337	13	32	,	,	PUNCT
bjos-8666337	13	33	e7	e7	PROPN
bjos-8666337	13	34	,	,	PUNCT
bjos-8666337	13	35	and	and	CCONJ
bjos-8666337	13	36	l1	l1	PROPN
bjos-8666337	13	37	genes	gene	NOUN
bjos-8666337	13	38	.	.	PUNCT
bjos-8666337	14	1	methods	method	NOUN
bjos-8666337	14	2	:	:	PUNCT
bjos-8666337	14	3	the	the	DET
bjos-8666337	14	4	case	case	NOUN
bjos-8666337	14	5	-	-	PUNCT
bjos-8666337	14	6	control	control	NOUN
bjos-8666337	14	7	research	research	NOUN
bjos-8666337	14	8	included	include	VERB
bjos-8666337	14	9	15	15	NUM
bjos-8666337	14	10	patients	patient	NOUN
bjos-8666337	14	11	with	with	ADP
bjos-8666337	14	12	hnscc	hnscc	NOUN
bjos-8666337	14	13	and	and	CCONJ
bjos-8666337	14	14	15	15	NUM
bjos-8666337	14	15	healthy	healthy	ADJ
bjos-8666337	14	16	volunteers	volunteer	NOUN
bjos-8666337	14	17	.	.	PUNCT
bjos-8666337	15	1	unstimulated	unstimulated	ADJ
bjos-8666337	15	2	entire	entire	ADJ
bjos-8666337	15	3	saliva	saliva	NOUN
bjos-8666337	15	4	samples	sample	NOUN
bjos-8666337	15	5	were	be	AUX
bjos-8666337	15	6	obtained	obtain	VERB
bjos-8666337	15	7	from	from	ADP
bjos-8666337	15	8	the	the	DET
bjos-8666337	15	9	case	case	NOUN
bjos-8666337	15	10	and	and	CCONJ
bjos-8666337	15	11	control	control	NOUN
bjos-8666337	15	12	groups	group	NOUN
bjos-8666337	15	13	by	by	ADP
bjos-8666337	15	14	spitting	spit	VERB
bjos-8666337	15	15	method	method	NOUN
bjos-8666337	15	16	.	.	PUNCT
bjos-8666337	16	1	genomic	genomic	ADJ
bjos-8666337	16	2	dna	dna	PROPN
bjos-8666337	16	3	was	be	AUX
bjos-8666337	16	4	isolated	isolate	VERB
bjos-8666337	16	5	from	from	ADP
bjos-8666337	16	6	all	all	DET
bjos-8666337	16	7	saliva	saliva	NOUN
bjos-8666337	16	8	samples	sample	NOUN
bjos-8666337	16	9	.	.	PUNCT
bjos-8666337	17	1	a	a	DET
bjos-8666337	17	2	pcr	pcr	ADJ
bjos-8666337	17	3	reaction	reaction	NOUN
bjos-8666337	17	4	was	be	AUX
bjos-8666337	17	5	used	use	VERB
bjos-8666337	17	6	to	to	PART
bjos-8666337	17	7	determine	determine	VERB
bjos-8666337	17	8	the	the	DET
bjos-8666337	17	9	presence	presence	NOUN
bjos-8666337	17	10	of	of	ADP
bjos-8666337	17	11	hpv	hpv	NOUN
bjos-8666337	17	12	in	in	ADP
bjos-8666337	17	13	saliva	saliva	NOUN
bjos-8666337	17	14	.	.	PUNCT
bjos-8666337	18	1	hpv	hpv	ADJ
bjos-8666337	18	2	-	-	PUNCT
bjos-8666337	18	3	positive	positive	ADJ
bjos-8666337	18	4	samples	sample	NOUN
bjos-8666337	18	5	were	be	AUX
bjos-8666337	18	6	genotyped	genotype	VERB
bjos-8666337	18	7	and	and	CCONJ
bjos-8666337	18	8	data	datum	NOUN
bjos-8666337	18	9	were	be	AUX
bjos-8666337	18	10	analyzed	analyze	VERB
bjos-8666337	18	11	.	.	PUNCT
bjos-8666337	19	1	we	we	PRON
bjos-8666337	19	2	conducted	conduct	VERB
bjos-8666337	19	3	a	a	DET
bjos-8666337	19	4	variant	variant	ADJ
bjos-8666337	19	5	study	study	NOUN
bjos-8666337	19	6	on	on	ADP
bjos-8666337	19	7	the	the	DET
bjos-8666337	19	8	hpv-16	hpv-16	PROPN
bjos-8666337	19	9	,	,	PUNCT
bjos-8666337	19	10	-18	-18	SYM
bjos-8666337	19	11	e6	e6	NOUN
bjos-8666337	19	12	,	,	PUNCT
bjos-8666337	19	13	and	and	CCONJ
bjos-8666337	19	14	e7	e7	PROPN
bjos-8666337	19	15	genes	gene	NOUN
bjos-8666337	19	16	.	.	PUNCT
bjos-8666337	20	1	results	result	NOUN
bjos-8666337	20	2	:	:	PUNCT
bjos-8666337	20	3	three	three	NUM
bjos-8666337	20	4	patients	patient	NOUN
bjos-8666337	20	5	with	with	ADP
bjos-8666337	20	6	hnscc	hnscc	NOUN
bjos-8666337	20	7	were	be	AUX
bjos-8666337	20	8	hpvpositive	hpvpositive	ADJ
bjos-8666337	20	9	for	for	ADP
bjos-8666337	20	10	two	two	NUM
bjos-8666337	20	11	hpv	hpv	ADJ
bjos-8666337	20	12	genotypes	genotype	NOUN
bjos-8666337	20	13	out	out	ADP
bjos-8666337	20	14	of	of	ADP
bjos-8666337	20	15	30	30	NUM
bjos-8666337	20	16	people	people	NOUN
bjos-8666337	20	17	diagnosed	diagnose	VERB
bjos-8666337	20	18	with	with	ADP
bjos-8666337	20	19	hpv	hpv	PROPN
bjos-8666337	20	20	-	-	PUNCT
bjos-8666337	20	21	dna	dna	PROPN
bjos-8666337	20	22	.	.	PUNCT
bjos-8666337	21	1	hpv-16	hpv-16	NUM
bjos-8666337	21	2	and	and	CCONJ
bjos-8666337	21	3	-18	-18	NUM
bjos-8666337	21	4	were	be	AUX
bjos-8666337	21	5	the	the	DET
bjos-8666337	21	6	most	most	ADV
bjos-8666337	21	7	common	common	ADJ
bjos-8666337	21	8	genotypes	genotype	NOUN
bjos-8666337	21	9	.	.	PUNCT
bjos-8666337	22	1	the	the	DET
bjos-8666337	22	2	hpv-16	hpv-16	PROPN
bjos-8666337	22	3	,	,	PUNCT
bjos-8666337	22	4	-18	-18	SYM
bjos-8666337	22	5	e6	e6	NOUN
bjos-8666337	22	6	,	,	PUNCT
bjos-8666337	22	7	and	and	CCONJ
bjos-8666337	22	8	e7	e7	PROPN
bjos-8666337	22	9	genes	gene	NOUN
bjos-8666337	22	10	were	be	AUX
bjos-8666337	22	11	sequenced	sequence	VERB
bjos-8666337	22	12	and	and	CCONJ
bjos-8666337	22	13	compared	compare	VERB
bjos-8666337	22	14	to	to	ADP
bjos-8666337	22	15	the	the	DET
bjos-8666337	22	16	hpv-16	hpv-16	PROPN
bjos-8666337	22	17	,	,	PUNCT
bjos-8666337	22	18	-18	-18	PUNCT
bjos-8666337	22	19	(	(	PUNCT
bjos-8666337	22	20	e6	e6	PROPN
bjos-8666337	22	21	,	,	PUNCT
bjos-8666337	22	22	e7	e7	PROPN
bjos-8666337	22	23	)	)	PUNCT
bjos-8666337	22	24	prototype	prototype	NOUN
bjos-8666337	22	25	sequence	sequence	NOUN
bjos-8666337	22	26	.	.	PUNCT
bjos-8666337	23	1	in	in	ADP
bjos-8666337	23	2	all	all	PRON
bjos-8666337	23	3	,	,	PUNCT
bjos-8666337	23	4	hpv-16	hpv-16	NUM
bjos-8666337	23	5	lineages	lineage	NOUN
bjos-8666337	23	6	a1	a1	NOUN
bjos-8666337	23	7	and	and	CCONJ
bjos-8666337	23	8	hpv-18	hpv-18	NOUN
bjos-8666337	23	9	lineages	lineage	NOUN
bjos-8666337	23	10	a3	a3	NOUN
bjos-8666337	23	11	were	be	AUX
bjos-8666337	23	12	discovered	discover	VERB
bjos-8666337	23	13	.	.	PUNCT
bjos-8666337	24	1	conclusion	conclusion	NOUN
bjos-8666337	24	2	:	:	PUNCT
bjos-8666337	24	3	regarding	regard	VERB
bjos-8666337	24	4	the	the	DET
bjos-8666337	24	5	variation	variation	NOUN
bjos-8666337	24	6	of	of	ADP
bjos-8666337	24	7	hpv	hpv	NOUN
bjos-8666337	24	8	found	find	VERB
bjos-8666337	24	9	in	in	ADP
bjos-8666337	24	10	iranian	iranian	ADJ
bjos-8666337	24	11	hnscc	hnscc	NOUN
bjos-8666337	24	12	patients	patient	NOUN
bjos-8666337	24	13	,	,	PUNCT
bjos-8666337	24	14	the	the	DET
bjos-8666337	24	15	need	need	NOUN
bjos-8666337	24	16	for	for	ADP
bjos-8666337	24	17	further	further	ADJ
bjos-8666337	24	18	studies	study	NOUN
bjos-8666337	24	19	in	in	ADP
bjos-8666337	24	20	hpv	hpv	ADJ
bjos-8666337	24	21	genotyping	genotyping	NOUN
bjos-8666337	24	22	was	be	AUX
bjos-8666337	24	23	seen	see	VERB
bjos-8666337	24	24	.	.	PUNCT
bjos-8666337	25	1	sequencing	sequence	VERB
bjos-8666337	25	2	hpv	hpv	ADJ
bjos-8666337	25	3	genes	gene	NOUN
bjos-8666337	25	4	in	in	ADP
bjos-8666337	25	5	hnscc	hnscc	NOUN
bjos-8666337	25	6	may	may	AUX
bjos-8666337	25	7	help	help	VERB
bjos-8666337	25	8	answer	answer	VERB
bjos-8666337	25	9	questions	question	NOUN
bjos-8666337	25	10	about	about	ADP
bjos-8666337	25	11	hpv	hpv	NOUN
bjos-8666337	25	12	genotyping	genotyping	NOUN
bjos-8666337	25	13	in	in	ADP
bjos-8666337	25	14	the	the	DET
bjos-8666337	25	15	iranian	iranian	ADJ
bjos-8666337	25	16	population	population	NOUN
bjos-8666337	25	17	.	.	PUNCT
bjos-8666337	26	1	hpv	hpv	ADJ
bjos-8666337	26	2	genotype	genotype	NOUN
bjos-8666337	26	3	analysis	analysis	NOUN
bjos-8666337	26	4	aids	aid	NOUN
bjos-8666337	26	5	in	in	ADP
bjos-8666337	26	6	the	the	DET
bjos-8666337	26	7	development	development	NOUN
bjos-8666337	26	8	of	of	ADP
bjos-8666337	26	9	vaccinations	vaccination	NOUN
bjos-8666337	26	10	against	against	ADP
bjos-8666337	26	11	hnscc	hnscc	NOUN
bjos-8666337	26	12	,	,	PUNCT
bjos-8666337	26	13	halting	halting	ADJ
bjos-8666337	26	14	disease	disease	NOUN
bjos-8666337	26	15	progression	progression	NOUN
bjos-8666337	26	16	and	and	CCONJ
bjos-8666337	26	17	preventing	prevent	VERB
bjos-8666337	26	18	hpv	hpv	NOUN
bjos-8666337	26	19	-	-	PUNCT
bjos-8666337	26	20	associated	associate	VERB
bjos-8666337	26	21	hnscc	hnscc	NOUN
bjos-8666337	26	22	.	.	PUNCT
bjos-8666337	27	1	keywords	keyword	NOUN
bjos-8666337	27	2	:	:	PUNCT
bjos-8666337	27	3	squamous	squamous	ADJ
bjos-8666337	27	4	cell	cell	NOUN
bjos-8666337	27	5	carcinoma	carcinoma	NOUN
bjos-8666337	27	6	of	of	ADP
bjos-8666337	27	7	head	head	NOUN
bjos-8666337	27	8	and	and	CCONJ
bjos-8666337	27	9	neck	neck	NOUN
bjos-8666337	27	10	.	.	PUNCT
bjos-8666337	28	1	saliva	saliva	NOUN
bjos-8666337	28	2	.	.	PUNCT
bjos-8666337	29	1	alphapapillomavirus	alphapapillomavirus	PROPN
bjos-8666337	29	2	.	.	PUNCT
bjos-8666337	30	1	phylogeny	phylogeny	PROPN
bjos-8666337	30	2	.	.	PUNCT
bjos-8666337	31	1	https://orcid.org/0000-0002-9999-1443	https://orcid.org/0000-0002-9999-1443	PROPN
bjos-8666337	31	2	https://orcid.org/0000-0003-0605-781x	https://orcid.org/0000-0003-0605-781x	VERB
bjos-8666337	31	3	https://orcid.org/0000-0001-5831-801x	https://orcid.org/0000-0001-5831-801x	SYM
bjos-8666337	31	4	https://orcid.org/0000-0002-5898-3893	https://orcid.org/0000-0002-5898-3893	VERB
bjos-8666337	31	5	2	2	NUM
bjos-8666337	31	6	koopaie	koopaie	PROPN
bjos-8666337	31	7	et	et	PROPN
bjos-8666337	31	8	al	al	PROPN
bjos-8666337	31	9	.	.	PROPN
bjos-8666337	32	1	braz	braz	PROPN
bjos-8666337	32	2	j	j	PROPN
bjos-8666337	32	3	oral	oral	PROPN
bjos-8666337	32	4	sci	sci	PROPN
bjos-8666337	32	5	.	.	PUNCT
bjos-8666337	33	1	2022;21	2022;21	NUM
bjos-8666337	33	2	:	:	PUNCT
bjos-8666337	33	3	e226337	e226337	NOUN
bjos-8666337	33	4	introduction	introduction	NOUN
bjos-8666337	33	5	squamous	squamous	ADJ
bjos-8666337	33	6	cell	cell	NOUN
bjos-8666337	33	7	carcinoma	carcinoma	NOUN
bjos-8666337	33	8	(	(	PUNCT
bjos-8666337	33	9	scc	scc	NOUN
bjos-8666337	33	10	)	)	PUNCT
bjos-8666337	33	11	accounts	account	VERB
bjos-8666337	33	12	for	for	ADP
bjos-8666337	33	13	90	90	NUM
bjos-8666337	33	14	%	%	NOUN
bjos-8666337	33	15	of	of	ADP
bjos-8666337	33	16	oral	oral	ADJ
bjos-8666337	33	17	cavity	cavity	NOUN
bjos-8666337	33	18	cancers	cancer	NOUN
bjos-8666337	33	19	,	,	PUNCT
bjos-8666337	33	20	and	and	CCONJ
bjos-8666337	33	21	about	about	ADV
bjos-8666337	33	22	400000	400000	NUM
bjos-8666337	33	23	new	new	ADJ
bjos-8666337	33	24	instances	instance	NOUN
bjos-8666337	33	25	of	of	ADP
bjos-8666337	33	26	head	head	NOUN
bjos-8666337	33	27	and	and	CCONJ
bjos-8666337	33	28	neck	neck	VERB
bjos-8666337	33	29	squamous	squamous	ADJ
bjos-8666337	33	30	cell	cell	NOUN
bjos-8666337	33	31	carcinoma	carcinoma	NOUN
bjos-8666337	33	32	(	(	PUNCT
bjos-8666337	33	33	hnscc	hnscc	NOUN
bjos-8666337	33	34	)	)	PUNCT
bjos-8666337	33	35	are	be	AUX
bjos-8666337	33	36	diagnosed	diagnose	VERB
bjos-8666337	33	37	each	each	DET
bjos-8666337	33	38	year1	year1	NOUN
bjos-8666337	33	39	.	.	PUNCT
bjos-8666337	34	1	men	man	NOUN
bjos-8666337	34	2	are	be	AUX
bjos-8666337	34	3	1.5	1.5	NUM
bjos-8666337	34	4	times	time	NOUN
bjos-8666337	34	5	more	more	ADV
bjos-8666337	34	6	likely	likely	ADJ
bjos-8666337	34	7	than	than	SCONJ
bjos-8666337	34	8	women	woman	NOUN
bjos-8666337	34	9	to	to	PART
bjos-8666337	34	10	develop	develop	VERB
bjos-8666337	34	11	hnscc2	hnscc2	PROPN
bjos-8666337	34	12	.	.	PUNCT
bjos-8666337	35	1	the	the	DET
bjos-8666337	35	2	prevalence	prevalence	NOUN
bjos-8666337	35	3	of	of	ADP
bjos-8666337	35	4	hnscc	hnscc	NOUN
bjos-8666337	35	5	varies	vary	VERB
bjos-8666337	35	6	by	by	ADP
bjos-8666337	35	7	geographic	geographic	ADJ
bjos-8666337	35	8	region	region	NOUN
bjos-8666337	35	9	and	and	CCONJ
bjos-8666337	35	10	race	race	NOUN
bjos-8666337	35	11	due	due	ADP
bjos-8666337	35	12	to	to	ADP
bjos-8666337	35	13	risk	risk	NOUN
bjos-8666337	35	14	factor	factor	NOUN
bjos-8666337	35	15	differences3	differences3	X
bjos-8666337	35	16	.	.	PUNCT
bjos-8666337	36	1	the	the	DET
bjos-8666337	36	2	incidence	incidence	NOUN
bjos-8666337	36	3	of	of	ADP
bjos-8666337	36	4	hnscc	hnscc	NOUN
bjos-8666337	36	5	is	be	AUX
bjos-8666337	36	6	higher	high	ADJ
bjos-8666337	36	7	in	in	ADP
bjos-8666337	36	8	india	india	PROPN
bjos-8666337	36	9	,	,	PUNCT
bjos-8666337	36	10	pakistan	pakistan	PROPN
bjos-8666337	36	11	,	,	PUNCT
bjos-8666337	36	12	and	and	CCONJ
bjos-8666337	36	13	bangladesh	bangladesh	NOUN
bjos-8666337	36	14	in	in	ADP
bjos-8666337	36	15	the	the	DET
bjos-8666337	36	16	southern	southern	ADJ
bjos-8666337	36	17	part	part	NOUN
bjos-8666337	36	18	of	of	ADP
bjos-8666337	36	19	asia1,4	asia1,4	PROPN
bjos-8666337	36	20	.	.	PUNCT
bjos-8666337	37	1	it	it	PRON
bjos-8666337	37	2	may	may	AUX
bjos-8666337	37	3	appear	appear	VERB
bjos-8666337	37	4	on	on	ADP
bjos-8666337	37	5	the	the	DET
bjos-8666337	37	6	mucosa	mucosa	NOUN
bjos-8666337	37	7	as	as	ADP
bjos-8666337	37	8	a	a	DET
bjos-8666337	37	9	red	red	ADJ
bjos-8666337	37	10	,	,	PUNCT
bjos-8666337	37	11	white	white	ADJ
bjos-8666337	37	12	,	,	PUNCT
bjos-8666337	37	13	or	or	CCONJ
bjos-8666337	37	14	red	red	ADJ
bjos-8666337	37	15	-	-	PUNCT
bjos-8666337	37	16	white	white	ADJ
bjos-8666337	37	17	prominence	prominence	NOUN
bjos-8666337	37	18	.	.	PUNCT
bjos-8666337	38	1	it	it	PRON
bjos-8666337	38	2	may	may	AUX
bjos-8666337	38	3	also	also	ADV
bjos-8666337	38	4	be	be	AUX
bjos-8666337	38	5	portrayed	portray	VERB
bjos-8666337	38	6	as	as	ADP
bjos-8666337	38	7	a	a	DET
bjos-8666337	38	8	severe	severe	ADJ
bjos-8666337	38	9	wound	wound	NOUN
bjos-8666337	38	10	with	with	ADP
bjos-8666337	38	11	noticeable	noticeable	ADJ
bjos-8666337	38	12	edges	edge	NOUN
bjos-8666337	38	13	.	.	PUNCT
bjos-8666337	39	1	it	it	PRON
bjos-8666337	39	2	is	be	AUX
bjos-8666337	39	3	often	often	ADV
bjos-8666337	39	4	linked	link	VERB
bjos-8666337	39	5	to	to	PART
bjos-8666337	39	6	lymph	lymph	VERB
bjos-8666337	39	7	node	node	ADJ
bjos-8666337	39	8	swelling5	swelling5	NOUN
bjos-8666337	39	9	.	.	PUNCT
bjos-8666337	40	1	hnscc	hnscc	NOUN
bjos-8666337	40	2	is	be	AUX
bjos-8666337	40	3	a	a	DET
bjos-8666337	40	4	complex	complex	ADJ
bjos-8666337	40	5	illness	illness	NOUN
bjos-8666337	40	6	with	with	ADP
bjos-8666337	40	7	a	a	DET
bjos-8666337	40	8	variety	variety	NOUN
bjos-8666337	40	9	of	of	ADP
bjos-8666337	40	10	intrinsic	intrinsic	ADJ
bjos-8666337	40	11	and	and	CCONJ
bjos-8666337	40	12	extrinsic	extrinsic	ADJ
bjos-8666337	40	13	risk	risk	NOUN
bjos-8666337	40	14	factors	factor	NOUN
bjos-8666337	40	15	that	that	PRON
bjos-8666337	40	16	contribute	contribute	VERB
bjos-8666337	40	17	to	to	ADP
bjos-8666337	40	18	its	its	PRON
bjos-8666337	40	19	development	development	NOUN
bjos-8666337	40	20	.	.	PUNCT
bjos-8666337	41	1	tobacco	tobacco	NOUN
bjos-8666337	41	2	and	and	CCONJ
bjos-8666337	41	3	alcohol	alcohol	NOUN
bjos-8666337	41	4	usage	usage	NOUN
bjos-8666337	41	5	,	,	PUNCT
bjos-8666337	41	6	infections	infection	NOUN
bjos-8666337	41	7	,	,	PUNCT
bjos-8666337	41	8	and	and	CCONJ
bjos-8666337	41	9	dietary	dietary	ADJ
bjos-8666337	41	10	variables	variable	NOUN
bjos-8666337	41	11	are	be	AUX
bjos-8666337	41	12	examples	example	NOUN
bjos-8666337	41	13	of	of	ADP
bjos-8666337	41	14	extrinsic	extrinsic	ADJ
bjos-8666337	41	15	risk	risk	NOUN
bjos-8666337	41	16	factors	factor	NOUN
bjos-8666337	41	17	.	.	PUNCT
bjos-8666337	42	1	iron	iron	NOUN
bjos-8666337	42	2	deficiency	deficiency	NOUN
bjos-8666337	42	3	anemia	anemia	NOUN
bjos-8666337	42	4	and	and	CCONJ
bjos-8666337	42	5	alterations	alteration	NOUN
bjos-8666337	42	6	in	in	ADP
bjos-8666337	42	7	cell	cell	NOUN
bjos-8666337	42	8	cycle	cycle	NOUN
bjos-8666337	42	9	control	control	NOUN
bjos-8666337	42	10	genes	gene	NOUN
bjos-8666337	42	11	are	be	AUX
bjos-8666337	42	12	among	among	ADP
bjos-8666337	42	13	the	the	DET
bjos-8666337	42	14	inherent	inherent	ADJ
bjos-8666337	42	15	risk	risk	NOUN
bjos-8666337	42	16	factors	factor	NOUN
bjos-8666337	42	17	for	for	ADP
bjos-8666337	42	18	hnscc6,7	hnscc6,7	PROPN
bjos-8666337	42	19	.	.	PUNCT
bjos-8666337	43	1	in	in	ADP
bjos-8666337	43	2	contrast	contrast	NOUN
bjos-8666337	43	3	to	to	ADP
bjos-8666337	43	4	other	other	ADJ
bjos-8666337	43	5	viruses	virus	NOUN
bjos-8666337	43	6	,	,	PUNCT
bjos-8666337	43	7	human	human	ADJ
bjos-8666337	43	8	papillomavirus	papillomavirus	NOUN
bjos-8666337	43	9	(	(	PUNCT
bjos-8666337	43	10	hpv	hpv	NOUN
bjos-8666337	43	11	)	)	PUNCT
bjos-8666337	43	12	has	have	VERB
bjos-8666337	43	13	a	a	DET
bjos-8666337	43	14	significant	significant	ADJ
bjos-8666337	43	15	role	role	NOUN
bjos-8666337	43	16	in	in	ADP
bjos-8666337	43	17	hnscc	hnscc	NOUN
bjos-8666337	43	18	pathogenesis	pathogenesis	NOUN
bjos-8666337	43	19	among	among	ADP
bjos-8666337	43	20	extrinsic	extrinsic	ADJ
bjos-8666337	43	21	risk	risk	NOUN
bjos-8666337	43	22	factors8	factors8	NOUN
bjos-8666337	43	23	.	.	PUNCT
bjos-8666337	44	1	hpv	hpv	PROPN
bjos-8666337	44	2	is	be	AUX
bjos-8666337	44	3	a	a	DET
bjos-8666337	44	4	dna	dna	PROPN
bjos-8666337	44	5	virus	virus	NOUN
bjos-8666337	44	6	that	that	PRON
bjos-8666337	44	7	attacks	attack	VERB
bjos-8666337	44	8	the	the	DET
bjos-8666337	44	9	skin	skin	NOUN
bjos-8666337	44	10	and	and	CCONJ
bjos-8666337	44	11	mucous	mucous	ADJ
bjos-8666337	44	12	membranes	membrane	NOUN
bjos-8666337	44	13	.	.	PUNCT
bjos-8666337	45	1	there	there	PRON
bjos-8666337	45	2	are	be	VERB
bjos-8666337	45	3	about	about	ADV
bjos-8666337	45	4	30	30	NUM
bjos-8666337	45	5	different	different	ADJ
bjos-8666337	45	6	types	type	NOUN
bjos-8666337	45	7	of	of	ADP
bjos-8666337	45	8	hpv	hpv	NOUN
bjos-8666337	45	9	viruses	virus	NOUN
bjos-8666337	45	10	that	that	PRON
bjos-8666337	45	11	have	have	AUX
bjos-8666337	45	12	been	be	AUX
bjos-8666337	45	13	linked	link	VERB
bjos-8666337	45	14	to	to	ADP
bjos-8666337	45	15	benign	benign	ADJ
bjos-8666337	45	16	and	and	CCONJ
bjos-8666337	45	17	malignant	malignant	ADJ
bjos-8666337	45	18	epithelial	epithelial	ADJ
bjos-8666337	45	19	lesions9	lesions9	NOUN
bjos-8666337	45	20	.	.	PUNCT
bjos-8666337	46	1	furthermore	furthermore	ADV
bjos-8666337	46	2	,	,	PUNCT
bjos-8666337	46	3	high	high	ADJ
bjos-8666337	46	4	-	-	PUNCT
bjos-8666337	46	5	risk	risk	NOUN
bjos-8666337	46	6	hpv	hpv	NOUN
bjos-8666337	46	7	strains	strain	NOUN
bjos-8666337	46	8	such	such	ADJ
bjos-8666337	46	9	as	as	ADP
bjos-8666337	46	10	hpv-16	hpv-16	NUM
bjos-8666337	46	11	and	and	CCONJ
bjos-8666337	46	12	hpv-18	hpv-18	NOUN
bjos-8666337	46	13	are	be	AUX
bjos-8666337	46	14	thought	think	VERB
bjos-8666337	46	15	to	to	PART
bjos-8666337	46	16	be	be	AUX
bjos-8666337	46	17	etiologic	etiologic	ADJ
bjos-8666337	46	18	factors	factor	NOUN
bjos-8666337	46	19	for	for	ADP
bjos-8666337	46	20	hnscc10,11	hnscc10,11	NOUN
bjos-8666337	46	21	.	.	PUNCT
bjos-8666337	47	1	the	the	DET
bjos-8666337	47	2	presence	presence	NOUN
bjos-8666337	47	3	of	of	ADP
bjos-8666337	47	4	hpv-16	hpv-16	NUM
bjos-8666337	47	5	in	in	ADP
bjos-8666337	47	6	exfoliated	exfoliated	ADJ
bjos-8666337	47	7	oral	oral	ADJ
bjos-8666337	47	8	epithelial	epithelial	ADJ
bjos-8666337	47	9	cells	cell	NOUN
bjos-8666337	47	10	may	may	AUX
bjos-8666337	47	11	raise	raise	VERB
bjos-8666337	47	12	the	the	DET
bjos-8666337	47	13	risk	risk	NOUN
bjos-8666337	47	14	of	of	ADP
bjos-8666337	47	15	hnscc	hnscc	NOUN
bjos-8666337	47	16	and	and	CCONJ
bjos-8666337	47	17	oropharyngeal	oropharyngeal	NOUN
bjos-8666337	47	18	cancer	cancer	NOUN
bjos-8666337	47	19	by	by	ADP
bjos-8666337	47	20	4	4	NUM
bjos-8666337	47	21	and	and	CCONJ
bjos-8666337	47	22	14	14	NUM
bjos-8666337	47	23	times	time	NOUN
bjos-8666337	47	24	,	,	PUNCT
bjos-8666337	47	25	respectively12	respectively12	NOUN
bjos-8666337	47	26	.	.	PUNCT
bjos-8666337	48	1	according	accord	VERB
bjos-8666337	48	2	to	to	ADP
bjos-8666337	48	3	reports	report	NOUN
bjos-8666337	48	4	,	,	PUNCT
bjos-8666337	48	5	hpv16	hpv16	NOUN
bjos-8666337	48	6	is	be	AUX
bjos-8666337	48	7	the	the	DET
bjos-8666337	48	8	most	most	ADV
bjos-8666337	48	9	common	common	ADJ
bjos-8666337	48	10	kind	kind	NOUN
bjos-8666337	48	11	in	in	ADP
bjos-8666337	48	12	nearly	nearly	ADV
bjos-8666337	48	13	all	all	PRON
bjos-8666337	48	14	geographical	geographical	ADJ
bjos-8666337	48	15	areas	area	NOUN
bjos-8666337	48	16	of	of	ADP
bjos-8666337	48	17	iran	iran	PROPN
bjos-8666337	48	18	,	,	PUNCT
bjos-8666337	48	19	followed	follow	VERB
bjos-8666337	48	20	by	by	ADP
bjos-8666337	48	21	hpv-1813,14	hpv-1813,14	PROPN
bjos-8666337	48	22	.	.	PUNCT
bjos-8666337	49	1	hpv-16	hpv-16	PROPN
bjos-8666337	49	2	,	,	PUNCT
bjos-8666337	49	3	hpv-18	hpv-18	PROPN
bjos-8666337	49	4	,	,	PUNCT
bjos-8666337	49	5	hpv-11	hpv-11	NOUN
bjos-8666337	49	6	,	,	PUNCT
bjos-8666337	49	7	and	and	CCONJ
bjos-8666337	49	8	hpv-52	hpv-52	X
bjos-8666337	49	9	as	as	ADP
bjos-8666337	49	10	the	the	DET
bjos-8666337	49	11	most	most	ADV
bjos-8666337	49	12	frequently	frequently	ADV
bjos-8666337	49	13	identified	identify	VERB
bjos-8666337	49	14	hpv	hpv	ADJ
bjos-8666337	49	15	types	type	NOUN
bjos-8666337	49	16	in	in	ADP
bjos-8666337	49	17	iranian	iranian	ADJ
bjos-8666337	49	18	patients	patient	NOUN
bjos-8666337	49	19	with	with	ADP
bjos-8666337	49	20	hnscc12,15	hnscc12,15	PROPN
bjos-8666337	49	21	.	.	PUNCT
bjos-8666337	50	1	although	although	SCONJ
bjos-8666337	50	2	the	the	DET
bjos-8666337	50	3	data	datum	NOUN
bjos-8666337	50	4	on	on	ADP
bjos-8666337	50	5	hpv	hpv	ADJ
bjos-8666337	50	6	types	type	NOUN
bjos-8666337	50	7	in	in	ADP
bjos-8666337	50	8	iran	iran	PROPN
bjos-8666337	50	9	is	be	AUX
bjos-8666337	50	10	well	well	ADV
bjos-8666337	50	11	-	-	PUNCT
bjos-8666337	50	12	documented	document	VERB
bjos-8666337	50	13	,	,	PUNCT
bjos-8666337	50	14	there	there	PRON
bjos-8666337	50	15	is	be	VERB
bjos-8666337	50	16	little	little	ADJ
bjos-8666337	50	17	information	information	NOUN
bjos-8666337	50	18	on	on	ADP
bjos-8666337	50	19	hpv	hpv	ADJ
bjos-8666337	50	20	variations	variation	NOUN
bjos-8666337	50	21	in	in	ADP
bjos-8666337	50	22	hnscc	hnscc	NOUN
bjos-8666337	50	23	.	.	PUNCT
bjos-8666337	51	1	the	the	DET
bjos-8666337	51	2	current	current	ADJ
bjos-8666337	51	3	research	research	NOUN
bjos-8666337	51	4	sought	seek	VERB
bjos-8666337	51	5	to	to	PART
bjos-8666337	51	6	examine	examine	VERB
bjos-8666337	51	7	basic	basic	ADJ
bjos-8666337	51	8	data	datum	NOUN
bjos-8666337	51	9	of	of	ADP
bjos-8666337	51	10	hpv-16	hpv-16	NUM
bjos-8666337	51	11	and	and	CCONJ
bjos-8666337	51	12	hpv-18	hpv-18	NOUN
bjos-8666337	51	13	variants	variant	NOUN
bjos-8666337	51	14	in	in	ADP
bjos-8666337	51	15	iranian	iranian	ADJ
bjos-8666337	51	16	patients	patient	NOUN
bjos-8666337	51	17	with	with	ADP
bjos-8666337	51	18	hnscc	hnscc	NOUN
bjos-8666337	51	19	by	by	ADP
bjos-8666337	51	20	examining	examine	VERB
bjos-8666337	51	21	the	the	DET
bjos-8666337	51	22	genetic	genetic	ADJ
bjos-8666337	51	23	variability	variability	NOUN
bjos-8666337	51	24	of	of	ADP
bjos-8666337	51	25	hpv-16	hpv-16	PROPN
bjos-8666337	51	26	and	and	CCONJ
bjos-8666337	51	27	hpv-18	hpv-18	NOUN
bjos-8666337	51	28	utilizing	utilize	VERB
bjos-8666337	51	29	the	the	DET
bjos-8666337	51	30	whole	whole	ADJ
bjos-8666337	51	31	e6	e6	NOUN
bjos-8666337	51	32	,	,	PUNCT
bjos-8666337	51	33	e7	e7	PROPN
bjos-8666337	51	34	,	,	PUNCT
bjos-8666337	51	35	and	and	CCONJ
bjos-8666337	51	36	l	l	NOUN
bjos-8666337	51	37	genes	gene	NOUN
bjos-8666337	51	38	.	.	PUNCT
bjos-8666337	52	1	the	the	DET
bjos-8666337	52	2	findings	finding	NOUN
bjos-8666337	52	3	of	of	ADP
bjos-8666337	52	4	our	our	PRON
bjos-8666337	52	5	study	study	NOUN
bjos-8666337	52	6	might	might	AUX
bjos-8666337	52	7	provide	provide	VERB
bjos-8666337	52	8	justification	justification	NOUN
bjos-8666337	52	9	for	for	ADP
bjos-8666337	52	10	future	future	ADJ
bjos-8666337	52	11	research	research	NOUN
bjos-8666337	52	12	into	into	ADP
bjos-8666337	52	13	hpv	hpv	ADJ
bjos-8666337	52	14	genetic	genetic	ADJ
bjos-8666337	52	15	epidemiology	epidemiology	NOUN
bjos-8666337	52	16	,	,	PUNCT
bjos-8666337	52	17	pathogenicity	pathogenicity	NOUN
bjos-8666337	52	18	,	,	PUNCT
bjos-8666337	52	19	and	and	CCONJ
bjos-8666337	52	20	evolution	evolution	NOUN
bjos-8666337	52	21	.	.	PUNCT
bjos-8666337	53	1	material	material	NOUN
bjos-8666337	53	2	and	and	CCONJ
bjos-8666337	53	3	method	method	VERB
bjos-8666337	53	4	ethical	ethical	ADJ
bjos-8666337	53	5	statement	statement	NOUN
bjos-8666337	53	6	this	this	DET
bjos-8666337	53	7	study	study	NOUN
bjos-8666337	53	8	was	be	AUX
bjos-8666337	53	9	approved	approve	VERB
bjos-8666337	53	10	by	by	ADP
bjos-8666337	53	11	the	the	DET
bjos-8666337	53	12	tehran	tehran	PROPN
bjos-8666337	53	13	university	university	PROPN
bjos-8666337	53	14	of	of	ADP
bjos-8666337	53	15	medical	medical	PROPN
bjos-8666337	53	16	sciences	sciences	PROPN
bjos-8666337	53	17	ethical	ethical	PROPN
bjos-8666337	53	18	committee	committee	PROPN
bjos-8666337	53	19	(	(	PUNCT
bjos-8666337	53	20	ethical	ethical	PROPN
bjos-8666337	53	21	code	code	PROPN
bjos-8666337	53	22	ir.tums.dentistry.rec.1398.036	ir.tums.dentistry.rec.1398.036	NOUN
bjos-8666337	53	23	)	)	PUNCT
bjos-8666337	53	24	.	.	PUNCT
bjos-8666337	54	1	after	after	ADP
bjos-8666337	54	2	describing	describe	VERB
bjos-8666337	54	3	the	the	DET
bjos-8666337	54	4	study	study	NOUN
bjos-8666337	54	5	objectives	objective	NOUN
bjos-8666337	54	6	,	,	PUNCT
bjos-8666337	54	7	written	write	VERB
bjos-8666337	54	8	informed	informed	ADJ
bjos-8666337	54	9	consent	consent	NOUN
bjos-8666337	54	10	was	be	AUX
bjos-8666337	54	11	obtained	obtain	VERB
bjos-8666337	54	12	from	from	ADP
bjos-8666337	54	13	all	all	DET
bjos-8666337	54	14	case	case	NOUN
bjos-8666337	54	15	and	and	CCONJ
bjos-8666337	54	16	control	control	NOUN
bjos-8666337	54	17	group	group	NOUN
bjos-8666337	54	18	subjects	subject	NOUN
bjos-8666337	54	19	.	.	PUNCT
bjos-8666337	55	1	study	study	NOUN
bjos-8666337	55	2	population	population	NOUN
bjos-8666337	55	3	this	this	DET
bjos-8666337	55	4	case	case	NOUN
bjos-8666337	55	5	-	-	PUNCT
bjos-8666337	55	6	control	control	NOUN
bjos-8666337	55	7	study	study	NOUN
bjos-8666337	55	8	was	be	AUX
bjos-8666337	55	9	performed	perform	VERB
bjos-8666337	55	10	in	in	ADP
bjos-8666337	55	11	imam	imam	PROPN
bjos-8666337	55	12	khomeini	khomeini	PROPN
bjos-8666337	55	13	hospital	hospital	PROPN
bjos-8666337	55	14	,	,	PUNCT
bjos-8666337	55	15	tehran	tehran	PROPN
bjos-8666337	55	16	university	university	PROPN
bjos-8666337	55	17	of	of	ADP
bjos-8666337	55	18	medical	medical	PROPN
bjos-8666337	55	19	sciences	sciences	PROPN
bjos-8666337	55	20	(	(	PUNCT
bjos-8666337	55	21	tehran	tehran	NOUN
bjos-8666337	55	22	,	,	PUNCT
bjos-8666337	55	23	iran	iran	PROPN
bjos-8666337	55	24	)	)	PUNCT
bjos-8666337	55	25	.	.	PUNCT
bjos-8666337	56	1	15	15	NUM
bjos-8666337	56	2	hnscc	hnscc	NOUN
bjos-8666337	56	3	patients	patient	NOUN
bjos-8666337	56	4	and	and	CCONJ
bjos-8666337	56	5	15	15	NUM
bjos-8666337	56	6	healthy	healthy	ADJ
bjos-8666337	56	7	volunteers	volunteer	NOUN
bjos-8666337	56	8	as	as	SCONJ
bjos-8666337	56	9	the	the	DET
bjos-8666337	56	10	control	control	NOUN
bjos-8666337	56	11	group	group	NOUN
bjos-8666337	56	12	enrolled	enrol	VERB
bjos-8666337	56	13	in	in	ADP
bjos-8666337	56	14	the	the	DET
bjos-8666337	56	15	study	study	NOUN
bjos-8666337	56	16	.	.	PUNCT
bjos-8666337	57	1	hnscc	hnscc	NOUN
bjos-8666337	57	2	of	of	ADP
bjos-8666337	57	3	all	all	DET
bjos-8666337	57	4	patients	patient	NOUN
bjos-8666337	57	5	was	be	AUX
bjos-8666337	57	6	confirmed	confirm	VERB
bjos-8666337	57	7	with	with	ADP
bjos-8666337	57	8	the	the	DET
bjos-8666337	57	9	histopathologic	histopathologic	NOUN
bjos-8666337	57	10	examination	examination	NOUN
bjos-8666337	57	11	,	,	PUNCT
bjos-8666337	57	12	and	and	CCONJ
bjos-8666337	57	13	they	they	PRON
bjos-8666337	57	14	had	have	AUX
bjos-8666337	57	15	not	not	PART
bjos-8666337	57	16	undergone	undergo	VERB
bjos-8666337	57	17	surgery	surgery	NOUN
bjos-8666337	57	18	,	,	PUNCT
bjos-8666337	57	19	chemotherapy	chemotherapy	NOUN
bjos-8666337	57	20	,	,	PUNCT
bjos-8666337	57	21	and	and	CCONJ
bjos-8666337	57	22	radiotherapy	radiotherapy	NOUN
bjos-8666337	57	23	.	.	PUNCT
bjos-8666337	58	1	the	the	DET
bjos-8666337	58	2	study	study	NOUN
bjos-8666337	58	3	participants	participant	NOUN
bjos-8666337	58	4	were	be	AUX
bjos-8666337	58	5	not	not	PART
bjos-8666337	58	6	affected	affect	VERB
bjos-8666337	58	7	by	by	ADP
bjos-8666337	58	8	any	any	DET
bjos-8666337	58	9	3	3	NUM
bjos-8666337	58	10	koopaie	koopaie	PROPN
bjos-8666337	58	11	et	et	PROPN
bjos-8666337	58	12	al	al	PROPN
bjos-8666337	58	13	.	.	PROPN
bjos-8666337	58	14	braz	braz	PROPN
bjos-8666337	58	15	j	j	PROPN
bjos-8666337	58	16	oral	oral	PROPN
bjos-8666337	58	17	sci	sci	PROPN
bjos-8666337	58	18	.	.	PUNCT
bjos-8666337	59	1	2022;21	2022;21	NUM
bjos-8666337	59	2	:	:	PUNCT
bjos-8666337	59	3	e226337	e226337	VERB
bjos-8666337	59	4	other	other	ADJ
bjos-8666337	59	5	malignancy	malignancy	NOUN
bjos-8666337	59	6	or	or	CCONJ
bjos-8666337	59	7	systemic	systemic	ADJ
bjos-8666337	59	8	disease	disease	NOUN
bjos-8666337	59	9	.	.	PUNCT
bjos-8666337	60	1	in	in	ADP
bjos-8666337	60	2	the	the	DET
bjos-8666337	60	3	intraoral	intraoral	ADJ
bjos-8666337	60	4	examination	examination	NOUN
bjos-8666337	60	5	,	,	PUNCT
bjos-8666337	60	6	there	there	PRON
bjos-8666337	60	7	was	be	VERB
bjos-8666337	60	8	no	no	DET
bjos-8666337	60	9	active	active	ADJ
bjos-8666337	60	10	dental	dental	ADJ
bjos-8666337	60	11	and	and	CCONJ
bjos-8666337	60	12	periodontal	periodontal	ADJ
bjos-8666337	60	13	infection	infection	NOUN
bjos-8666337	60	14	.	.	PUNCT
bjos-8666337	61	1	the	the	DET
bjos-8666337	61	2	control	control	NOUN
bjos-8666337	61	3	group	group	NOUN
bjos-8666337	61	4	was	be	AUX
bjos-8666337	61	5	matched	match	VERB
bjos-8666337	61	6	with	with	ADP
bjos-8666337	61	7	the	the	DET
bjos-8666337	61	8	case	case	NOUN
bjos-8666337	61	9	group	group	NOUN
bjos-8666337	61	10	for	for	ADP
bjos-8666337	61	11	age	age	NOUN
bjos-8666337	61	12	,	,	PUNCT
bjos-8666337	61	13	sex	sex	NOUN
bjos-8666337	61	14	,	,	PUNCT
bjos-8666337	61	15	tobacco	tobacco	NOUN
bjos-8666337	61	16	,	,	PUNCT
bjos-8666337	61	17	and	and	CCONJ
bjos-8666337	61	18	alcohol	alcohol	NOUN
bjos-8666337	61	19	consumption	consumption	NOUN
bjos-8666337	61	20	.	.	PUNCT
bjos-8666337	62	1	unstimulated	unstimulated	ADJ
bjos-8666337	62	2	whole	whole	ADJ
bjos-8666337	62	3	saliva	saliva	NOUN
bjos-8666337	62	4	samples	sample	NOUN
bjos-8666337	62	5	were	be	AUX
bjos-8666337	62	6	collected	collect	VERB
bjos-8666337	62	7	from	from	ADP
bjos-8666337	62	8	the	the	DET
bjos-8666337	62	9	case	case	NOUN
bjos-8666337	62	10	and	and	CCONJ
bjos-8666337	62	11	control	control	NOUN
bjos-8666337	62	12	group	group	NOUN
bjos-8666337	62	13	using	use	VERB
bjos-8666337	62	14	the	the	DET
bjos-8666337	62	15	spitting	spit	VERB
bjos-8666337	62	16	method	method	NOUN
bjos-8666337	62	17	with	with	ADP
bjos-8666337	62	18	a	a	DET
bjos-8666337	62	19	minimum	minimum	NOUN
bjos-8666337	62	20	of	of	ADP
bjos-8666337	62	21	5	5	NUM
bjos-8666337	62	22	ml	ml	NOUN
bjos-8666337	62	23	saliva	saliva	NOUN
bjos-8666337	62	24	.	.	PUNCT
bjos-8666337	63	1	all	all	DET
bjos-8666337	63	2	participants	participant	NOUN
bjos-8666337	63	3	in	in	ADP
bjos-8666337	63	4	the	the	DET
bjos-8666337	63	5	case	case	NOUN
bjos-8666337	63	6	and	and	CCONJ
bjos-8666337	63	7	control	control	NOUN
bjos-8666337	63	8	group	group	NOUN
bjos-8666337	63	9	were	be	AUX
bjos-8666337	63	10	asked	ask	VERB
bjos-8666337	63	11	not	not	PART
bjos-8666337	63	12	to	to	PART
bjos-8666337	63	13	eat	eat	VERB
bjos-8666337	63	14	,	,	PUNCT
bjos-8666337	63	15	drink	drink	VERB
bjos-8666337	63	16	or	or	CCONJ
bjos-8666337	63	17	brush	brush	VERB
bjos-8666337	63	18	their	their	PRON
bjos-8666337	63	19	teeth	tooth	NOUN
bjos-8666337	63	20	,	,	PUNCT
bjos-8666337	63	21	smoke	smoke	VERB
bjos-8666337	63	22	at	at	ADP
bjos-8666337	63	23	least	least	ADV
bjos-8666337	63	24	one	one	NUM
bjos-8666337	63	25	hour	hour	NOUN
bjos-8666337	63	26	prior	prior	ADV
bjos-8666337	63	27	to	to	ADP
bjos-8666337	63	28	the	the	DET
bjos-8666337	63	29	trial	trial	NOUN
bjos-8666337	63	30	,	,	PUNCT
bjos-8666337	63	31	and	and	CCONJ
bjos-8666337	63	32	not	not	PART
bjos-8666337	63	33	consume	consume	VERB
bjos-8666337	63	34	any	any	DET
bjos-8666337	63	35	alcoholic	alcoholic	ADJ
bjos-8666337	63	36	beverages	beverage	NOUN
bjos-8666337	63	37	24	24	NUM
bjos-8666337	63	38	hours	hour	NOUN
bjos-8666337	63	39	prior	prior	ADV
bjos-8666337	63	40	to	to	ADP
bjos-8666337	63	41	collection1	collection1	PROPN
bjos-8666337	63	42	.	.	PUNCT
bjos-8666337	64	1	the	the	DET
bjos-8666337	64	2	authors	author	NOUN
bjos-8666337	64	3	confirm	confirm	VERB
bjos-8666337	64	4	that	that	SCONJ
bjos-8666337	64	5	all	all	DET
bjos-8666337	64	6	methods	method	NOUN
bjos-8666337	64	7	were	be	AUX
bjos-8666337	64	8	performed	perform	VERB
bjos-8666337	64	9	in	in	ADP
bjos-8666337	64	10	accordance	accordance	NOUN
bjos-8666337	64	11	with	with	ADP
bjos-8666337	64	12	the	the	DET
bjos-8666337	64	13	relevant	relevant	ADJ
bjos-8666337	64	14	guidelines	guideline	NOUN
bjos-8666337	64	15	and	and	CCONJ
bjos-8666337	64	16	regulations	regulation	NOUN
bjos-8666337	64	17	.	.	PUNCT
bjos-8666337	65	1	evaluation	evaluation	NOUN
bjos-8666337	65	2	of	of	ADP
bjos-8666337	65	3	the	the	DET
bjos-8666337	65	4	presence	presence	NOUN
bjos-8666337	65	5	of	of	ADP
bjos-8666337	65	6	hpv	hpv	NOUN
bjos-8666337	65	7	with	with	ADP
bjos-8666337	65	8	my09	my09	PROPN
bjos-8666337	65	9	/	/	SYM
bjos-8666337	65	10	11	11	NUM
bjos-8666337	65	11	primer	primer	NOUN
bjos-8666337	65	12	genomic	genomic	NOUN
bjos-8666337	65	13	dna	dna	PROPN
bjos-8666337	65	14	was	be	AUX
bjos-8666337	65	15	extracted	extract	VERB
bjos-8666337	65	16	from	from	ADP
bjos-8666337	65	17	saliva	saliva	NOUN
bjos-8666337	65	18	samples	sample	NOUN
bjos-8666337	65	19	of	of	ADP
bjos-8666337	65	20	the	the	DET
bjos-8666337	65	21	case	case	NOUN
bjos-8666337	65	22	(	(	PUNCT
bjos-8666337	65	23	hnscc	hnscc	NOUN
bjos-8666337	65	24	patients	patient	NOUN
bjos-8666337	65	25	)	)	PUNCT
bjos-8666337	65	26	and	and	CCONJ
bjos-8666337	65	27	control	control	NOUN
bjos-8666337	65	28	group	group	NOUN
bjos-8666337	65	29	using	use	VERB
bjos-8666337	65	30	the	the	DET
bjos-8666337	65	31	high	high	ADJ
bjos-8666337	65	32	pure	pure	ADJ
bjos-8666337	65	33	viral	viral	ADJ
bjos-8666337	65	34	nucleic	nucleic	ADJ
bjos-8666337	65	35	acid	acid	NOUN
bjos-8666337	65	36	kit	kit	NOUN
bjos-8666337	65	37	(	(	PUNCT
bjos-8666337	65	38	roche	roche	PROPN
bjos-8666337	65	39	diagnostics	diagnostic	NOUN
bjos-8666337	65	40	gmbh	gmbh	PROPN
bjos-8666337	65	41	,	,	PUNCT
bjos-8666337	65	42	roche	roche	PROPN
bjos-8666337	65	43	applied	apply	VERB
bjos-8666337	65	44	science	science	PROPN
bjos-8666337	65	45	,	,	PUNCT
bjos-8666337	65	46	mannheim	mannheim	PROPN
bjos-8666337	65	47	,	,	PUNCT
bjos-8666337	65	48	germany	germany	PROPN
bjos-8666337	65	49	)	)	PUNCT
bjos-8666337	65	50	as	as	SCONJ
bjos-8666337	65	51	directed	direct	VERB
bjos-8666337	65	52	by	by	ADP
bjos-8666337	65	53	the	the	DET
bjos-8666337	65	54	manufacturer	manufacturer	NOUN
bjos-8666337	65	55	.	.	PUNCT
bjos-8666337	66	1	the	the	DET
bjos-8666337	66	2	dna	dna	PROPN
bjos-8666337	66	3	concentration	concentration	NOUN
bjos-8666337	66	4	was	be	AUX
bjos-8666337	66	5	measured	measure	VERB
bjos-8666337	66	6	using	use	VERB
bjos-8666337	66	7	the	the	DET
bjos-8666337	66	8	nd-1000	nd-1000	PROPN
bjos-8666337	66	9	nanodrop	nanodrop	NOUN
bjos-8666337	66	10	at	at	ADP
bjos-8666337	66	11	260/280	260/280	PROPN
bjos-8666337	66	12	nm	nm	NOUN
bjos-8666337	66	13	.	.	PUNCT
bjos-8666337	67	1	furthermore	furthermore	ADV
bjos-8666337	67	2	,	,	PUNCT
bjos-8666337	67	3	the	the	DET
bjos-8666337	67	4	dna	dna	PROPN
bjos-8666337	67	5	integrity	integrity	NOUN
bjos-8666337	67	6	was	be	AUX
bjos-8666337	67	7	tested	test	VERB
bjos-8666337	67	8	using	use	VERB
bjos-8666337	67	9	a	a	DET
bjos-8666337	67	10	1.5	1.5	NUM
bjos-8666337	67	11	percent	percent	NOUN
bjos-8666337	67	12	agarose	agarose	NOUN
bjos-8666337	67	13	gel	gel	NOUN
bjos-8666337	67	14	and	and	CCONJ
bjos-8666337	67	15	kept	keep	VERB
bjos-8666337	67	16	at	at	ADP
bjos-8666337	67	17	20	20	NUM
bjos-8666337	67	18	°	°	ADP
bjos-8666337	67	19	c	c	NOUN
bjos-8666337	67	20	for	for	ADP
bjos-8666337	67	21	future	future	ADJ
bjos-8666337	67	22	study	study	NOUN
bjos-8666337	67	23	.	.	PUNCT
bjos-8666337	68	1	the	the	DET
bjos-8666337	68	2	presence	presence	NOUN
bjos-8666337	68	3	of	of	ADP
bjos-8666337	68	4	hpv	hpv	NOUN
bjos-8666337	68	5	in	in	ADP
bjos-8666337	68	6	the	the	DET
bjos-8666337	68	7	saliva	saliva	NOUN
bjos-8666337	68	8	was	be	AUX
bjos-8666337	68	9	determined	determine	VERB
bjos-8666337	68	10	using	use	VERB
bjos-8666337	68	11	the	the	DET
bjos-8666337	68	12	my09	my09	PROPN
bjos-8666337	68	13	/	/	SYM
bjos-8666337	68	14	my11	my11	PROPN
bjos-8666337	68	15	oligonucleotide	oligonucleotide	VERB
bjos-8666337	68	16	primers	primer	NOUN
bjos-8666337	68	17	5’-cgt	5’-cgt	NUM
bjos-8666337	68	18	ccm	ccm	NOUN
bjos-8666337	68	19	arr	arr	NOUN
bjos-8666337	68	20	gga	gga	PROPN
bjos-8666337	68	21	wac	wac	PROPN
bjos-8666337	68	22	tga	tga	PROPN
bjos-8666337	68	23	tc-3	tc-3	X
bjos-8666337	68	24	’	'	PUNCT
bjos-8666337	68	25	and	and	CCONJ
bjos-8666337	68	26	5’-cgt	5’-cgt	NUM
bjos-8666337	68	27	cag	cag	PROPN
bjos-8666337	68	28	ggw	ggw	PROPN
bjos-8666337	68	29	cat	cat	PROPN
bjos-8666337	68	30	aay	aay	PROPN
bjos-8666337	68	31	aat	aat	X
bjos-8666337	68	32	gg-3	gg-3	PRON
bjos-8666337	68	33	’	'	PUNCT
bjos-8666337	68	34	,	,	PUNCT
bjos-8666337	68	35	which	which	PRON
bjos-8666337	68	36	amplify	amplify	VERB
bjos-8666337	68	37	a	a	DET
bjos-8666337	68	38	region	region	NOUN
bjos-8666337	68	39	of	of	ADP
bjos-8666337	68	40	about	about	ADV
bjos-8666337	68	41	450	450	NUM
bjos-8666337	68	42	pb	pb	NOUN
bjos-8666337	68	43	in	in	ADP
bjos-8666337	68	44	the	the	DET
bjos-8666337	68	45	genome	genome	NOUN
bjos-8666337	68	46	of	of	ADP
bjos-8666337	68	47	most	most	ADJ
bjos-8666337	68	48	hvp	hvp	NOUN
bjos-8666337	68	49	types16	types16	NOUN
bjos-8666337	68	50	.	.	PUNCT
bjos-8666337	69	1	a	a	DET
bjos-8666337	69	2	25	25	NUM
bjos-8666337	69	3	l	l	NOUN
bjos-8666337	69	4	reaction	reaction	NOUN
bjos-8666337	69	5	mixture	mixture	NOUN
bjos-8666337	69	6	containing	contain	VERB
bjos-8666337	69	7	10	10	NUM
bjos-8666337	69	8	pmol	pmol	NOUN
bjos-8666337	69	9	of	of	ADP
bjos-8666337	69	10	each	each	DET
bjos-8666337	69	11	primer	primer	NOUN
bjos-8666337	69	12	,	,	PUNCT
bjos-8666337	69	13	50	50	NUM
bjos-8666337	69	14	m	m	NOUN
bjos-8666337	69	15	of	of	ADP
bjos-8666337	69	16	each	each	DET
bjos-8666337	69	17	dntp	dntp	NOUN
bjos-8666337	69	18	,	,	PUNCT
bjos-8666337	69	19	200	200	NUM
bjos-8666337	69	20	ng	ng	PROPN
bjos-8666337	69	21	of	of	ADP
bjos-8666337	69	22	dna	dna	PROPN
bjos-8666337	69	23	template	template	NOUN
bjos-8666337	69	24	,	,	PUNCT
bjos-8666337	69	25	2	2	NUM
bjos-8666337	69	26	u	u	NOUN
bjos-8666337	69	27	of	of	ADP
bjos-8666337	69	28	taq	taq	PROPN
bjos-8666337	69	29	dna	dna	PROPN
bjos-8666337	69	30	polymerase	polymerase	NOUN
bjos-8666337	69	31	,	,	PUNCT
bjos-8666337	69	32	20	20	NUM
bjos-8666337	69	33	mm	mm	NOUN
bjos-8666337	69	34	tris	tris	PROPN
bjos-8666337	69	35	-	-	PUNCT
bjos-8666337	69	36	hcl	hcl	NOUN
bjos-8666337	69	37	,	,	PUNCT
bjos-8666337	69	38	and	and	CCONJ
bjos-8666337	69	39	3	3	NUM
bjos-8666337	69	40	mm	mm	NOUN
bjos-8666337	69	41	mgcl2	mgcl2	PROPN
bjos-8666337	69	42	was	be	AUX
bjos-8666337	69	43	used	use	VERB
bjos-8666337	69	44	for	for	ADP
bjos-8666337	69	45	the	the	DET
bjos-8666337	69	46	pcr	pcr	ADJ
bjos-8666337	69	47	process	process	NOUN
bjos-8666337	69	48	.	.	PUNCT
bjos-8666337	70	1	the	the	DET
bjos-8666337	70	2	pcr	pcr	PROPN
bjos-8666337	70	3	was	be	AUX
bjos-8666337	70	4	started	start	VERB
bjos-8666337	70	5	with	with	ADP
bjos-8666337	70	6	a	a	DET
bjos-8666337	70	7	5	5	NUM
bjos-8666337	70	8	minute	minute	NOUN
bjos-8666337	70	9	denaturation	denaturation	NOUN
bjos-8666337	70	10	at	at	ADP
bjos-8666337	70	11	95	95	NUM
bjos-8666337	70	12	°	°	NOUN
bjos-8666337	70	13	c	c	NOUN
bjos-8666337	70	14	,	,	PUNCT
bjos-8666337	70	15	followed	follow	VERB
bjos-8666337	70	16	by	by	ADP
bjos-8666337	70	17	35	35	NUM
bjos-8666337	70	18	cycles	cycle	NOUN
bjos-8666337	70	19	of	of	ADP
bjos-8666337	70	20	denaturation	denaturation	NOUN
bjos-8666337	70	21	for	for	ADP
bjos-8666337	70	22	30	30	NUM
bjos-8666337	70	23	seconds	second	NOUN
bjos-8666337	70	24	at	at	ADP
bjos-8666337	70	25	95	95	NUM
bjos-8666337	70	26	°	°	NOUN
bjos-8666337	70	27	c	c	VERB
bjos-8666337	70	28	,	,	PUNCT
bjos-8666337	70	29	annealing	anneal	VERB
bjos-8666337	70	30	for	for	ADP
bjos-8666337	70	31	30	30	NUM
bjos-8666337	70	32	seconds	second	NOUN
bjos-8666337	70	33	at	at	ADP
bjos-8666337	70	34	55	55	NUM
bjos-8666337	70	35	°	°	NOUN
bjos-8666337	70	36	c	c	NOUN
bjos-8666337	70	37	,	,	PUNCT
bjos-8666337	70	38	and	and	CCONJ
bjos-8666337	70	39	extension	extension	NOUN
bjos-8666337	70	40	for	for	ADP
bjos-8666337	70	41	30	30	NUM
bjos-8666337	70	42	seconds	second	NOUN
bjos-8666337	70	43	at	at	ADP
bjos-8666337	70	44	72	72	NUM
bjos-8666337	70	45	°	°	NOUN
bjos-8666337	70	46	c	c	NOUN
bjos-8666337	70	47	,	,	PUNCT
bjos-8666337	70	48	with	with	ADP
bjos-8666337	70	49	a	a	DET
bjos-8666337	70	50	final	final	ADJ
bjos-8666337	70	51	extension	extension	NOUN
bjos-8666337	70	52	at	at	ADP
bjos-8666337	70	53	72	72	NUM
bjos-8666337	70	54	°	°	ADP
bjos-8666337	70	55	c	c	NOUN
bjos-8666337	70	56	for	for	ADP
bjos-8666337	70	57	7	7	NUM
bjos-8666337	70	58	minutes	minute	NOUN
bjos-8666337	70	59	.	.	PUNCT
bjos-8666337	71	1	a	a	DET
bjos-8666337	71	2	negative	negative	ADJ
bjos-8666337	71	3	pcr	pcr	ADJ
bjos-8666337	71	4	control	control	NOUN
bjos-8666337	71	5	,	,	PUNCT
bjos-8666337	71	6	consisting	consist	VERB
bjos-8666337	71	7	of	of	ADP
bjos-8666337	71	8	a	a	DET
bjos-8666337	71	9	reaction	reaction	NOUN
bjos-8666337	71	10	mixture	mixture	NOUN
bjos-8666337	71	11	devoid	devoid	ADJ
bjos-8666337	71	12	of	of	ADP
bjos-8666337	71	13	template	template	NOUN
bjos-8666337	71	14	dna	dna	NOUN
bjos-8666337	71	15	,	,	PUNCT
bjos-8666337	71	16	was	be	AUX
bjos-8666337	71	17	added	add	VERB
bjos-8666337	71	18	to	to	ADP
bjos-8666337	71	19	each	each	DET
bjos-8666337	71	20	pair	pair	NOUN
bjos-8666337	71	21	of	of	ADP
bjos-8666337	71	22	pcr	pcr	ADJ
bjos-8666337	71	23	reactions	reaction	NOUN
bjos-8666337	71	24	.	.	PUNCT
bjos-8666337	72	1	electrophoresis	electrophoresis	NOUN
bjos-8666337	72	2	on	on	ADP
bjos-8666337	72	3	a	a	DET
bjos-8666337	72	4	1	1	NUM
bjos-8666337	72	5	percent	percent	NOUN
bjos-8666337	72	6	agarose	agarose	NOUN
bjos-8666337	72	7	gel	gel	NOUN
bjos-8666337	72	8	was	be	AUX
bjos-8666337	72	9	used	use	VERB
bjos-8666337	72	10	to	to	PART
bjos-8666337	72	11	examine	examine	VERB
bjos-8666337	72	12	the	the	DET
bjos-8666337	72	13	pcr	pcr	ADJ
bjos-8666337	72	14	results	result	NOUN
bjos-8666337	72	15	.	.	PUNCT
bjos-8666337	73	1	variant	variant	ADJ
bjos-8666337	73	2	analysis	analysis	NOUN
bjos-8666337	73	3	of	of	ADP
bjos-8666337	73	4	hpv-16	hpv-16	NUM
bjos-8666337	73	5	e6	e6	PROPN
bjos-8666337	73	6	and	and	CCONJ
bjos-8666337	73	7	e7	e7	PROPN
bjos-8666337	73	8	genes	gene	NOUN
bjos-8666337	73	9	pcr	pcr	NOUN
bjos-8666337	73	10	was	be	AUX
bjos-8666337	73	11	used	use	VERB
bjos-8666337	73	12	to	to	PART
bjos-8666337	73	13	examine	examine	VERB
bjos-8666337	73	14	the	the	DET
bjos-8666337	73	15	hpv-16	hpv-16	NUM
bjos-8666337	73	16	e6	e6	PROPN
bjos-8666337	73	17	and	and	CCONJ
bjos-8666337	73	18	e7	e7	PROPN
bjos-8666337	73	19	genes	gene	NOUN
bjos-8666337	73	20	,	,	PUNCT
bjos-8666337	73	21	with	with	ADP
bjos-8666337	73	22	an	an	DET
bjos-8666337	73	23	amplicon	amplicon	NOUN
bjos-8666337	73	24	size	size	NOUN
bjos-8666337	73	25	of	of	ADP
bjos-8666337	73	26	762	762	NUM
bjos-8666337	73	27	bp	bp	NOUN
bjos-8666337	73	28	targeted	target	VERB
bjos-8666337	73	29	(	(	PUNCT
bjos-8666337	73	30	table	table	NOUN
bjos-8666337	73	31	1	1	NUM
bjos-8666337	73	32	)	)	PUNCT
bjos-8666337	73	33	.	.	PUNCT
bjos-8666337	74	1	a	a	DET
bjos-8666337	74	2	50	50	NUM
bjos-8666337	74	3	l	l	NOUN
bjos-8666337	74	4	reaction	reaction	NOUN
bjos-8666337	74	5	mixture	mixture	NOUN
bjos-8666337	74	6	containing	contain	VERB
bjos-8666337	74	7	10	10	NUM
bjos-8666337	74	8	pmol	pmol	NOUN
bjos-8666337	74	9	of	of	ADP
bjos-8666337	74	10	each	each	DET
bjos-8666337	74	11	primer	primer	NOUN
bjos-8666337	74	12	,	,	PUNCT
bjos-8666337	74	13	50	50	NUM
bjos-8666337	74	14	m	m	NOUN
bjos-8666337	74	15	of	of	ADP
bjos-8666337	74	16	each	each	DET
bjos-8666337	74	17	dntp	dntp	NOUN
bjos-8666337	74	18	,	,	PUNCT
bjos-8666337	74	19	200	200	NUM
bjos-8666337	74	20	ng	ng	PROPN
bjos-8666337	74	21	of	of	ADP
bjos-8666337	74	22	dna	dna	PROPN
bjos-8666337	74	23	template	template	NOUN
bjos-8666337	74	24	,	,	PUNCT
bjos-8666337	74	25	2	2	NUM
bjos-8666337	74	26	u	u	NOUN
bjos-8666337	74	27	of	of	ADP
bjos-8666337	74	28	taq	taq	PROPN
bjos-8666337	74	29	dna	dna	PROPN
bjos-8666337	74	30	polymerase	polymerase	NOUN
bjos-8666337	74	31	,	,	PUNCT
bjos-8666337	74	32	20	20	NUM
bjos-8666337	74	33	mm	mm	NOUN
bjos-8666337	74	34	tris	tris	PROPN
bjos-8666337	74	35	-	-	PUNCT
bjos-8666337	74	36	hcl	hcl	NOUN
bjos-8666337	74	37	,	,	PUNCT
bjos-8666337	74	38	and	and	CCONJ
bjos-8666337	74	39	3	3	NUM
bjos-8666337	74	40	mm	mm	NOUN
bjos-8666337	74	41	mgcl2	mgcl2	PROPN
bjos-8666337	74	42	was	be	AUX
bjos-8666337	74	43	used	use	VERB
bjos-8666337	74	44	for	for	ADP
bjos-8666337	74	45	the	the	DET
bjos-8666337	74	46	pcr	pcr	ADJ
bjos-8666337	74	47	process	process	NOUN
bjos-8666337	74	48	.	.	PUNCT
bjos-8666337	75	1	an	an	DET
bjos-8666337	75	2	initial	initial	ADJ
bjos-8666337	75	3	denaturation	denaturation	NOUN
bjos-8666337	75	4	of	of	ADP
bjos-8666337	75	5	5	5	NUM
bjos-8666337	75	6	minutes	minute	NOUN
bjos-8666337	75	7	at	at	ADP
bjos-8666337	75	8	95	95	NUM
bjos-8666337	75	9	°	°	NUM
bjos-8666337	75	10	c	c	NOUN
bjos-8666337	75	11	was	be	AUX
bjos-8666337	75	12	followed	follow	VERB
bjos-8666337	75	13	by	by	ADP
bjos-8666337	75	14	40	40	NUM
bjos-8666337	75	15	cycles	cycle	NOUN
bjos-8666337	75	16	of	of	ADP
bjos-8666337	75	17	denaturation	denaturation	NOUN
bjos-8666337	75	18	at	at	ADP
bjos-8666337	75	19	95	95	NUM
bjos-8666337	75	20	°	°	ADP
bjos-8666337	75	21	c	c	NOUN
bjos-8666337	75	22	for	for	ADP
bjos-8666337	75	23	30	30	NUM
bjos-8666337	75	24	seconds	second	NOUN
bjos-8666337	75	25	,	,	PUNCT
bjos-8666337	75	26	annealing	anneal	VERB
bjos-8666337	75	27	at	at	ADP
bjos-8666337	75	28	55	55	NUM
bjos-8666337	75	29	°	°	ADP
bjos-8666337	75	30	c	c	NOUN
bjos-8666337	75	31	for	for	ADP
bjos-8666337	75	32	50	50	NUM
bjos-8666337	75	33	seconds	second	NOUN
bjos-8666337	75	34	,	,	PUNCT
bjos-8666337	75	35	extension	extension	NOUN
bjos-8666337	75	36	at	at	ADP
bjos-8666337	75	37	72	72	NUM
bjos-8666337	75	38	°	°	ADP
bjos-8666337	75	39	c	c	NOUN
bjos-8666337	75	40	for	for	ADP
bjos-8666337	75	41	50	50	NUM
bjos-8666337	75	42	seconds	second	NOUN
bjos-8666337	75	43	,	,	PUNCT
bjos-8666337	75	44	and	and	CCONJ
bjos-8666337	75	45	final	final	ADJ
bjos-8666337	75	46	elongation	elongation	NOUN
bjos-8666337	75	47	at	at	ADP
bjos-8666337	75	48	72	72	NUM
bjos-8666337	75	49	°	°	ADP
bjos-8666337	75	50	c	c	NOUN
bjos-8666337	75	51	for	for	ADP
bjos-8666337	75	52	10	10	NUM
bjos-8666337	75	53	minutes	minute	NOUN
bjos-8666337	75	54	.	.	PUNCT
bjos-8666337	76	1	a	a	DET
bjos-8666337	76	2	negative	negative	ADJ
bjos-8666337	76	3	control	control	NOUN
bjos-8666337	76	4	,	,	PUNCT
bjos-8666337	76	5	consisting	consist	VERB
bjos-8666337	76	6	of	of	ADP
bjos-8666337	76	7	a	a	DET
bjos-8666337	76	8	reaction	reaction	NOUN
bjos-8666337	76	9	mixture	mixture	NOUN
bjos-8666337	76	10	devoid	devoid	ADJ
bjos-8666337	76	11	of	of	ADP
bjos-8666337	76	12	template	template	NOUN
bjos-8666337	76	13	dna	dna	NOUN
bjos-8666337	76	14	,	,	PUNCT
bjos-8666337	76	15	was	be	AUX
bjos-8666337	76	16	added	add	VERB
bjos-8666337	76	17	to	to	ADP
bjos-8666337	76	18	each	each	DET
bjos-8666337	76	19	pair	pair	NOUN
bjos-8666337	76	20	of	of	ADP
bjos-8666337	76	21	pcr	pcr	ADJ
bjos-8666337	76	22	reactions	reaction	NOUN
bjos-8666337	76	23	.	.	PUNCT
bjos-8666337	77	1	electrophoresis	electrophoresis	NOUN
bjos-8666337	77	2	on	on	ADP
bjos-8666337	77	3	a	a	DET
bjos-8666337	77	4	1	1	NUM
bjos-8666337	77	5	percent	percent	NOUN
bjos-8666337	77	6	agarose	agarose	NOUN
bjos-8666337	77	7	gel	gel	NOUN
bjos-8666337	77	8	was	be	AUX
bjos-8666337	77	9	used	use	VERB
bjos-8666337	77	10	to	to	PART
bjos-8666337	77	11	examine	examine	VERB
bjos-8666337	77	12	the	the	DET
bjos-8666337	77	13	pcr	pcr	ADJ
bjos-8666337	77	14	results	result	NOUN
bjos-8666337	77	15	.	.	PUNCT
bjos-8666337	78	1	variant	variant	ADJ
bjos-8666337	78	2	analysis	analysis	NOUN
bjos-8666337	78	3	of	of	ADP
bjos-8666337	78	4	hpv-16	hpv-16	PROPN
bjos-8666337	78	5	l1	l1	PROPN
bjos-8666337	78	6	gene	gene	PROPN
bjos-8666337	78	7	hpv-16	hpv-16	PROPN
bjos-8666337	78	8	l1	l1	PROPN
bjos-8666337	78	9	gene	gene	NOUN
bjos-8666337	78	10	was	be	AUX
bjos-8666337	78	11	analyzed	analyze	VERB
bjos-8666337	78	12	by	by	ADP
bjos-8666337	78	13	pcr	pcr	PROPN
bjos-8666337	78	14	(	(	PUNCT
bjos-8666337	78	15	table	table	NOUN
bjos-8666337	78	16	1	1	NUM
bjos-8666337	78	17	)	)	PUNCT
bjos-8666337	78	18	,	,	PUNCT
bjos-8666337	78	19	targeting	target	VERB
bjos-8666337	78	20	an	an	DET
bjos-8666337	78	21	amplicon	amplicon	NOUN
bjos-8666337	78	22	size	size	NOUN
bjos-8666337	78	23	of	of	ADP
bjos-8666337	78	24	7932	7932	NUM
bjos-8666337	78	25	bp	bp	PROPN
bjos-8666337	78	26	.	.	PROPN
bjos-8666337	79	1	4	4	NUM
bjos-8666337	79	2	koopaie	koopaie	PROPN
bjos-8666337	79	3	et	et	PROPN
bjos-8666337	79	4	al	al	PROPN
bjos-8666337	79	5	.	.	PROPN
bjos-8666337	79	6	braz	braz	PROPN
bjos-8666337	79	7	j	j	PROPN
bjos-8666337	79	8	oral	oral	PROPN
bjos-8666337	79	9	sci	sci	PROPN
bjos-8666337	79	10	.	.	PUNCT
bjos-8666337	80	1	2022;21	2022;21	NUM
bjos-8666337	80	2	:	:	PUNCT
bjos-8666337	80	3	e226337	e226337	NOUN
bjos-8666337	80	4	table	table	NOUN
bjos-8666337	80	5	1	1	NUM
bjos-8666337	80	6	.	.	PUNCT
bjos-8666337	81	1	primers	primer	NOUN
bjos-8666337	81	2	for	for	ADP
bjos-8666337	81	3	pcr	pcr	ADJ
bjos-8666337	81	4	analyzing	analyzing	NOUN
bjos-8666337	81	5	of	of	ADP
bjos-8666337	81	6	hpv-16	hpv-16	NUM
bjos-8666337	81	7	e6	e6	NOUN
bjos-8666337	81	8	,	,	PUNCT
bjos-8666337	81	9	e7	e7	PROPN
bjos-8666337	81	10	and	and	CCONJ
bjos-8666337	81	11	l1	l1	PROPN
bjos-8666337	81	12	and	and	CCONJ
bjos-8666337	81	13	hpv-18	hpv-18	NUM
bjos-8666337	81	14	e6	e6	NOUN
bjos-8666337	81	15	,	,	PUNCT
bjos-8666337	81	16	e7	e7	PROPN
bjos-8666337	81	17	and	and	CCONJ
bjos-8666337	81	18	l1	l1	PROPN
bjos-8666337	81	19	primer	primer	NOUN
bjos-8666337	81	20	sequences	sequence	NOUN
bjos-8666337	81	21	genes	gene	NOUN
bjos-8666337	81	22	5’-cga	5’-cga	NUM
bjos-8666337	81	23	aac	aac	NOUN
bjos-8666337	81	24	cgg	cgg	NOUN
bjos-8666337	81	25	tta	tta	PROPN
bjos-8666337	81	26	gta	gta	PROPN
bjos-8666337	81	27	taa	taa	PROPN
bjos-8666337	81	28	aag	aag	PROPN
bjos-8666337	81	29	cag	cag	PROPN
bjos-8666337	81	30	ac-3	ac-3	PROPN
bjos-8666337	81	31	’	'	PUNCT
bjos-8666337	82	1	hpv-16	hpv-16	PROPN
bjos-8666337	82	2	e6	e6	PROPN
bjos-8666337	82	3	5’-tag	5’-tag	NUM
bjos-8666337	82	4	att	att	PROPN
bjos-8666337	82	5	atg	atg	PROPN
bjos-8666337	82	6	gtt	gtt	PROPN
bjos-8666337	82	7	tct	tct	PROPN
bjos-8666337	82	8	gag	gag	PROPN
bjos-8666337	82	9	aac	aac	PROPN
bjos-8666337	82	10	a-3	a-3	PROPN
bjos-8666337	82	11	’	'	PUNCT
bjos-8666337	82	12	hpv-16	hpv-16	PROPN
bjos-8666337	82	13	e7	e7	PROPN
bjos-8666337	82	14	5’-atg	5’-atg	NUM
bjos-8666337	82	15	tgc	tgc	NOUN
bjos-8666337	82	16	ctg	ctg	NOUN
bjos-8666337	82	17	tat	tat	NOUN
bjos-8666337	82	18	aca	aca	PROPN
bjos-8666337	82	19	cgg	cgg	PROPN
bjos-8666337	82	20	gtc-3	gtc-3	NOUN
bjos-8666337	82	21	’	'	PUNCT
bjos-8666337	82	22	hpv-16	hpv-16	PROPN
bjos-8666337	82	23	l1	l1	PROPN
bjos-8666337	82	24	,	,	PUNCT
bjos-8666337	82	25	forward	forward	ADV
bjos-8666337	82	26	5’-tta	5’-tta	NUM
bjos-8666337	82	27	ctt	ctt	PROPN
bjos-8666337	82	28	cct	cct	PROPN
bjos-8666337	82	29	ggc	ggc	PROPN
bjos-8666337	82	30	acg	acg	PROPN
bjos-8666337	82	31	tac	tac	PROPN
bjos-8666337	82	32	acg	acg	PROPN
bjos-8666337	82	33	c	c	PROPN
bjos-8666337	82	34	hpv-16	hpv-16	PROPN
bjos-8666337	82	35	l1	l1	PROPN
bjos-8666337	82	36	,	,	PUNCT
bjos-8666337	82	37	reverse	reverse	VERB
bjos-8666337	82	38	5’-atg	5’-atg	NUM
bjos-8666337	82	39	gcg	gcg	NOUN
bjos-8666337	82	40	cgc	cgc	PROPN
bjos-8666337	82	41	ttt	ttt	PROPN
bjos-8666337	82	42	gag	gag	PROPN
bjos-8666337	82	43	gat	gat	PROPN
bjos-8666337	82	44	cc	cc	PROPN
bjos-8666337	82	45	-3	-3	PUNCT
bjos-8666337	82	46	’	'	PUNCT
bjos-8666337	82	47	hpv-18	hpv-18	NUM
bjos-8666337	82	48	e6	e6	PROPN
bjos-8666337	82	49	5’tta	5’tta	NUM
bjos-8666337	82	50	ctg	ctg	NOUN
bjos-8666337	82	51	ctg	ctg	NOUN
bjos-8666337	82	52	gga	gga	PROPN
bjos-8666337	82	53	tgc	tgc	PROPN
bjos-8666337	82	54	aca	aca	PROPN
bjos-8666337	82	55	cc	cc	PROPN
bjos-8666337	82	56	-3	-3	PUNCT
bjos-8666337	82	57	’	'	PUNCT
bjos-8666337	82	58	hpv-18	hpv-18	NUM
bjos-8666337	82	59	e7	e7	PROPN
bjos-8666337	82	60	5’atg	5’atg	NUM
bjos-8666337	82	61	tgc	tgc	NOUN
bjos-8666337	82	62	ctg	ctg	NOUN
bjos-8666337	82	63	tat	tat	NOUN
bjos-8666337	82	64	aca	aca	PROPN
bjos-8666337	82	65	cgg	cgg	PROPN
bjos-8666337	82	66	gtc	gtc	PROPN
bjos-8666337	82	67	-3	-3	PUNCT
bjos-8666337	82	68	’	'	PUNCT
bjos-8666337	82	69	hpv-18	hpv-18	NUM
bjos-8666337	82	70	l1	l1	PROPN
bjos-8666337	82	71	,	,	PUNCT
bjos-8666337	82	72	forward	forward	ADV
bjos-8666337	82	73	5’tta	5’tta	NUM
bjos-8666337	82	74	ctt	ctt	PROPN
bjos-8666337	82	75	cct	cct	PROPN
bjos-8666337	82	76	ggc	ggc	PROPN
bjos-8666337	82	77	acg	acg	PROPN
bjos-8666337	82	78	tac	tac	PROPN
bjos-8666337	82	79	acg	acg	PROPN
bjos-8666337	82	80	c	c	PROPN
bjos-8666337	82	81	-3	-3	PUNCT
bjos-8666337	82	82	’	'	PUNCT
bjos-8666337	82	83	hpv-18	hpv-18	NUM
bjos-8666337	82	84	l1	l1	PROPN
bjos-8666337	82	85	,	,	PUNCT
bjos-8666337	82	86	reverse	reverse	VERB
bjos-8666337	82	87	pcr	pcr	ADJ
bjos-8666337	82	88	reaction	reaction	NOUN
bjos-8666337	82	89	method	method	NOUN
bjos-8666337	82	90	is	be	AUX
bjos-8666337	82	91	similar	similar	ADJ
bjos-8666337	82	92	to	to	ADP
bjos-8666337	82	93	that	that	PRON
bjos-8666337	82	94	described	describe	VERB
bjos-8666337	82	95	for	for	ADP
bjos-8666337	82	96	hpv-16	hpv-16	NUM
bjos-8666337	82	97	e6	e6	PROPN
bjos-8666337	82	98	and	and	CCONJ
bjos-8666337	82	99	e7	e7	PROPN
bjos-8666337	82	100	genes	gene	NOUN
bjos-8666337	82	101	,	,	PUNCT
bjos-8666337	82	102	and	and	CCONJ
bjos-8666337	82	103	the	the	DET
bjos-8666337	82	104	schematic	schematic	ADJ
bjos-8666337	82	105	of	of	ADP
bjos-8666337	82	106	hpv-16	hpv-16	NUM
bjos-8666337	82	107	e6	e6	NOUN
bjos-8666337	82	108	primers	primer	NOUN
bjos-8666337	82	109	design	design	NOUN
bjos-8666337	82	110	is	be	AUX
bjos-8666337	82	111	depicted	depict	VERB
bjos-8666337	82	112	in	in	ADP
bjos-8666337	82	113	figure	figure	NOUN
bjos-8666337	82	114	1	1	NUM
bjos-8666337	82	115	.	.	PUNCT
bjos-8666337	83	1	figure	figure	NOUN
bjos-8666337	83	2	1	1	NUM
bjos-8666337	83	3	.	.	PUNCT
bjos-8666337	84	1	schematic	schematic	ADJ
bjos-8666337	84	2	primers	primer	NOUN
bjos-8666337	84	3	design	design	VERB
bjos-8666337	84	4	for	for	ADP
bjos-8666337	84	5	pcr	pcr	ADJ
bjos-8666337	84	6	analyzing	analyzing	NOUN
bjos-8666337	84	7	of	of	ADP
bjos-8666337	84	8	hpv-16	hpv-16	NUM
bjos-8666337	84	9	e6	e6	NOUN
bjos-8666337	84	10	.	.	PUNCT
bjos-8666337	85	1	variant	variant	ADJ
bjos-8666337	85	2	analysis	analysis	NOUN
bjos-8666337	85	3	of	of	ADP
bjos-8666337	85	4	hpv-18	hpv-18	NOUN
bjos-8666337	85	5	e6	e6	NOUN
bjos-8666337	85	6	and	and	CCONJ
bjos-8666337	85	7	e7	e7	PROPN
bjos-8666337	85	8	genes	gene	VERB
bjos-8666337	85	9	the	the	DET
bjos-8666337	85	10	hpv-18	hpv-18	NUM
bjos-8666337	85	11	e6	e6	NOUN
bjos-8666337	85	12	and	and	CCONJ
bjos-8666337	85	13	e7	e7	PROPN
bjos-8666337	85	14	genes	gene	NOUN
bjos-8666337	85	15	were	be	AUX
bjos-8666337	85	16	amplified	amplify	VERB
bjos-8666337	85	17	using	use	VERB
bjos-8666337	85	18	polymerase	polymerase	NOUN
bjos-8666337	85	19	chain	chain	NOUN
bjos-8666337	85	20	reaction	reaction	NOUN
bjos-8666337	85	21	(	(	PUNCT
bjos-8666337	85	22	pcr	pcr	PROPN
bjos-8666337	85	23	)	)	PUNCT
bjos-8666337	85	24	with	with	ADP
bjos-8666337	85	25	an	an	DET
bjos-8666337	85	26	amplicon	amplicon	NOUN
bjos-8666337	85	27	size	size	NOUN
bjos-8666337	85	28	of	of	ADP
bjos-8666337	85	29	835	835	NUM
bjos-8666337	85	30	base	base	NOUN
bjos-8666337	85	31	pairs	pair	NOUN
bjos-8666337	85	32	as	as	ADP
bjos-8666337	85	33	the	the	DET
bjos-8666337	85	34	target	target	NOUN
bjos-8666337	85	35	(	(	PUNCT
bjos-8666337	85	36	table	table	NOUN
bjos-8666337	85	37	2	2	NUM
bjos-8666337	85	38	)	)	PUNCT
bjos-8666337	85	39	.	.	PUNCT
bjos-8666337	86	1	a	a	DET
bjos-8666337	86	2	50	50	NUM
bjos-8666337	86	3	-	-	PUNCT
bjos-8666337	86	4	l	l	NOUN
bjos-8666337	86	5	reaction	reaction	NOUN
bjos-8666337	86	6	mixture	mixture	NOUN
bjos-8666337	86	7	containing	contain	VERB
bjos-8666337	86	8	10	10	NUM
bjos-8666337	86	9	pmol	pmol	NOUN
bjos-8666337	86	10	of	of	ADP
bjos-8666337	86	11	each	each	DET
bjos-8666337	86	12	primer	primer	NOUN
bjos-8666337	86	13	,	,	PUNCT
bjos-8666337	86	14	50	50	NUM
bjos-8666337	86	15	m	m	NOUN
bjos-8666337	86	16	of	of	ADP
bjos-8666337	86	17	each	each	DET
bjos-8666337	86	18	dntp	dntp	NOUN
bjos-8666337	86	19	,	,	PUNCT
bjos-8666337	86	20	200	200	NUM
bjos-8666337	86	21	ng	ng	PROPN
bjos-8666337	86	22	of	of	ADP
bjos-8666337	86	23	dna	dna	PROPN
bjos-8666337	86	24	template	template	NOUN
bjos-8666337	86	25	,	,	PUNCT
bjos-8666337	86	26	2	2	NUM
bjos-8666337	86	27	u	u	NOUN
bjos-8666337	86	28	of	of	ADP
bjos-8666337	86	29	taq	taq	PROPN
bjos-8666337	86	30	dna	dna	PROPN
bjos-8666337	86	31	polymerase	polymerase	NOUN
bjos-8666337	86	32	,	,	PUNCT
bjos-8666337	86	33	20	20	NUM
bjos-8666337	86	34	mm	mm	NOUN
bjos-8666337	86	35	tris	tris	PROPN
bjos-8666337	86	36	-	-	PUNCT
bjos-8666337	86	37	hcl	hcl	NOUN
bjos-8666337	86	38	,	,	PUNCT
bjos-8666337	86	39	and	and	CCONJ
bjos-8666337	86	40	3	3	NUM
bjos-8666337	86	41	mm	mm	NOUN
bjos-8666337	86	42	mgcl2	mgcl2	PROPN
bjos-8666337	86	43	was	be	AUX
bjos-8666337	86	44	used	use	VERB
bjos-8666337	86	45	for	for	ADP
bjos-8666337	86	46	the	the	DET
bjos-8666337	86	47	pcr	pcr	ADJ
bjos-8666337	86	48	process	process	NOUN
bjos-8666337	86	49	.	.	PUNCT
bjos-8666337	87	1	the	the	DET
bjos-8666337	87	2	primers	primer	NOUN
bjos-8666337	87	3	were	be	AUX
bjos-8666337	87	4	desaturated	desaturate	VERB
bjos-8666337	87	5	for	for	ADP
bjos-8666337	87	6	5	5	NUM
bjos-8666337	87	7	minutes	minute	NOUN
bjos-8666337	87	8	at	at	ADP
bjos-8666337	87	9	95	95	NUM
bjos-8666337	87	10	°	°	NOUN
bjos-8666337	87	11	c	c	NOUN
bjos-8666337	87	12	,	,	PUNCT
bjos-8666337	87	13	followed	follow	VERB
bjos-8666337	87	14	by	by	ADP
bjos-8666337	87	15	40	40	NUM
bjos-8666337	87	16	cycles	cycle	NOUN
bjos-8666337	87	17	of	of	ADP
bjos-8666337	87	18	denaturation	denaturation	NOUN
bjos-8666337	87	19	at	at	ADP
bjos-8666337	87	20	95	95	NUM
bjos-8666337	87	21	°	°	ADP
bjos-8666337	87	22	c	c	NOUN
bjos-8666337	87	23	for	for	ADP
bjos-8666337	87	24	30	30	NUM
bjos-8666337	87	25	seconds	second	NOUN
bjos-8666337	87	26	,	,	PUNCT
bjos-8666337	87	27	annealing	anneal	VERB
bjos-8666337	87	28	at	at	ADP
bjos-8666337	87	29	55	55	NUM
bjos-8666337	87	30	°	°	ADP
bjos-8666337	87	31	c	c	NOUN
bjos-8666337	87	32	for	for	ADP
bjos-8666337	87	33	50	50	NUM
bjos-8666337	87	34	seconds	second	NOUN
bjos-8666337	87	35	,	,	PUNCT
bjos-8666337	87	36	extension	extension	NOUN
bjos-8666337	87	37	at	at	ADP
bjos-8666337	87	38	72	72	NUM
bjos-8666337	87	39	°	°	ADP
bjos-8666337	87	40	c	c	NOUN
bjos-8666337	87	41	for	for	ADP
bjos-8666337	87	42	50	50	NUM
bjos-8666337	87	43	seconds	second	NOUN
bjos-8666337	87	44	,	,	PUNCT
bjos-8666337	87	45	and	and	CCONJ
bjos-8666337	87	46	final	final	ADJ
bjos-8666337	87	47	elongation	elongation	NOUN
bjos-8666337	87	48	at	at	ADP
bjos-8666337	87	49	72	72	NUM
bjos-8666337	87	50	°	°	ADP
bjos-8666337	87	51	c	c	NOUN
bjos-8666337	87	52	for	for	ADP
bjos-8666337	87	53	10	10	NUM
bjos-8666337	87	54	minutes	minute	NOUN
bjos-8666337	87	55	.	.	PUNCT
bjos-8666337	88	1	each	each	DET
bjos-8666337	88	2	set	set	NOUN
bjos-8666337	88	3	of	of	ADP
bjos-8666337	88	4	pcr	pcr	ADJ
bjos-8666337	88	5	reactions	reaction	NOUN
bjos-8666337	88	6	contained	contain	VERB
bjos-8666337	88	7	a	a	DET
bjos-8666337	88	8	negative	negative	ADJ
bjos-8666337	88	9	control	control	NOUN
bjos-8666337	88	10	consisting	consist	VERB
bjos-8666337	88	11	of	of	ADP
bjos-8666337	88	12	a	a	DET
bjos-8666337	88	13	reaction	reaction	NOUN
bjos-8666337	88	14	mixture	mixture	NOUN
bjos-8666337	88	15	devoid	devoid	ADJ
bjos-8666337	88	16	of	of	ADP
bjos-8666337	88	17	template	template	NOUN
bjos-8666337	88	18	dna	dna	NOUN
bjos-8666337	88	19	.	.	PUNCT
bjos-8666337	89	1	electrophoresis	electrophoresis	NOUN
bjos-8666337	89	2	on	on	ADP
bjos-8666337	89	3	a	a	DET
bjos-8666337	89	4	1	1	NUM
bjos-8666337	89	5	%	%	NOUN
bjos-8666337	89	6	agarose	agarose	NOUN
bjos-8666337	89	7	gel	gel	NOUN
bjos-8666337	89	8	was	be	AUX
bjos-8666337	89	9	used	use	VERB
bjos-8666337	89	10	to	to	PART
bjos-8666337	89	11	verify	verify	VERB
bjos-8666337	89	12	the	the	DET
bjos-8666337	89	13	pcr	pcr	ADJ
bjos-8666337	89	14	results	result	NOUN
bjos-8666337	89	15	.	.	PUNCT
bjos-8666337	90	1	5	5	NUM
bjos-8666337	90	2	koopaie	koopaie	PROPN
bjos-8666337	90	3	et	et	PROPN
bjos-8666337	90	4	al	al	PROPN
bjos-8666337	90	5	.	.	PROPN
bjos-8666337	90	6	braz	braz	PROPN
bjos-8666337	90	7	j	j	PROPN
bjos-8666337	90	8	oral	oral	PROPN
bjos-8666337	90	9	sci	sci	PROPN
bjos-8666337	90	10	.	.	PUNCT
bjos-8666337	91	1	2022;21	2022;21	NUM
bjos-8666337	91	2	:	:	PUNCT
bjos-8666337	91	3	e226337	e226337	VERB
bjos-8666337	91	4	variant	variant	ADJ
bjos-8666337	91	5	analysis	analysis	NOUN
bjos-8666337	91	6	of	of	ADP
bjos-8666337	91	7	hpv-18	hpv-18	NOUN
bjos-8666337	91	8	l1	l1	PROPN
bjos-8666337	91	9	gene	gene	NOUN
bjos-8666337	91	10	the	the	DET
bjos-8666337	91	11	hpv-18	hpv-18	PROPN
bjos-8666337	91	12	l1	l1	PROPN
bjos-8666337	91	13	gene	gene	NOUN
bjos-8666337	91	14	was	be	AUX
bjos-8666337	91	15	examined	examine	VERB
bjos-8666337	91	16	using	use	VERB
bjos-8666337	91	17	a	a	DET
bjos-8666337	91	18	pcr	pcr	NOUN
bjos-8666337	91	19	assay	assay	NOUN
bjos-8666337	91	20	with	with	ADP
bjos-8666337	91	21	an	an	DET
bjos-8666337	91	22	amplicon	amplicon	NOUN
bjos-8666337	91	23	size	size	NOUN
bjos-8666337	91	24	of	of	ADP
bjos-8666337	91	25	7857	7857	NUM
bjos-8666337	91	26	bp	bp	PROPN
bjos-8666337	91	27	(	(	PUNCT
bjos-8666337	91	28	table	table	NOUN
bjos-8666337	91	29	1	1	NUM
bjos-8666337	91	30	)	)	PUNCT
bjos-8666337	91	31	.	.	PUNCT
bjos-8666337	92	1	the	the	DET
bjos-8666337	92	2	pcr	pcr	PROPN
bjos-8666337	92	3	reaction	reaction	NOUN
bjos-8666337	92	4	technique	technique	NOUN
bjos-8666337	92	5	is	be	AUX
bjos-8666337	92	6	identical	identical	ADJ
bjos-8666337	92	7	to	to	ADP
bjos-8666337	92	8	that	that	PRON
bjos-8666337	92	9	described	describe	VERB
bjos-8666337	92	10	previously	previously	ADV
bjos-8666337	92	11	for	for	ADP
bjos-8666337	92	12	the	the	DET
bjos-8666337	92	13	hpv-16	hpv-16	NUM
bjos-8666337	92	14	e6	e6	PROPN
bjos-8666337	92	15	and	and	CCONJ
bjos-8666337	92	16	e7	e7	PROPN
bjos-8666337	92	17	genes	gene	NOUN
bjos-8666337	92	18	,	,	PUNCT
bjos-8666337	92	19	and	and	CCONJ
bjos-8666337	92	20	a	a	DET
bjos-8666337	92	21	schematic	schematic	ADJ
bjos-8666337	92	22	primer	primer	NOUN
bjos-8666337	92	23	design	design	NOUN
bjos-8666337	92	24	is	be	AUX
bjos-8666337	92	25	shown	show	VERB
bjos-8666337	92	26	in	in	ADP
bjos-8666337	92	27	figure	figure	NOUN
bjos-8666337	92	28	2	2	NUM
bjos-8666337	92	29	for	for	ADP
bjos-8666337	92	30	reference	reference	NOUN
bjos-8666337	92	31	.	.	PUNCT
bjos-8666337	93	1	figure	figure	NOUN
bjos-8666337	93	2	2	2	NUM
bjos-8666337	93	3	.	.	PUNCT
bjos-8666337	93	4	schematic	schematic	ADJ
bjos-8666337	93	5	primers	primer	NOUN
bjos-8666337	93	6	design	design	VERB
bjos-8666337	93	7	for	for	ADP
bjos-8666337	93	8	pcr	pcr	ADJ
bjos-8666337	93	9	analyzing	analyzing	NOUN
bjos-8666337	93	10	of	of	ADP
bjos-8666337	93	11	hpv-18	hpv-18	NOUN
bjos-8666337	93	12	l1	l1	PROPN
bjos-8666337	93	13	,	,	PUNCT
bjos-8666337	93	14	r.	r.	PROPN
bjos-8666337	93	15	abi	abi	PROPN
bjos-8666337	93	16	prism	prism	PROPN
bjos-8666337	93	17	377	377	NUM
bjos-8666337	93	18	sequencer	sequencer	NOUN
bjos-8666337	93	19	genetic	genetic	ADJ
bjos-8666337	93	20	analyzer	analyzer	NOUN
bjos-8666337	93	21	equipment	equipment	NOUN
bjos-8666337	93	22	(	(	PUNCT
bjos-8666337	93	23	applied	apply	VERB
bjos-8666337	93	24	biosystems	biosystem	NOUN
bjos-8666337	93	25	foster	foster	PROPN
bjos-8666337	93	26	city	city	PROPN
bjos-8666337	93	27	,	,	PUNCT
bjos-8666337	93	28	canada	canada	PROPN
bjos-8666337	93	29	)	)	PUNCT
bjos-8666337	93	30	was	be	AUX
bjos-8666337	93	31	used	use	VERB
bjos-8666337	93	32	to	to	PART
bjos-8666337	93	33	sequence	sequence	VERB
bjos-8666337	93	34	all	all	PRON
bjos-8666337	93	35	of	of	ADP
bjos-8666337	93	36	the	the	DET
bjos-8666337	93	37	pcr	pcr	ADJ
bjos-8666337	93	38	products	product	NOUN
bjos-8666337	93	39	from	from	ADP
bjos-8666337	93	40	the	the	DET
bjos-8666337	93	41	e6	e6	PROPN
bjos-8666337	93	42	and	and	CCONJ
bjos-8666337	93	43	e7	e7	PROPN
bjos-8666337	93	44	genes	gene	NOUN
bjos-8666337	93	45	to	to	PART
bjos-8666337	93	46	evaluate	evaluate	VERB
bjos-8666337	93	47	the	the	DET
bjos-8666337	93	48	hpv-16	hpv-16	NUM
bjos-8666337	93	49	and	and	CCONJ
bjos-8666337	93	50	hpv-18	hpv-18	NOUN
bjos-8666337	93	51	variants	variant	NOUN
bjos-8666337	93	52	.	.	PUNCT
bjos-8666337	94	1	the	the	DET
bjos-8666337	94	2	sequences	sequence	NOUN
bjos-8666337	94	3	were	be	AUX
bjos-8666337	94	4	run	run	VERB
bjos-8666337	94	5	according	accord	VERB
bjos-8666337	94	6	to	to	ADP
bjos-8666337	94	7	the	the	DET
bjos-8666337	94	8	big	big	ADJ
bjos-8666337	94	9	-	-	PUNCT
bjos-8666337	94	10	dye	dye	NOUN
bjos-8666337	94	11	terminator	terminator	NOUN
bjos-8666337	94	12	protocol	protocol	NOUN
bjos-8666337	94	13	(	(	PUNCT
bjos-8666337	94	14	applied	apply	VERB
bjos-8666337	94	15	biosystems	biosystem	NOUN
bjos-8666337	94	16	)	)	PUNCT
bjos-8666337	94	17	(	(	PUNCT
bjos-8666337	94	18	geneali	geneali	ADJ
bjos-8666337	94	19	,	,	PUNCT
bjos-8666337	94	20	seoul	seoul	PROPN
bjos-8666337	94	21	,	,	PUNCT
bjos-8666337	94	22	south	south	PROPN
bjos-8666337	94	23	korea	korea	PROPN
bjos-8666337	94	24	)	)	PUNCT
bjos-8666337	94	25	.	.	PUNCT
bjos-8666337	95	1	it	it	PRON
bjos-8666337	95	2	was	be	AUX
bjos-8666337	95	3	determined	determine	VERB
bjos-8666337	95	4	that	that	SCONJ
bjos-8666337	95	5	the	the	DET
bjos-8666337	95	6	reference	reference	NOUN
bjos-8666337	95	7	sequences	sequence	NOUN
bjos-8666337	95	8	were	be	AUX
bjos-8666337	95	9	unique	unique	ADJ
bjos-8666337	95	10	to	to	ADP
bjos-8666337	95	11	each	each	DET
bjos-8666337	95	12	lineage	lineage	NOUN
bjos-8666337	95	13	and	and	CCONJ
bjos-8666337	95	14	sublineage	sublineage	NOUN
bjos-8666337	95	15	by	by	ADP
bjos-8666337	95	16	aligning	align	VERB
bjos-8666337	95	17	them	they	PRON
bjos-8666337	95	18	to	to	ADP
bjos-8666337	95	19	all	all	DET
bjos-8666337	95	20	previously	previously	ADV
bjos-8666337	95	21	known	know	VERB
bjos-8666337	95	22	lineages	lineage	NOUN
bjos-8666337	95	23	and	and	CCONJ
bjos-8666337	95	24	sublineages	sublineage	NOUN
bjos-8666337	95	25	of	of	ADP
bjos-8666337	95	26	a1	a1	NOUN
bjos-8666337	95	27	-	-	PUNCT
bjos-8666337	95	28	4	4	NUM
bjos-8666337	95	29	,	,	PUNCT
bjos-8666337	95	30	b1	b1	NOUN
bjos-8666337	95	31	-	-	PUNCT
bjos-8666337	95	32	4	4	NUM
bjos-8666337	95	33	,	,	PUNCT
bjos-8666337	95	34	c2	c2	PROPN
bjos-8666337	95	35	-	-	PUNCT
bjos-8666337	95	36	4	4	NUM
bjos-8666337	95	37	,	,	PUNCT
bjos-8666337	95	38	and	and	CCONJ
bjos-8666337	95	39	d1	d1	PROPN
bjos-8666337	95	40	-	-	PUNCT
bjos-8666337	95	41	316	316	NUM
bjos-8666337	95	42	.	.	PUNCT
bjos-8666337	96	1	the	the	DET
bjos-8666337	96	2	maximum	maximum	ADJ
bjos-8666337	96	3	likelihood	likelihood	NOUN
bjos-8666337	96	4	approach	approach	NOUN
bjos-8666337	96	5	was	be	AUX
bjos-8666337	96	6	employed	employ	VERB
bjos-8666337	96	7	to	to	PART
bjos-8666337	96	8	build	build	VERB
bjos-8666337	96	9	the	the	DET
bjos-8666337	96	10	phylogenetic	phylogenetic	ADJ
bjos-8666337	96	11	tree	tree	NOUN
bjos-8666337	96	12	,	,	PUNCT
bjos-8666337	96	13	which	which	PRON
bjos-8666337	96	14	was	be	AUX
bjos-8666337	96	15	done	do	VERB
bjos-8666337	96	16	using	use	VERB
bjos-8666337	96	17	mega	mega	ADJ
bjos-8666337	96	18	software	software	NOUN
bjos-8666337	96	19	version	version	NOUN
bjos-8666337	96	20	6	6	NUM
bjos-8666337	96	21	.	.	PUNCT
bjos-8666337	97	1	in	in	ADP
bjos-8666337	97	2	order	order	NOUN
bjos-8666337	97	3	to	to	PART
bjos-8666337	97	4	analyze	analyze	VERB
bjos-8666337	97	5	the	the	DET
bjos-8666337	97	6	hpv-18	hpv-18	NOUN
bjos-8666337	97	7	lineages	lineage	NOUN
bjos-8666337	97	8	and	and	CCONJ
bjos-8666337	97	9	sublineages	sublineage	NOUN
bjos-8666337	97	10	,	,	PUNCT
bjos-8666337	97	11	all	all	DET
bjos-8666337	97	12	hpv-18	hpv-18	NOUN
bjos-8666337	97	13	sequences	sequence	NOUN
bjos-8666337	97	14	were	be	AUX
bjos-8666337	97	15	analyzed	analyze	VERB
bjos-8666337	97	16	using	use	VERB
bjos-8666337	97	17	the	the	DET
bjos-8666337	97	18	mega	mega	ADJ
bjos-8666337	97	19	software	software	NOUN
bjos-8666337	97	20	version	version	NOUN
bjos-8666337	97	21	,	,	PUNCT
bjos-8666337	97	22	which	which	PRON
bjos-8666337	97	23	was	be	AUX
bjos-8666337	97	24	used	use	VERB
bjos-8666337	97	25	to	to	PART
bjos-8666337	97	26	depict	depict	VERB
bjos-8666337	97	27	the	the	DET
bjos-8666337	97	28	phylogenetic	phylogenetic	ADJ
bjos-8666337	97	29	tree	tree	NOUN
bjos-8666337	97	30	according	accord	VERB
bjos-8666337	97	31	to	to	ADP
bjos-8666337	97	32	the	the	DET
bjos-8666337	97	33	maximum	maximum	ADJ
bjos-8666337	97	34	likelihood	likelihood	NOUN
bjos-8666337	97	35	method	method	NOUN
bjos-8666337	97	36	with	with	ADP
bjos-8666337	97	37	the	the	DET
bjos-8666337	97	38	reliability	reliability	NOUN
bjos-8666337	97	39	of	of	ADP
bjos-8666337	97	40	bootstrap	bootstrap	NOUN
bjos-8666337	97	41	on	on	ADP
bjos-8666337	97	42	1000	1000	NUM
bjos-8666337	97	43	replicates	replicate	NOUN
bjos-8666337	97	44	using	use	VERB
bjos-8666337	97	45	the	the	DET
bjos-8666337	97	46	maximum	maximum	ADJ
bjos-8666337	97	47	likelihood	likelihood	NOUN
bjos-8666337	97	48	method	method	NOUN
bjos-8666337	97	49	with	with	ADP
bjos-8666337	97	50	bootstrap	bootstrap	NOUN
bjos-8666337	97	51	reliability	reliability	NOUN
bjos-8666337	97	52	on	on	ADP
bjos-8666337	97	53	1000	1000	NUM
bjos-8666337	97	54	replicates	replicate	NOUN
bjos-8666337	97	55	.	.	PUNCT
bjos-8666337	98	1	the	the	DET
bjos-8666337	98	2	a1	a1	NOUN
bjos-8666337	98	3	-	-	PUNCT
bjos-8666337	98	4	5	5	NUM
bjos-8666337	98	5	,	,	PUNCT
bjos-8666337	98	6	c	c	NOUN
bjos-8666337	98	7	,	,	PUNCT
bjos-8666337	98	8	and	and	CCONJ
bjos-8666337	98	9	b1	b1	NOUN
bjos-8666337	98	10	-	-	PUNCT
bjos-8666337	98	11	3	3	NUM
bjos-8666337	98	12	reference	reference	NOUN
bjos-8666337	98	13	sequences	sequence	NOUN
bjos-8666337	98	14	for	for	ADP
bjos-8666337	98	15	hpv-18	hpv-18	NUM
bjos-8666337	98	16	were	be	AUX
bjos-8666337	98	17	also	also	ADV
bjos-8666337	98	18	obtained	obtain	VERB
bjos-8666337	98	19	from	from	ADP
bjos-8666337	98	20	the	the	DET
bjos-8666337	98	21	genbank	genbank	PROPN
bjos-8666337	98	22	database	database	NOUN
bjos-8666337	98	23	,	,	PUNCT
bjos-8666337	98	24	as	as	SCONJ
bjos-8666337	98	25	were	be	AUX
bjos-8666337	98	26	the	the	DET
bjos-8666337	98	27	lineage	lineage	NOUN
bjos-8666337	98	28	and	and	CCONJ
bjos-8666337	98	29	sublineage	sublineage	NOUN
bjos-8666337	98	30	-	-	PUNCT
bjos-8666337	98	31	specific	specific	ADJ
bjos-8666337	98	32	reference	reference	NOUN
bjos-8666337	98	33	sequences	sequence	NOUN
bjos-8666337	98	34	for	for	ADP
bjos-8666337	98	35	hpv-18	hpv-18	NOUN
bjos-8666337	98	36	.	.	PROPN
bjos-8666337	98	37	6	6	NUM
bjos-8666337	98	38	koopaie	koopaie	PROPN
bjos-8666337	98	39	et	et	PROPN
bjos-8666337	98	40	al	al	PROPN
bjos-8666337	98	41	.	.	PROPN
bjos-8666337	99	1	braz	braz	PROPN
bjos-8666337	99	2	j	j	PROPN
bjos-8666337	99	3	oral	oral	PROPN
bjos-8666337	99	4	sci	sci	PROPN
bjos-8666337	99	5	.	.	PUNCT
bjos-8666337	100	1	2022;21	2022;21	NUM
bjos-8666337	100	2	:	:	PUNCT
bjos-8666337	100	3	e226337	e226337	NOUN
bjos-8666337	100	4	results	result	VERB
bjos-8666337	100	5	this	this	DET
bjos-8666337	100	6	research	research	NOUN
bjos-8666337	100	7	comprised	comprise	VERB
bjos-8666337	100	8	30	30	NUM
bjos-8666337	100	9	people	people	NOUN
bjos-8666337	100	10	diagnosed	diagnose	VERB
bjos-8666337	100	11	with	with	ADP
bjos-8666337	100	12	hpv	hpv	PROPN
bjos-8666337	100	13	-	-	PUNCT
bjos-8666337	100	14	dna	dna	PROPN
bjos-8666337	100	15	over	over	ADP
bjos-8666337	100	16	a	a	DET
bjos-8666337	100	17	year	year	NOUN
bjos-8666337	100	18	(	(	PUNCT
bjos-8666337	100	19	from	from	ADP
bjos-8666337	100	20	march	march	PROPN
bjos-8666337	100	21	2020	2020	NUM
bjos-8666337	100	22	to	to	ADP
bjos-8666337	100	23	march	march	PROPN
bjos-8666337	100	24	2021	2021	NUM
bjos-8666337	100	25	)	)	PUNCT
bjos-8666337	100	26	.	.	PUNCT
bjos-8666337	101	1	ten	ten	NUM
bjos-8666337	101	2	patients	patient	NOUN
bjos-8666337	101	3	were	be	AUX
bjos-8666337	101	4	male	male	ADJ
bjos-8666337	101	5	and	and	CCONJ
bjos-8666337	101	6	five	five	NUM
bjos-8666337	101	7	were	be	AUX
bjos-8666337	101	8	female	female	ADJ
bjos-8666337	101	9	in	in	ADP
bjos-8666337	101	10	the	the	DET
bjos-8666337	101	11	patient	patient	NOUN
bjos-8666337	101	12	group	group	NOUN
bjos-8666337	101	13	.	.	PUNCT
bjos-8666337	102	1	the	the	DET
bjos-8666337	102	2	control	control	PROPN
bjos-8666337	102	3	group	group	NOUN
bjos-8666337	102	4	consisted	consist	VERB
bjos-8666337	102	5	of	of	ADP
bjos-8666337	102	6	9	9	NUM
bjos-8666337	102	7	males	male	NOUN
bjos-8666337	102	8	and	and	CCONJ
bjos-8666337	102	9	6	6	NUM
bjos-8666337	102	10	females	female	NOUN
bjos-8666337	102	11	.	.	PUNCT
bjos-8666337	103	1	the	the	DET
bjos-8666337	103	2	mean	mean	ADJ
bjos-8666337	103	3	age	age	NOUN
bjos-8666337	103	4	and	and	CCONJ
bjos-8666337	103	5	standard	standard	ADJ
bjos-8666337	103	6	deviation	deviation	NOUN
bjos-8666337	103	7	(	(	PUNCT
bjos-8666337	103	8	sd	sd	NOUN
bjos-8666337	103	9	)	)	PUNCT
bjos-8666337	103	10	of	of	ADP
bjos-8666337	103	11	patient	patient	NOUN
bjos-8666337	103	12	and	and	CCONJ
bjos-8666337	103	13	control	control	NOUN
bjos-8666337	103	14	group	group	NOUN
bjos-8666337	103	15	were	be	AUX
bjos-8666337	103	16	53.84±13.61	53.84±13.61	NUM
bjos-8666337	103	17	and	and	CCONJ
bjos-8666337	103	18	45.23±12.80	45.23±12.80	NUM
bjos-8666337	103	19	,	,	PUNCT
bjos-8666337	103	20	respectively	respectively	ADV
bjos-8666337	103	21	.	.	PUNCT
bjos-8666337	104	1	four	four	NUM
bjos-8666337	104	2	patients	patient	NOUN
bjos-8666337	104	3	in	in	ADP
bjos-8666337	104	4	the	the	DET
bjos-8666337	104	5	hnscc	hnscc	NOUN
bjos-8666337	104	6	group	group	NOUN
bjos-8666337	104	7	had	have	VERB
bjos-8666337	104	8	tongue	tongue	PROPN
bjos-8666337	104	9	scc	scc	PROPN
bjos-8666337	104	10	,	,	PUNCT
bjos-8666337	104	11	six	six	NUM
bjos-8666337	104	12	had	have	VERB
bjos-8666337	104	13	oropharyngeal	oropharyngeal	ADJ
bjos-8666337	104	14	scc	scc	NOUN
bjos-8666337	104	15	,	,	PUNCT
bjos-8666337	104	16	three	three	NUM
bjos-8666337	104	17	had	have	VERB
bjos-8666337	104	18	soft	soft	ADJ
bjos-8666337	104	19	palate	palate	NOUN
bjos-8666337	104	20	scc	scc	NOUN
bjos-8666337	104	21	,	,	PUNCT
bjos-8666337	104	22	and	and	CCONJ
bjos-8666337	104	23	two	two	NUM
bjos-8666337	104	24	had	have	VERB
bjos-8666337	104	25	laryngeal	laryngeal	PROPN
bjos-8666337	104	26	scc	scc	PROPN
bjos-8666337	104	27	.	.	PUNCT
bjos-8666337	105	1	figure	figure	NOUN
bjos-8666337	105	2	3	3	NUM
bjos-8666337	105	3	.	.	PROPN
bjos-8666337	105	4	hpv-16	hpv-16	NUM
bjos-8666337	105	5	and	and	CCONJ
bjos-8666337	105	6	hpv-18	hpv-18	PROPN
bjos-8666337	105	7	(	(	PUNCT
bjos-8666337	105	8	e6	e6	PROPN
bjos-8666337	105	9	,	,	PUNCT
bjos-8666337	105	10	e7	e7	PROPN
bjos-8666337	105	11	)	)	PUNCT
bjos-8666337	105	12	were	be	AUX
bjos-8666337	105	13	sequenced	sequence	VERB
bjos-8666337	105	14	in	in	ADP
bjos-8666337	105	15	genomes	genome	NOUN
bjos-8666337	105	16	isolated	isolate	VERB
bjos-8666337	105	17	from	from	ADP
bjos-8666337	105	18	saliva	saliva	NOUN
bjos-8666337	105	19	of	of	ADP
bjos-8666337	105	20	subjects	subject	NOUN
bjos-8666337	105	21	.	.	PUNCT
bjos-8666337	106	1	when	when	SCONJ
bjos-8666337	106	2	the	the	DET
bjos-8666337	106	3	sequences	sequence	NOUN
bjos-8666337	106	4	recovered	recover	VERB
bjos-8666337	106	5	in	in	ADP
bjos-8666337	106	6	this	this	DET
bjos-8666337	106	7	research	research	NOUN
bjos-8666337	106	8	were	be	AUX
bjos-8666337	106	9	compared	compare	VERB
bjos-8666337	106	10	to	to	ADP
bjos-8666337	106	11	the	the	DET
bjos-8666337	106	12	sequences	sequence	NOUN
bjos-8666337	106	13	of	of	ADP
bjos-8666337	106	14	samples	sample	NOUN
bjos-8666337	106	15	in	in	ADP
bjos-8666337	106	16	the	the	DET
bjos-8666337	106	17	hpv-18	hpv-18	NUM
bjos-8666337	106	18	e6	e6	NOUN
bjos-8666337	106	19	,	,	PUNCT
bjos-8666337	106	20	e7	e7	PROPN
bjos-8666337	106	21	,	,	PUNCT
bjos-8666337	106	22	and	and	CCONJ
bjos-8666337	106	23	l1	l1	PROPN
bjos-8666337	106	24	gene	gene	NOUN
bjos-8666337	106	25	banks	bank	NOUN
bjos-8666337	106	26	,	,	PUNCT
bjos-8666337	106	27	it	it	PRON
bjos-8666337	106	28	was	be	AUX
bjos-8666337	106	29	discovered	discover	VERB
bjos-8666337	106	30	that	that	SCONJ
bjos-8666337	106	31	the	the	DET
bjos-8666337	106	32	viral	viral	ADJ
bjos-8666337	106	33	strain	strain	NOUN
bjos-8666337	106	34	isolated	isolate	VERB
bjos-8666337	106	35	from	from	ADP
bjos-8666337	106	36	the	the	DET
bjos-8666337	106	37	patient	patient	NOUN
bjos-8666337	106	38	’s	’s	PART
bjos-8666337	106	39	saliva	saliva	NOUN
bjos-8666337	106	40	belonged	belong	VERB
bjos-8666337	106	41	to	to	ADP
bjos-8666337	106	42	lineage	lineage	NOUN
bjos-8666337	106	43	a3	a3	NOUN
bjos-8666337	106	44	(	(	PUNCT
bjos-8666337	106	45	figure	figure	NOUN
bjos-8666337	106	46	4	4	NUM
bjos-8666337	106	47	-	-	SYM
bjos-8666337	106	48	d	d	PROPN
bjos-8666337	106	49	,	,	PUNCT
bjos-8666337	106	50	e	e	NOUN
bjos-8666337	106	51	,	,	PUNCT
bjos-8666337	106	52	f	f	NOUN
bjos-8666337	106	53	)	)	PUNCT
bjos-8666337	106	54	.	.	PUNCT
bjos-8666337	107	1	overall	overall	ADJ
bjos-8666337	107	2	,	,	PUNCT
bjos-8666337	107	3	lineages	lineage	NOUN
bjos-8666337	107	4	a1	a1	NOUN
bjos-8666337	107	5	of	of	ADP
bjos-8666337	107	6	hpv-16	hpv-16	PROPN
bjos-8666337	107	7	(	(	PUNCT
bjos-8666337	107	8	figure	figure	VERB
bjos-8666337	107	9	a	a	PRON
bjos-8666337	107	10	,	,	PUNCT
bjos-8666337	107	11	b	b	NOUN
bjos-8666337	107	12	,	,	PUNCT
bjos-8666337	107	13	c	c	NOUN
bjos-8666337	107	14	)	)	PUNCT
bjos-8666337	107	15	and	and	CCONJ
bjos-8666337	107	16	a3	a3	NOUN
bjos-8666337	107	17	of	of	ADP
bjos-8666337	107	18	hpv-18	hpv-18	NOUN
bjos-8666337	107	19	variations	variation	NOUN
bjos-8666337	107	20	(	(	PUNCT
bjos-8666337	107	21	figure	figure	VERB
bjos-8666337	107	22	4	4	NUM
bjos-8666337	107	23	-	-	SYM
bjos-8666337	107	24	d	d	PROPN
bjos-8666337	107	25	,	,	PUNCT
bjos-8666337	107	26	e	e	NOUN
bjos-8666337	107	27	,	,	PUNCT
bjos-8666337	107	28	f	f	X
bjos-8666337	107	29	)	)	PUNCT
bjos-8666337	107	30	were	be	AUX
bjos-8666337	107	31	discovered	discover	VERB
bjos-8666337	107	32	(	(	PUNCT
bjos-8666337	107	33	figure	figure	NOUN
bjos-8666337	107	34	4	4	NUM
bjos-8666337	107	35	)	)	PUNCT
bjos-8666337	107	36	,	,	PUNCT
bjos-8666337	107	37	as	as	SCONJ
bjos-8666337	107	38	shown	show	VERB
bjos-8666337	107	39	by	by	ADP
bjos-8666337	107	40	the	the	DET
bjos-8666337	107	41	red	red	ADJ
bjos-8666337	107	42	outlined	outline	VERB
bjos-8666337	107	43	data	datum	NOUN
bjos-8666337	107	44	.	.	PUNCT
bjos-8666337	108	1	7	7	NUM
bjos-8666337	108	2	koopaie	koopaie	PROPN
bjos-8666337	108	3	et	et	PROPN
bjos-8666337	108	4	al	al	PROPN
bjos-8666337	108	5	.	.	PROPN
bjos-8666337	108	6	braz	braz	PROPN
bjos-8666337	108	7	j	j	PROPN
bjos-8666337	108	8	oral	oral	PROPN
bjos-8666337	108	9	sci	sci	PROPN
bjos-8666337	108	10	.	.	PUNCT
bjos-8666337	109	1	2022;21	2022;21	NUM
bjos-8666337	109	2	:	:	PUNCT
bjos-8666337	109	3	e226337	e226337	VERB
bjos-8666337	109	4	a	a	DET
bjos-8666337	109	5	b	b	NOUN
bjos-8666337	109	6	c	c	NOUN
bjos-8666337	109	7	d	d	X
bjos-8666337	109	8	e	e	X
bjos-8666337	109	9	f	f	PROPN
bjos-8666337	109	10	fi	fi	X
bjos-8666337	109	11	gu	gu	X
bjos-8666337	109	12	re	re	PROPN
bjos-8666337	109	13	4	4	NUM
bjos-8666337	109	14	.	.	PUNCT
bjos-8666337	110	1	t	t	NOUN
bjos-8666337	110	2	he	he	PRON
bjos-8666337	111	1	p	p	PROPN
bjos-8666337	111	2	hy	hy	X
bjos-8666337	111	3	lo	lo	PROPN
bjos-8666337	111	4	ge	ge	PROPN
bjos-8666337	111	5	ne	ne	PROPN
bjos-8666337	111	6	tic	tic	PROPN
bjos-8666337	111	7	tr	tr	AUX
bjos-8666337	111	8	ee	ee	ADV
bjos-8666337	111	9	in	in	ADP
bjos-8666337	111	10	c	c	PROPN
bjos-8666337	111	11	om	om	PROPN
bjos-8666337	111	12	pa	pa	PROPN
bjos-8666337	111	13	ris	ris	PROPN
bjos-8666337	111	14	on	on	ADP
bjos-8666337	111	15	w	w	PROPN
bjos-8666337	111	16	ith	ith	NOUN
bjos-8666337	111	17	th	th	PROPN
bjos-8666337	111	18	e	e	X
bjos-8666337	111	19	se	se	X
bjos-8666337	111	20	qu	qu	PROPN
bjos-8666337	111	21	en	en	PROPN
bjos-8666337	111	22	ce	ce	PROPN
bjos-8666337	112	1	o	o	X
bjos-8666337	112	2	f	f	X
bjos-8666337	112	3	s	s	AUX
bjos-8666337	112	4	am	be	AUX
bjos-8666337	112	5	pl	pl	X
bjos-8666337	112	6	es	es	X
bjos-8666337	112	7	in	in	ADP
bjos-8666337	112	8	th	th	NUM
bjos-8666337	112	9	e	e	NOUN
bjos-8666337	112	10	h	h	NOUN
bjos-8666337	113	1	pv	pv	NOUN
bjos-8666337	113	2	-1	-1	ADP
bjos-8666337	113	3	6	6	NUM
bjos-8666337	113	4	e6	e6	NOUN
bjos-8666337	113	5	,	,	PUNCT
bjos-8666337	113	6	e	e	X
bjos-8666337	113	7	7	7	NUM
bjos-8666337	113	8	an	an	DET
bjos-8666337	113	9	d	d	PROPN
bjos-8666337	113	10	l1	l1	PROPN
bjos-8666337	113	11	a	a	DET
bjos-8666337	113	12	nd	nd	NOUN
bjos-8666337	113	13	h	h	NOUN
bjos-8666337	113	14	pv	pv	NOUN
bjos-8666337	113	15	-1	-1	INTJ
bjos-8666337	113	16	8	8	NUM
bjos-8666337	113	17	e6	e6	NOUN
bjos-8666337	113	18	,	,	PUNCT
bjos-8666337	113	19	e	e	X
bjos-8666337	113	20	7	7	NUM
bjos-8666337	113	21	an	an	DET
bjos-8666337	113	22	d	d	PROPN
bjos-8666337	113	23	l1	l1	PROPN
bjos-8666337	113	24	g	g	PROPN
bjos-8666337	113	25	en	en	PROPN
bjos-8666337	113	26	e	e	PROPN
bjos-8666337	113	27	ba	ba	PROPN
bjos-8666337	113	28	nk	nk	PROPN
bjos-8666337	113	29	s	s	PROPN
bjos-8666337	113	30	ho	ho	PROPN
bjos-8666337	113	31	w	w	PROPN
bjos-8666337	113	32	ed	ed	PROPN
bjos-8666337	113	33	th	th	X
bjos-8666337	113	34	at	at	ADP
bjos-8666337	113	35	th	th	X
bjos-8666337	113	36	e	e	X
bjos-8666337	113	37	vi	vi	PROPN
bjos-8666337	113	38	ru	ru	PROPN
bjos-8666337	113	39	s	s	PROPN
bjos-8666337	113	40	st	st	PROPN
bjos-8666337	113	41	ra	ra	PROPN
bjos-8666337	113	42	in	in	ADP
bjos-8666337	113	43	is	be	AUX
bjos-8666337	113	44	ol	ol	ADJ
bjos-8666337	113	45	at	at	ADP
bjos-8666337	113	46	ed	ed	PROPN
bjos-8666337	114	1	fr	fr	INTJ
bjos-8666337	115	1	om	om	PROPN
bjos-8666337	115	2	th	th	X
bjos-8666337	115	3	e	e	X
bjos-8666337	115	4	pa	pa	NOUN
bjos-8666337	115	5	tie	tie	VERB
bjos-8666337	115	6	nt	not	PART
bjos-8666337	115	7	’s	’s	ADJ
bjos-8666337	115	8	sa	sa	PROPN
bjos-8666337	115	9	liv	liv	PROPN
bjos-8666337	115	10	a	a	DET
bjos-8666337	115	11	be	be	AUX
bjos-8666337	115	12	lo	lo	PROPN
bjos-8666337	115	13	ng	ng	NOUN
bjos-8666337	115	14	s	s	PROPN
bjos-8666337	115	15	to	to	ADP
bjos-8666337	115	16	ty	ty	INTJ
bjos-8666337	115	17	pe	pe	PROPN
bjos-8666337	115	18	1	1	NUM
bjos-8666337	115	19	6	6	NUM
bjos-8666337	115	20	;	;	PUNCT
bjos-8666337	115	21	li	li	PROPN
bjos-8666337	115	22	ne	ne	PROPN
bjos-8666337	115	23	ag	ag	PROPN
bjos-8666337	115	24	es	es	ADP
bjos-8666337	115	25	a	a	DET
bjos-8666337	115	26	1	1	NUM
bjos-8666337	115	27	(	(	PUNCT
bjos-8666337	115	28	a	a	PRON
bjos-8666337	115	29	,	,	PUNCT
bjos-8666337	115	30	b	b	PROPN
bjos-8666337	115	31	a	a	DET
bjos-8666337	115	32	nd	nd	NOUN
bjos-8666337	115	33	c	c	NOUN
bjos-8666337	115	34	)	)	PUNCT
bjos-8666337	116	1	a	a	DET
bjos-8666337	116	2	nd	nd	INTJ
bjos-8666337	116	3	ty	ty	INTJ
bjos-8666337	116	4	pe	pe	PROPN
bjos-8666337	116	5	1	1	NUM
bjos-8666337	116	6	8	8	NUM
bjos-8666337	116	7	;	;	PUNCT
bjos-8666337	116	8	li	li	PROPN
bjos-8666337	116	9	ne	ne	PROPN
bjos-8666337	116	10	ag	ag	PROPN
bjos-8666337	116	11	es	es	ADP
bjos-8666337	116	12	a	a	DET
bjos-8666337	116	13	3	3	NUM
bjos-8666337	116	14	(	(	PUNCT
bjos-8666337	116	15	d	d	NOUN
bjos-8666337	116	16	,	,	PUNCT
bjos-8666337	116	17	e	e	PROPN
bjos-8666337	116	18	a	a	PRON
bjos-8666337	116	19	nd	nd	NOUN
bjos-8666337	116	20	f	f	PROPN
bjos-8666337	116	21	)	)	PUNCT
bjos-8666337	116	22	.	.	PUNCT
bjos-8666337	117	1	8	8	NUM
bjos-8666337	117	2	koopaie	koopaie	PROPN
bjos-8666337	117	3	et	et	PROPN
bjos-8666337	117	4	al	al	PROPN
bjos-8666337	117	5	.	.	PROPN
bjos-8666337	117	6	braz	braz	PROPN
bjos-8666337	117	7	j	j	PROPN
bjos-8666337	117	8	oral	oral	PROPN
bjos-8666337	117	9	sci	sci	PROPN
bjos-8666337	117	10	.	.	PUNCT
bjos-8666337	118	1	2022;21	2022;21	NUM
bjos-8666337	118	2	:	:	PUNCT
bjos-8666337	118	3	e226337	e226337	NOUN
bjos-8666337	118	4	discussion	discussion	NOUN
bjos-8666337	118	5	hnscc	hnscc	NOUN
bjos-8666337	118	6	is	be	AUX
bjos-8666337	118	7	a	a	DET
bjos-8666337	118	8	group	group	NOUN
bjos-8666337	118	9	of	of	ADP
bjos-8666337	118	10	heterogenic	heterogenic	ADJ
bjos-8666337	118	11	cancers	cancer	NOUN
bjos-8666337	118	12	with	with	ADP
bjos-8666337	118	13	multiple	multiple	ADJ
bjos-8666337	118	14	risk	risk	NOUN
bjos-8666337	118	15	factors	factor	NOUN
bjos-8666337	118	16	.	.	PUNCT
bjos-8666337	119	1	hpv	hpv	PROPN
bjos-8666337	119	2	positivity	positivity	NOUN
bjos-8666337	119	3	may	may	AUX
bjos-8666337	119	4	be	be	AUX
bjos-8666337	119	5	an	an	DET
bjos-8666337	119	6	important	important	ADJ
bjos-8666337	119	7	contributing	contribute	VERB
bjos-8666337	119	8	factor	factor	NOUN
bjos-8666337	119	9	in	in	ADP
bjos-8666337	119	10	the	the	DET
bjos-8666337	119	11	histologic	histologic	ADJ
bjos-8666337	119	12	grade	grade	NOUN
bjos-8666337	119	13	and	and	CCONJ
bjos-8666337	119	14	prognosis	prognosis	NOUN
bjos-8666337	119	15	of	of	ADP
bjos-8666337	119	16	cases	case	NOUN
bjos-8666337	119	17	with	with	ADP
bjos-8666337	119	18	hnscc2	hnscc2	PROPN
bjos-8666337	119	19	.	.	PUNCT
bjos-8666337	120	1	risk	risk	NOUN
bjos-8666337	120	2	factors	factor	NOUN
bjos-8666337	120	3	of	of	ADP
bjos-8666337	120	4	hpv	hpv	NOUN
bjos-8666337	120	5	transmission	transmission	NOUN
bjos-8666337	120	6	include	include	VERB
bjos-8666337	120	7	multiple	multiple	ADJ
bjos-8666337	120	8	sex	sex	NOUN
bjos-8666337	120	9	partners	partner	NOUN
bjos-8666337	120	10	,	,	PUNCT
bjos-8666337	120	11	tobacco	tobacco	NOUN
bjos-8666337	120	12	consumption	consumption	NOUN
bjos-8666337	120	13	,	,	PUNCT
bjos-8666337	120	14	and	and	CCONJ
bjos-8666337	120	15	hiv	hiv	PROPN
bjos-8666337	120	16	infection	infection	NOUN
bjos-8666337	120	17	.	.	PUNCT
bjos-8666337	121	1	the	the	DET
bjos-8666337	121	2	roots	root	NOUN
bjos-8666337	121	3	of	of	ADP
bjos-8666337	121	4	hpv	hpv	NOUN
bjos-8666337	121	5	transmission	transmission	NOUN
bjos-8666337	121	6	include	include	VERB
bjos-8666337	121	7	sexual	sexual	ADJ
bjos-8666337	121	8	or	or	CCONJ
bjos-8666337	121	9	nonsexual	nonsexual	ADJ
bjos-8666337	121	10	contact	contact	NOUN
bjos-8666337	121	11	with	with	ADP
bjos-8666337	121	12	the	the	DET
bjos-8666337	121	13	affected	affected	ADJ
bjos-8666337	121	14	person	person	NOUN
bjos-8666337	121	15	,	,	PUNCT
bjos-8666337	121	16	transmission	transmission	NOUN
bjos-8666337	121	17	through	through	ADP
bjos-8666337	121	18	saliva	saliva	NOUN
bjos-8666337	121	19	contaminated	contaminate	VERB
bjos-8666337	121	20	with	with	ADP
bjos-8666337	121	21	the	the	DET
bjos-8666337	121	22	viruses	virus	NOUN
bjos-8666337	121	23	,	,	PUNCT
bjos-8666337	121	24	breastfeeding	breastfeeding	NOUN
bjos-8666337	121	25	,	,	PUNCT
bjos-8666337	121	26	transmission	transmission	NOUN
bjos-8666337	121	27	during	during	ADP
bjos-8666337	121	28	labor3	labor3	PROPN
bjos-8666337	121	29	.	.	PUNCT
bjos-8666337	122	1	in	in	ADP
bjos-8666337	122	2	the	the	DET
bjos-8666337	122	3	elderly	elderly	ADJ
bjos-8666337	122	4	,	,	PUNCT
bjos-8666337	122	5	the	the	DET
bjos-8666337	122	6	most	most	ADV
bjos-8666337	122	7	important	important	ADJ
bjos-8666337	122	8	predisposing	predispose	VERB
bjos-8666337	122	9	factors	factor	NOUN
bjos-8666337	122	10	for	for	ADP
bjos-8666337	122	11	hnscc	hnscc	NOUN
bjos-8666337	122	12	are	be	AUX
bjos-8666337	122	13	alcohol	alcohol	NOUN
bjos-8666337	122	14	and	and	CCONJ
bjos-8666337	122	15	tobacco	tobacco	NOUN
bjos-8666337	122	16	use	use	NOUN
bjos-8666337	122	17	,	,	PUNCT
bjos-8666337	122	18	but	but	CCONJ
bjos-8666337	122	19	in	in	ADP
bjos-8666337	122	20	younger	young	ADJ
bjos-8666337	122	21	people	people	NOUN
bjos-8666337	122	22	,	,	PUNCT
bjos-8666337	122	23	the	the	DET
bjos-8666337	122	24	role	role	NOUN
bjos-8666337	122	25	of	of	ADP
bjos-8666337	122	26	alcohol	alcohol	NOUN
bjos-8666337	122	27	,	,	PUNCT
bjos-8666337	122	28	and	and	CCONJ
bjos-8666337	122	29	tobacco	tobacco	NOUN
bjos-8666337	122	30	in	in	ADP
bjos-8666337	122	31	hnscc	hnscc	NOUN
bjos-8666337	122	32	is	be	AUX
bjos-8666337	122	33	lower	low	ADJ
bjos-8666337	122	34	and	and	CCONJ
bjos-8666337	122	35	the	the	DET
bjos-8666337	122	36	number	number	NOUN
bjos-8666337	122	37	of	of	ADP
bjos-8666337	122	38	young	young	ADJ
bjos-8666337	122	39	people	people	NOUN
bjos-8666337	122	40	with	with	ADP
bjos-8666337	122	41	hpv	hpv	NOUN
bjos-8666337	122	42	are	be	AUX
bjos-8666337	122	43	more	more	ADJ
bjos-8666337	122	44	than	than	ADP
bjos-8666337	122	45	older	old	ADJ
bjos-8666337	122	46	ones	one	NOUN
bjos-8666337	122	47	.	.	PUNCT
bjos-8666337	123	1	hence	hence	ADV
bjos-8666337	123	2	,	,	PUNCT
bjos-8666337	123	3	the	the	DET
bjos-8666337	123	4	hpv	hpv	PROPN
bjos-8666337	123	5	virus	virus	NOUN
bjos-8666337	123	6	may	may	AUX
bjos-8666337	123	7	be	be	AUX
bjos-8666337	123	8	one	one	NUM
bjos-8666337	123	9	of	of	ADP
bjos-8666337	123	10	the	the	DET
bjos-8666337	123	11	major	major	ADJ
bjos-8666337	123	12	risk	risk	NOUN
bjos-8666337	123	13	factors	factor	NOUN
bjos-8666337	123	14	for	for	ADP
bjos-8666337	123	15	hnscc	hnscc	NOUN
bjos-8666337	123	16	in	in	ADP
bjos-8666337	123	17	the	the	DET
bjos-8666337	123	18	young	young	ADJ
bjos-8666337	123	19	population4	population4	NOUN
bjos-8666337	123	20	.	.	PUNCT
bjos-8666337	124	1	the	the	DET
bjos-8666337	124	2	annual	annual	ADJ
bjos-8666337	124	3	incidence	incidence	NOUN
bjos-8666337	124	4	of	of	ADP
bjos-8666337	124	5	oropharyngeal	oropharyngeal	ADJ
bjos-8666337	124	6	scc	scc	NOUN
bjos-8666337	124	7	was	be	AUX
bjos-8666337	124	8	increased	increase	VERB
bjos-8666337	124	9	,	,	PUNCT
bjos-8666337	124	10	while	while	SCONJ
bjos-8666337	124	11	scc	scc	ADJ
bjos-8666337	124	12	incidence	incidence	NOUN
bjos-8666337	124	13	in	in	ADP
bjos-8666337	124	14	the	the	DET
bjos-8666337	124	15	other	other	ADJ
bjos-8666337	124	16	sites	site	NOUN
bjos-8666337	124	17	of	of	ADP
bjos-8666337	124	18	oral	oral	ADJ
bjos-8666337	124	19	cavity	cavity	NOUN
bjos-8666337	124	20	was	be	AUX
bjos-8666337	124	21	decreased	decrease	VERB
bjos-8666337	124	22	.	.	PUNCT
bjos-8666337	125	1	these	these	DET
bjos-8666337	125	2	differences	difference	NOUN
bjos-8666337	125	3	may	may	AUX
bjos-8666337	125	4	be	be	AUX
bjos-8666337	125	5	attributed	attribute	VERB
bjos-8666337	125	6	to	to	ADP
bjos-8666337	125	7	the	the	DET
bjos-8666337	125	8	role	role	NOUN
bjos-8666337	125	9	of	of	ADP
bjos-8666337	125	10	hpv	hpv	NOUN
bjos-8666337	125	11	in	in	ADP
bjos-8666337	125	12	hnscc	hnscc	NOUN
bjos-8666337	125	13	pathogenesis5	pathogenesis5	NOUN
bjos-8666337	125	14	.	.	PUNCT
bjos-8666337	126	1	the	the	DET
bjos-8666337	126	2	role	role	NOUN
bjos-8666337	126	3	of	of	ADP
bjos-8666337	126	4	hpv	hpv	PROPN
bjos-8666337	126	5	virus	virus	NOUN
bjos-8666337	126	6	in	in	ADP
bjos-8666337	126	7	anogenital	anogenital	ADJ
bjos-8666337	126	8	cancers	cancer	NOUN
bjos-8666337	126	9	is	be	AUX
bjos-8666337	126	10	confirmed	confirm	VERB
bjos-8666337	126	11	.	.	PUNCT
bjos-8666337	127	1	furthermore	furthermore	ADV
bjos-8666337	127	2	,	,	PUNCT
bjos-8666337	127	3	hpv	hpv	PROPN
bjos-8666337	127	4	has	have	VERB
bjos-8666337	127	5	a	a	DET
bjos-8666337	127	6	role	role	NOUN
bjos-8666337	127	7	in	in	ADP
bjos-8666337	127	8	20	20	NUM
bjos-8666337	127	9	–	–	SYM
bjos-8666337	127	10	40	40	NUM
bjos-8666337	127	11	%	%	NOUN
bjos-8666337	127	12	of	of	ADP
bjos-8666337	127	13	hnscc6	hnscc6	PROPN
bjos-8666337	127	14	.	.	PUNCT
bjos-8666337	128	1	pcr	pcr	PROPN
bjos-8666337	128	2	test	test	NOUN
bjos-8666337	128	3	to	to	PART
bjos-8666337	128	4	detect	detect	VERB
bjos-8666337	128	5	the	the	DET
bjos-8666337	128	6	expression	expression	NOUN
bjos-8666337	128	7	of	of	ADP
bjos-8666337	128	8	e6	e6	PROPN
bjos-8666337	128	9	and	and	CCONJ
bjos-8666337	128	10	e7	e7	PROPN
bjos-8666337	128	11	oncogenes	oncogene	NOUN
bjos-8666337	128	12	in	in	ADP
bjos-8666337	128	13	hpv	hpv	PROPN
bjos-8666337	128	14	virus	virus	NOUN
bjos-8666337	128	15	is	be	AUX
bjos-8666337	128	16	the	the	DET
bjos-8666337	128	17	best	good	ADJ
bjos-8666337	128	18	diagnostic	diagnostic	ADJ
bjos-8666337	128	19	test	test	NOUN
bjos-8666337	128	20	for	for	ADP
bjos-8666337	128	21	detection	detection	NOUN
bjos-8666337	128	22	of	of	ADP
bjos-8666337	128	23	hpv	hpv	NOUN
bjos-8666337	128	24	in	in	ADP
bjos-8666337	128	25	hnscc7	hnscc7	PROPN
bjos-8666337	128	26	.	.	PUNCT
bjos-8666337	129	1	the	the	DET
bjos-8666337	129	2	carcinogenic	carcinogenic	NOUN
bjos-8666337	129	3	’s	’s	PART
bjos-8666337	129	4	mechanism	mechanism	NOUN
bjos-8666337	129	5	of	of	ADP
bjos-8666337	129	6	hnscc	hnscc	NOUN
bjos-8666337	129	7	is	be	AUX
bjos-8666337	129	8	attributed	attribute	VERB
bjos-8666337	129	9	to	to	ADP
bjos-8666337	129	10	e6	e6	PROPN
bjos-8666337	129	11	and	and	CCONJ
bjos-8666337	129	12	e7	e7	PROPN
bjos-8666337	129	13	oncogenes	oncogene	NOUN
bjos-8666337	129	14	.	.	PUNCT
bjos-8666337	130	1	hpv	hpv	PROPN
bjos-8666337	130	2	-	-	PUNCT
bjos-8666337	130	3	e7	e7	PROPN
bjos-8666337	130	4	protein	protein	NOUN
bjos-8666337	130	5	disrupts	disrupt	VERB
bjos-8666337	130	6	the	the	DET
bjos-8666337	130	7	prb	prb	ADV
bjos-8666337	130	8	-	-	PUNCT
bjos-8666337	130	9	mediated	mediate	VERB
bjos-8666337	130	10	cell	cell	NOUN
bjos-8666337	130	11	-	-	PUNCT
bjos-8666337	130	12	cycle	cycle	NOUN
bjos-8666337	130	13	control	control	NOUN
bjos-8666337	130	14	and	and	CCONJ
bjos-8666337	130	15	causes	cause	VERB
bjos-8666337	130	16	a	a	DET
bjos-8666337	130	17	reduction	reduction	NOUN
bjos-8666337	130	18	in	in	ADP
bjos-8666337	130	19	cyclin	cyclin	NOUN
bjos-8666337	130	20	d1	d1	PROPN
bjos-8666337	130	21	synthesis	synthesis	NOUN
bjos-8666337	130	22	and	and	CCONJ
bjos-8666337	130	23	the	the	DET
bjos-8666337	130	24	over	over	NOUN
bjos-8666337	130	25	-	-	PUNCT
bjos-8666337	130	26	expression	expression	NOUN
bjos-8666337	130	27	of	of	ADP
bjos-8666337	130	28	the	the	DET
bjos-8666337	130	29	cyclin	cyclin	NOUN
bjos-8666337	130	30	-	-	PUNCT
bjos-8666337	130	31	dependent	dependent	ADJ
bjos-8666337	130	32	kinase	kinase	NOUN
bjos-8666337	130	33	4/6	4/6	NUM
bjos-8666337	130	34	inhibitor	inhibitor	NOUN
bjos-8666337	130	35	p16ink4a	p16ink4a	NOUN
bjos-8666337	130	36	.	.	PUNCT
bjos-8666337	131	1	hpv	hpv	PROPN
bjos-8666337	131	2	e6	e6	PROPN
bjos-8666337	131	3	protein	protein	NOUN
bjos-8666337	131	4	promotes	promote	VERB
bjos-8666337	131	5	the	the	DET
bjos-8666337	131	6	destruction	destruction	NOUN
bjos-8666337	131	7	of	of	ADP
bjos-8666337	131	8	p53	p53	NOUN
bjos-8666337	131	9	tumor	tumor	NOUN
bjos-8666337	131	10	suppressor	suppressor	PROPN
bjos-8666337	131	11	gene8	gene8	PROPN
bjos-8666337	131	12	.	.	PUNCT
bjos-8666337	132	1	hpv	hpv	PROPN
bjos-8666337	132	2	positive	positive	ADJ
bjos-8666337	132	3	hnscc	hnscc	NOUN
bjos-8666337	132	4	patients	patient	NOUN
bjos-8666337	132	5	have	have	VERB
bjos-8666337	132	6	a	a	DET
bjos-8666337	132	7	better	well	ADJ
bjos-8666337	132	8	prognosis	prognosis	NOUN
bjos-8666337	132	9	than	than	ADP
bjos-8666337	132	10	hpv	hpv	ADJ
bjos-8666337	132	11	negative	negative	ADJ
bjos-8666337	132	12	patients	patient	NOUN
bjos-8666337	132	13	,	,	PUNCT
bjos-8666337	132	14	and	and	CCONJ
bjos-8666337	132	15	their	their	PRON
bjos-8666337	132	16	response	response	NOUN
bjos-8666337	132	17	to	to	ADP
bjos-8666337	132	18	treatment	treatment	NOUN
bjos-8666337	132	19	is	be	AUX
bjos-8666337	132	20	better9	better9	ADJ
bjos-8666337	132	21	.	.	PUNCT
bjos-8666337	133	1	some	some	DET
bjos-8666337	133	2	studies	study	NOUN
bjos-8666337	133	3	suggested	suggest	VERB
bjos-8666337	133	4	that	that	SCONJ
bjos-8666337	133	5	hpv-18	hpv-18	NOUN
bjos-8666337	133	6	is	be	AUX
bjos-8666337	133	7	the	the	DET
bjos-8666337	133	8	dominant	dominant	ADJ
bjos-8666337	133	9	type	type	NOUN
bjos-8666337	133	10	of	of	ADP
bjos-8666337	133	11	hpv	hpv	NOUN
bjos-8666337	133	12	in	in	ADP
bjos-8666337	133	13	iranian	iranian	ADJ
bjos-8666337	133	14	hnscc	hnscc	NOUN
bjos-8666337	133	15	patients	patient	NOUN
bjos-8666337	133	16	,	,	PUNCT
bjos-8666337	133	17	but	but	CCONJ
bjos-8666337	133	18	these	these	DET
bjos-8666337	133	19	reports	report	NOUN
bjos-8666337	133	20	are	be	AUX
bjos-8666337	133	21	controversial	controversial	ADJ
bjos-8666337	133	22	and	and	CCONJ
bjos-8666337	133	23	this	this	DET
bjos-8666337	133	24	controversy	controversy	NOUN
bjos-8666337	133	25	attribute	attribute	NOUN
bjos-8666337	133	26	to	to	ADP
bjos-8666337	133	27	the	the	DET
bjos-8666337	133	28	geographic	geographic	ADJ
bjos-8666337	133	29	,	,	PUNCT
bjos-8666337	133	30	cultural	cultural	ADJ
bjos-8666337	133	31	,	,	PUNCT
bjos-8666337	133	32	and	and	CCONJ
bjos-8666337	133	33	habit	habit	NOUN
bjos-8666337	133	34	difference10,11	difference10,11	NOUN
bjos-8666337	133	35	.	.	PUNCT
bjos-8666337	134	1	wood	wood	NOUN
bjos-8666337	134	2	et	et	PROPN
bjos-8666337	134	3	al.13	al.13	NOUN
bjos-8666337	134	4	showed	show	VERB
bjos-8666337	134	5	that	that	SCONJ
bjos-8666337	134	6	the	the	DET
bjos-8666337	134	7	prevalence	prevalence	NOUN
bjos-8666337	134	8	of	of	ADP
bjos-8666337	134	9	oral	oral	ADJ
bjos-8666337	134	10	hpv	hpv	NOUN
bjos-8666337	134	11	varied	varied	ADJ
bjos-8666337	134	12	significantly	significantly	ADV
bjos-8666337	134	13	in	in	ADP
bjos-8666337	134	14	different	different	ADJ
bjos-8666337	134	15	geographical	geographical	ADJ
bjos-8666337	134	16	areas	area	NOUN
bjos-8666337	134	17	.	.	PUNCT
bjos-8666337	135	1	seifi	seifi	NOUN
bjos-8666337	135	2	et	et	PROPN
bjos-8666337	135	3	al.11	al.11	PROPN
bjos-8666337	135	4	introduced	introduce	VERB
bjos-8666337	135	5	hpv-18	hpv-18	NOUN
bjos-8666337	135	6	as	as	ADP
bjos-8666337	135	7	the	the	DET
bjos-8666337	135	8	dominant	dominant	ADJ
bjos-8666337	135	9	type	type	NOUN
bjos-8666337	135	10	of	of	ADP
bjos-8666337	135	11	virus	virus	NOUN
bjos-8666337	135	12	in	in	ADP
bjos-8666337	135	13	east	east	PROPN
bjos-8666337	135	14	azerbaijan	azerbaijan	PROPN
bjos-8666337	135	15	province	province	PROPN
bjos-8666337	135	16	of	of	ADP
bjos-8666337	135	17	iran	iran	PROPN
bjos-8666337	135	18	.	.	PUNCT
bjos-8666337	136	1	delavarian	delavarian	PROPN
bjos-8666337	136	2	et	et	PROPN
bjos-8666337	136	3	al.14	al.14	PROPN
bjos-8666337	136	4	found	find	VERB
bjos-8666337	136	5	no	no	DET
bjos-8666337	136	6	correlation	correlation	NOUN
bjos-8666337	136	7	between	between	ADP
bjos-8666337	136	8	oral	oral	ADJ
bjos-8666337	136	9	scc	scc	NOUN
bjos-8666337	136	10	and	and	CCONJ
bjos-8666337	136	11	hpv	hpv	ADJ
bjos-8666337	136	12	infection	infection	NOUN
bjos-8666337	136	13	.	.	PUNCT
bjos-8666337	137	1	these	these	DET
bjos-8666337	137	2	results	result	NOUN
bjos-8666337	137	3	were	be	AUX
bjos-8666337	137	4	in	in	ADP
bjos-8666337	137	5	line	line	NOUN
bjos-8666337	137	6	with	with	ADP
bjos-8666337	137	7	sibers	siber	NOUN
bjos-8666337	137	8	et	et	NOUN
bjos-8666337	137	9	al.12	al.12	PROPN
bjos-8666337	137	10	and	and	CCONJ
bjos-8666337	137	11	sisk	sisk	PROPN
bjos-8666337	137	12	et	et	PROPN
bjos-8666337	137	13	al.15	al.15	PROPN
bjos-8666337	137	14	but	but	CCONJ
bjos-8666337	137	15	in	in	ADP
bjos-8666337	137	16	contrast	contrast	NOUN
bjos-8666337	137	17	with	with	ADP
bjos-8666337	137	18	kreimer	kreimer	PROPN
bjos-8666337	137	19	et	et	PROPN
bjos-8666337	137	20	al.17	al.17	PROPN
bjos-8666337	137	21	.	.	PUNCT
bjos-8666337	138	1	a	a	DET
bjos-8666337	138	2	systematic	systematic	ADJ
bjos-8666337	138	3	review	review	NOUN
bjos-8666337	138	4	study	study	NOUN
bjos-8666337	138	5	by	by	ADP
bjos-8666337	138	6	jalilvand	jalilvand	PROPN
bjos-8666337	138	7	et	et	PROPN
bjos-8666337	138	8	al	al	PROPN
bjos-8666337	138	9	.	.	PROPN
bjos-8666337	138	10	stated	state	VERB
bjos-8666337	138	11	that	that	SCONJ
bjos-8666337	138	12	hpv	hpv	PROPN
bjos-8666337	138	13	was	be	AUX
bjos-8666337	138	14	detected	detect	VERB
bjos-8666337	138	15	in	in	ADP
bjos-8666337	138	16	44.4	44.4	NUM
bjos-8666337	138	17	%	%	NOUN
bjos-8666337	138	18	of	of	ADP
bjos-8666337	138	19	patients	patient	NOUN
bjos-8666337	138	20	with	with	ADP
bjos-8666337	138	21	head	head	NOUN
bjos-8666337	138	22	and	and	CCONJ
bjos-8666337	138	23	neck	neck	NOUN
bjos-8666337	138	24	cancers16	cancers16	NOUN
bjos-8666337	138	25	.	.	PUNCT
bjos-8666337	139	1	the	the	DET
bjos-8666337	139	2	most	most	ADV
bjos-8666337	139	3	common	common	ADJ
bjos-8666337	139	4	hpv	hpv	ADJ
bjos-8666337	139	5	types	type	NOUN
bjos-8666337	139	6	were	be	AUX
bjos-8666337	139	7	hpv-16	hpv-16	NUM
bjos-8666337	139	8	and	and	CCONJ
bjos-8666337	139	9	-18	-18	PROPN
bjos-8666337	139	10	.	.	PUNCT
bjos-8666337	140	1	there	there	PRON
bjos-8666337	140	2	was	be	VERB
bjos-8666337	140	3	a	a	DET
bjos-8666337	140	4	strong	strong	ADJ
bjos-8666337	140	5	association	association	NOUN
bjos-8666337	140	6	between	between	ADP
bjos-8666337	140	7	hpv-16	hpv-16	NUM
bjos-8666337	140	8	and	and	CCONJ
bjos-8666337	140	9	oropharyngeal	oropharyngeal	NOUN
bjos-8666337	140	10	cancer	cancer	NOUN
bjos-8666337	140	11	.	.	PUNCT
bjos-8666337	141	1	these	these	DET
bjos-8666337	141	2	studies	study	NOUN
bjos-8666337	141	3	reflect	reflect	VERB
bjos-8666337	141	4	the	the	DET
bjos-8666337	141	5	controversial	controversial	ADJ
bjos-8666337	141	6	reports	report	NOUN
bjos-8666337	141	7	about	about	ADP
bjos-8666337	141	8	hpv	hpv	NOUN
bjos-8666337	141	9	prevalence	prevalence	NOUN
bjos-8666337	141	10	and	and	CCONJ
bjos-8666337	141	11	its	its	PRON
bjos-8666337	141	12	subtypes	subtype	NOUN
bjos-8666337	141	13	in	in	ADP
bjos-8666337	141	14	iran	iran	PROPN
bjos-8666337	141	15	.	.	PUNCT
bjos-8666337	142	1	this	this	DET
bjos-8666337	142	2	controversy	controversy	NOUN
bjos-8666337	142	3	recently	recently	ADV
bjos-8666337	142	4	confirmed	confirm	VERB
bjos-8666337	142	5	by	by	ADP
bjos-8666337	142	6	a	a	DET
bjos-8666337	142	7	systematic	systematic	ADJ
bjos-8666337	142	8	review	review	NOUN
bjos-8666337	142	9	study18	study18	NOUN
bjos-8666337	142	10	.	.	PUNCT
bjos-8666337	143	1	in	in	ADP
bjos-8666337	143	2	conclusion	conclusion	NOUN
bjos-8666337	143	3	,	,	PUNCT
bjos-8666337	143	4	the	the	DET
bjos-8666337	143	5	hpv	hpv	NOUN
bjos-8666337	143	6	vaccine	vaccine	NOUN
bjos-8666337	143	7	is	be	AUX
bjos-8666337	143	8	available	available	ADJ
bjos-8666337	143	9	for	for	ADP
bjos-8666337	143	10	the	the	DET
bjos-8666337	143	11	prevention	prevention	NOUN
bjos-8666337	143	12	of	of	ADP
bjos-8666337	143	13	cervical	cervical	ADJ
bjos-8666337	143	14	cancer	cancer	NOUN
bjos-8666337	143	15	.	.	PUNCT
bjos-8666337	144	1	gardasil	gardasil	PROPN
bjos-8666337	144	2	is	be	AUX
bjos-8666337	144	3	a	a	DET
bjos-8666337	144	4	type	type	NOUN
bjos-8666337	144	5	of	of	ADP
bjos-8666337	144	6	hpv	hpv	ADJ
bjos-8666337	144	7	vaccine	vaccine	NOUN
bjos-8666337	144	8	which	which	PRON
bjos-8666337	144	9	induces	induce	VERB
bjos-8666337	144	10	immunity	immunity	NOUN
bjos-8666337	144	11	against	against	ADP
bjos-8666337	144	12	hpv-6	hpv-6	PRON
bjos-8666337	144	13	,	,	PUNCT
bjos-8666337	144	14	-11	-11	NUM
bjos-8666337	144	15	,	,	PUNCT
bjos-8666337	144	16	-16	-16	NUM
bjos-8666337	144	17	,	,	PUNCT
bjos-8666337	144	18	-18	-18	NUM
bjos-8666337	144	19	.	.	PUNCT
bjos-8666337	145	1	clinical	clinical	ADJ
bjos-8666337	145	2	trials	trial	NOUN
bjos-8666337	145	3	on	on	ADP
bjos-8666337	145	4	the	the	DET
bjos-8666337	145	5	effectiveness	effectiveness	NOUN
bjos-8666337	145	6	of	of	ADP
bjos-8666337	145	7	this	this	DET
bjos-8666337	145	8	vaccine	vaccine	NOUN
bjos-8666337	145	9	showed	show	VERB
bjos-8666337	145	10	over	over	ADP
bjos-8666337	145	11	98	98	NUM
bjos-8666337	145	12	%	%	NOUN
bjos-8666337	145	13	efficacy	efficacy	NOUN
bjos-8666337	145	14	in	in	ADP
bjos-8666337	145	15	the	the	DET
bjos-8666337	145	16	prevention	prevention	NOUN
bjos-8666337	145	17	of	of	ADP
bjos-8666337	145	18	cervical	cervical	ADJ
bjos-8666337	145	19	,	,	PUNCT
bjos-8666337	145	20	anal	anal	ADJ
bjos-8666337	145	21	,	,	PUNCT
bjos-8666337	145	22	vulvar	vulvar	NOUN
bjos-8666337	145	23	,	,	PUNCT
bjos-8666337	145	24	and	and	CCONJ
bjos-8666337	145	25	vaginal	vaginal	ADJ
bjos-8666337	145	26	cancers19	cancers19	NOUN
bjos-8666337	145	27	.	.	PUNCT
bjos-8666337	146	1	genomic	genomic	ADJ
bjos-8666337	146	2	analysis	analysis	NOUN
bjos-8666337	146	3	of	of	ADP
bjos-8666337	146	4	hpv	hpv	NOUN
bjos-8666337	146	5	in	in	ADP
bjos-8666337	146	6	the	the	DET
bjos-8666337	146	7	saliva	saliva	NOUN
bjos-8666337	146	8	of	of	ADP
bjos-8666337	146	9	hnscc	hnscc	NOUN
bjos-8666337	146	10	patients	patient	NOUN
bjos-8666337	146	11	in	in	ADP
bjos-8666337	146	12	the	the	DET
bjos-8666337	146	13	present	present	ADJ
bjos-8666337	146	14	study	study	NOUN
bjos-8666337	146	15	is	be	AUX
bjos-8666337	146	16	a	a	DET
bjos-8666337	146	17	starting	starting	NOUN
bjos-8666337	146	18	point	point	NOUN
bjos-8666337	146	19	for	for	ADP
bjos-8666337	146	20	designing	design	VERB
bjos-8666337	146	21	a	a	DET
bjos-8666337	146	22	vaccine	vaccine	NOUN
bjos-8666337	146	23	to	to	PART
bjos-8666337	146	24	prevent	prevent	VERB
bjos-8666337	146	25	hpv	hpv	NOUN
bjos-8666337	146	26	-	-	PUNCT
bjos-8666337	146	27	associated	associate	VERB
bjos-8666337	146	28	hnscc	hnscc	NOUN
bjos-8666337	146	29	.	.	PUNCT
bjos-8666337	147	1	disclosure	disclosure	NOUN
bjos-8666337	147	2	statement	statement	NOUN
bjos-8666337	147	3	no	no	DET
bjos-8666337	147	4	potential	potential	ADJ
bjos-8666337	147	5	conflict	conflict	NOUN
bjos-8666337	147	6	of	of	ADP
bjos-8666337	147	7	interest	interest	NOUN
bjos-8666337	147	8	was	be	AUX
bjos-8666337	147	9	reported	report	VERB
bjos-8666337	147	10	by	by	ADP
bjos-8666337	147	11	the	the	DET
bjos-8666337	147	12	authors	author	NOUN
bjos-8666337	147	13	.	.	PUNCT
bjos-8666337	148	1	9	9	NUM
bjos-8666337	148	2	koopaie	koopaie	PROPN
bjos-8666337	148	3	et	et	PROPN
bjos-8666337	148	4	al	al	PROPN
bjos-8666337	148	5	.	.	PROPN
bjos-8666337	148	6	braz	braz	PROPN
bjos-8666337	148	7	j	j	PROPN
bjos-8666337	148	8	oral	oral	PROPN
bjos-8666337	148	9	sci	sci	PROPN
bjos-8666337	148	10	.	.	PUNCT
bjos-8666337	149	1	2022;21	2022;21	NUM
bjos-8666337	149	2	:	:	PUNCT
bjos-8666337	149	3	e226337	e226337	NOUN
bjos-8666337	149	4	acknowledgments	acknowledgment	NOUN
bjos-8666337	149	5	the	the	DET
bjos-8666337	149	6	authors	author	NOUN
bjos-8666337	149	7	would	would	AUX
bjos-8666337	149	8	like	like	VERB
bjos-8666337	149	9	to	to	PART
bjos-8666337	149	10	acknowledge	acknowledge	VERB
bjos-8666337	149	11	the	the	DET
bjos-8666337	149	12	help	help	NOUN
bjos-8666337	149	13	and	and	CCONJ
bjos-8666337	149	14	support	support	NOUN
bjos-8666337	149	15	by	by	ADP
bjos-8666337	149	16	imam	imam	PROPN
bjos-8666337	149	17	khomeini	khomeini	PROPN
bjos-8666337	149	18	hospital	hospital	PROPN
bjos-8666337	149	19	,	,	PUNCT
bjos-8666337	149	20	tehran	tehran	PROPN
bjos-8666337	149	21	university	university	PROPN
bjos-8666337	149	22	of	of	ADP
bjos-8666337	149	23	medical	medical	PROPN
bjos-8666337	149	24	sciences	science	NOUN
bjos-8666337	149	25	and	and	CCONJ
bjos-8666337	149	26	school	school	NOUN
bjos-8666337	149	27	of	of	ADP
bjos-8666337	149	28	dentistry	dentistry	NOUN
bjos-8666337	149	29	,	,	PUNCT
bjos-8666337	149	30	tehran	tehran	PROPN
bjos-8666337	149	31	university	university	PROPN
bjos-8666337	149	32	of	of	ADP
bjos-8666337	149	33	medical	medical	ADJ
bjos-8666337	149	34	sciences	science	NOUN
bjos-8666337	149	35	for	for	ADP
bjos-8666337	149	36	their	their	PRON
bjos-8666337	149	37	constant	constant	ADJ
bjos-8666337	149	38	assistance	assistance	NOUN
bjos-8666337	149	39	with	with	ADP
bjos-8666337	149	40	the	the	DET
bjos-8666337	149	41	research	research	NOUN
bjos-8666337	149	42	.	.	PUNCT
bjos-8666337	150	1	data	datum	NOUN
bjos-8666337	150	2	availability	availability	NOUN
bjos-8666337	150	3	datasets	dataset	NOUN
bjos-8666337	150	4	related	relate	VERB
bjos-8666337	150	5	to	to	ADP
bjos-8666337	150	6	this	this	DET
bjos-8666337	150	7	article	article	NOUN
bjos-8666337	150	8	will	will	AUX
bjos-8666337	150	9	be	be	AUX
bjos-8666337	150	10	available	available	ADJ
bjos-8666337	150	11	upon	upon	SCONJ
bjos-8666337	150	12	request	request	NOUN
bjos-8666337	150	13	to	to	ADP
bjos-8666337	150	14	the	the	DET
bjos-8666337	150	15	corresponding	corresponding	ADJ
bjos-8666337	150	16	author	author	NOUN
bjos-8666337	150	17	.	.	PUNCT
bjos-8666337	151	1	authors	author	NOUN
bjos-8666337	151	2	contribution	contribution	VERB
bjos-8666337	151	3	mk	mk	PROPN
bjos-8666337	151	4	and	and	CCONJ
bjos-8666337	151	5	md	md	PROPN
bjos-8666337	151	6	conceived	conceive	VERB
bjos-8666337	151	7	the	the	DET
bjos-8666337	151	8	study	study	NOUN
bjos-8666337	151	9	idea	idea	NOUN
bjos-8666337	151	10	and	and	CCONJ
bjos-8666337	151	11	led	lead	VERB
bjos-8666337	151	12	data	datum	NOUN
bjos-8666337	151	13	collection	collection	NOUN
bjos-8666337	151	14	.	.	PUNCT
bjos-8666337	152	1	mk	mk	PROPN
bjos-8666337	152	2	,	,	PUNCT
bjos-8666337	152	3	man	man	NOUN
bjos-8666337	152	4	,	,	PUNCT
bjos-8666337	152	5	and	and	CCONJ
bjos-8666337	152	6	md	md	PROPN
bjos-8666337	152	7	created	create	VERB
bjos-8666337	152	8	the	the	DET
bjos-8666337	152	9	study	study	NOUN
bjos-8666337	152	10	protocol	protocol	NOUN
bjos-8666337	152	11	and	and	CCONJ
bjos-8666337	152	12	wrote	write	VERB
bjos-8666337	152	13	the	the	DET
bjos-8666337	152	14	original	original	ADJ
bjos-8666337	152	15	draft	draft	NOUN
bjos-8666337	152	16	.	.	PUNCT
bjos-8666337	153	1	man	man	NOUN
bjos-8666337	153	2	and	and	CCONJ
bjos-8666337	153	3	sm	sm	PROPN
bjos-8666337	153	4	contributed	contribute	VERB
bjos-8666337	153	5	in	in	ADP
bjos-8666337	153	6	collecting	collect	VERB
bjos-8666337	153	7	the	the	DET
bjos-8666337	153	8	saliva	saliva	NOUN
bjos-8666337	153	9	sample	sample	NOUN
bjos-8666337	153	10	.	.	PUNCT
bjos-8666337	154	1	md	md	PROPN
bjos-8666337	154	2	,	,	PUNCT
bjos-8666337	154	3	mk	mk	PROPN
bjos-8666337	154	4	and	and	CCONJ
bjos-8666337	154	5	man	man	NOUN
bjos-8666337	154	6	contributed	contribute	VERB
bjos-8666337	154	7	to	to	ADP
bjos-8666337	154	8	data	data	NOUN
bjos-8666337	154	9	analysis	analysis	NOUN
bjos-8666337	154	10	/	/	SYM
bjos-8666337	154	11	interpretation	interpretation	NOUN
bjos-8666337	154	12	and	and	CCONJ
bjos-8666337	154	13	preparation	preparation	NOUN
bjos-8666337	154	14	of	of	ADP
bjos-8666337	154	15	the	the	DET
bjos-8666337	154	16	manuscript	manuscript	NOUN
bjos-8666337	154	17	.	.	PUNCT
bjos-8666337	155	1	mk	mk	PROPN
bjos-8666337	155	2	,	,	PUNCT
bjos-8666337	155	3	man	man	NOUN
bjos-8666337	155	4	and	and	CCONJ
bjos-8666337	155	5	sm	sm	PROPN
bjos-8666337	155	6	led	lead	VERB
bjos-8666337	155	7	the	the	DET
bjos-8666337	155	8	writing	writing	NOUN
bjos-8666337	155	9	review	review	NOUN
bjos-8666337	155	10	&	&	CCONJ
bjos-8666337	155	11	editing	editing	PROPN
bjos-8666337	155	12	.	.	PUNCT
bjos-8666337	156	1	mk	mk	NOUN
bjos-8666337	156	2	and	and	CCONJ
bjos-8666337	156	3	md	md	PROPN
bjos-8666337	156	4	interpreted	interpret	VERB
bjos-8666337	156	5	the	the	DET
bjos-8666337	156	6	results	result	NOUN
bjos-8666337	156	7	.	.	PUNCT
bjos-8666337	157	1	all	all	DET
bjos-8666337	157	2	authors	author	NOUN
bjos-8666337	157	3	read	read	VERB
bjos-8666337	157	4	and	and	CCONJ
bjos-8666337	157	5	approved	approve	VERB
bjos-8666337	157	6	the	the	DET
bjos-8666337	157	7	final	final	ADJ
bjos-8666337	157	8	manuscript	manuscript	NOUN
bjos-8666337	157	9	.	.	PUNCT
bjos-8666337	158	1	references	reference	NOUN
bjos-8666337	158	2	1	1	NUM
bjos-8666337	158	3	.	.	PUNCT
bjos-8666337	158	4	jasim	jasim	PROPN
bjos-8666337	158	5	h	h	PROPN
bjos-8666337	158	6	,	,	PUNCT
bjos-8666337	158	7	carlsson	carlsson	PROPN
bjos-8666337	158	8	a	a	PROPN
bjos-8666337	158	9	,	,	PUNCT
bjos-8666337	158	10	hedenberg	hedenberg	PROPN
bjos-8666337	158	11	-	-	PUNCT
bjos-8666337	158	12	magnusson	magnusson	PROPN
bjos-8666337	158	13	b	b	PROPN
bjos-8666337	158	14	,	,	PUNCT
bjos-8666337	158	15	ghafouri	ghafouri	PROPN
bjos-8666337	158	16	b	b	PROPN
bjos-8666337	158	17	,	,	PUNCT
bjos-8666337	158	18	ernberg	ernberg	PROPN
bjos-8666337	158	19	m.	m.	NOUN
bjos-8666337	158	20	saliva	saliva	NOUN
bjos-8666337	158	21	as	as	ADP
bjos-8666337	158	22	a	a	DET
bjos-8666337	158	23	medium	medium	NOUN
bjos-8666337	158	24	to	to	PART
bjos-8666337	158	25	detect	detect	VERB
bjos-8666337	158	26	and	and	CCONJ
bjos-8666337	158	27	measure	measure	VERB
bjos-8666337	158	28	biomarkers	biomarker	NOUN
bjos-8666337	158	29	related	relate	VERB
bjos-8666337	158	30	to	to	ADP
bjos-8666337	158	31	pain	pain	NOUN
bjos-8666337	158	32	.	.	PUNCT
bjos-8666337	159	1	sci	sci	PROPN
bjos-8666337	159	2	rep	rep	PROPN
bjos-8666337	159	3	.	.	PROPN
bjos-8666337	159	4	2018	2018	NUM
bjos-8666337	159	5	feb	feb	X
bjos-8666337	159	6	19;8(1):3220	19;8(1):3220	NUM
bjos-8666337	159	7	.	.	PUNCT
bjos-8666337	159	8	doi	doi	NOUN
bjos-8666337	159	9	:	:	PUNCT
bjos-8666337	159	10	10.1038	10.1038	NUM
bjos-8666337	159	11	/	/	SYM
bjos-8666337	159	12	s41598	s41598	NOUN
bjos-8666337	159	13	-	-	PUNCT
bjos-8666337	159	14	018	018	NUM
bjos-8666337	159	15	-	-	PUNCT
bjos-8666337	159	16	21131	21131	NUM
bjos-8666337	159	17	-	-	SYM
bjos-8666337	159	18	4	4	NUM
bjos-8666337	159	19	.	.	NOUN
bjos-8666337	159	20	2	2	NUM
bjos-8666337	159	21	.	.	X
bjos-8666337	160	1	wang	wang	PROPN
bjos-8666337	160	2	s	s	PROPN
bjos-8666337	160	3	,	,	PUNCT
bjos-8666337	160	4	zhuang	zhuang	PROPN
bjos-8666337	160	5	x	x	PROPN
bjos-8666337	160	6	,	,	PUNCT
bjos-8666337	160	7	gao	gao	PROPN
bjos-8666337	160	8	c	c	PROPN
bjos-8666337	160	9	,	,	PUNCT
bjos-8666337	160	10	qiao	qiao	NOUN
bjos-8666337	160	11	t.	t.	ADJ
bjos-8666337	160	12	expression	expression	NOUN
bjos-8666337	160	13	of	of	ADP
bjos-8666337	160	14	p16	p16	NOUN
bjos-8666337	160	15	,	,	PUNCT
bjos-8666337	160	16	p53	p53	NOUN
bjos-8666337	160	17	,	,	PUNCT
bjos-8666337	160	18	and	and	CCONJ
bjos-8666337	160	19	tlr9	tlr9	NOUN
bjos-8666337	160	20	in	in	ADP
bjos-8666337	160	21	hpv	hpv	PROPN
bjos-8666337	160	22	-	-	PUNCT
bjos-8666337	160	23	associated	associate	VERB
bjos-8666337	160	24	head	head	NOUN
bjos-8666337	160	25	and	and	CCONJ
bjos-8666337	160	26	neck	neck	NOUN
bjos-8666337	160	27	squamous	squamous	ADJ
bjos-8666337	160	28	cell	cell	NOUN
bjos-8666337	160	29	carcinoma	carcinoma	NOUN
bjos-8666337	160	30	:	:	PUNCT
bjos-8666337	160	31	clinicopathological	clinicopathological	ADJ
bjos-8666337	160	32	correlations	correlation	NOUN
bjos-8666337	160	33	and	and	CCONJ
bjos-8666337	160	34	potential	potential	ADJ
bjos-8666337	160	35	prognostic	prognostic	ADJ
bjos-8666337	160	36	significance	significance	NOUN
bjos-8666337	160	37	.	.	PUNCT
bjos-8666337	161	1	onco	onco	NOUN
bjos-8666337	161	2	targets	target	NOUN
bjos-8666337	161	3	ther	ther	ADV
bjos-8666337	161	4	.	.	PUNCT
bjos-8666337	162	1	2021	2021	NUM
bjos-8666337	162	2	feb	feb	X
bjos-8666337	162	3	5;14:867	5;14:867	NUM
bjos-8666337	162	4	-	-	SYM
bjos-8666337	162	5	77	77	NUM
bjos-8666337	162	6	.	.	PUNCT
bjos-8666337	163	1	doi	doi	NOUN
bjos-8666337	163	2	:	:	PUNCT
bjos-8666337	163	3	10.2147	10.2147	NUM
bjos-8666337	163	4	/	/	SYM
bjos-8666337	163	5	ott.s293163	ott.s293163	NOUN
bjos-8666337	163	6	.	.	PUNCT
bjos-8666337	164	1	3	3	X
bjos-8666337	164	2	.	.	X
bjos-8666337	164	3	wierzbicka	wierzbicka	PROPN
bjos-8666337	164	4	m	m	PROPN
bjos-8666337	164	5	,	,	PUNCT
bjos-8666337	164	6	klussmann	klussmann	PROPN
bjos-8666337	164	7	jp	jp	PROPN
bjos-8666337	164	8	,	,	PUNCT
bjos-8666337	164	9	san	san	PROPN
bjos-8666337	164	10	giorgi	giorgi	PROPN
bjos-8666337	164	11	mr	mr	PROPN
bjos-8666337	164	12	,	,	PUNCT
bjos-8666337	164	13	wuerdemann	wuerdemann	PROPN
bjos-8666337	164	14	n	n	CCONJ
bjos-8666337	164	15	,	,	PUNCT
bjos-8666337	164	16	dikkers	dikker	NOUN
bjos-8666337	164	17	fg	fg	PROPN
bjos-8666337	164	18	.	.	PROPN
bjos-8666337	164	19	oral	oral	ADJ
bjos-8666337	164	20	and	and	CCONJ
bjos-8666337	164	21	laryngeal	laryngeal	ADJ
bjos-8666337	164	22	hpv	hpv	ADJ
bjos-8666337	164	23	infection	infection	NOUN
bjos-8666337	164	24	:	:	PUNCT
bjos-8666337	164	25	incidence	incidence	NOUN
bjos-8666337	164	26	,	,	PUNCT
bjos-8666337	164	27	prevalence	prevalence	NOUN
bjos-8666337	164	28	and	and	CCONJ
bjos-8666337	164	29	risk	risk	NOUN
bjos-8666337	164	30	factors	factor	NOUN
bjos-8666337	164	31	,	,	PUNCT
bjos-8666337	164	32	with	with	ADP
bjos-8666337	164	33	special	special	ADJ
bjos-8666337	164	34	regard	regard	NOUN
bjos-8666337	164	35	to	to	ADP
bjos-8666337	164	36	concurrent	concurrent	ADJ
bjos-8666337	164	37	infection	infection	NOUN
bjos-8666337	164	38	in	in	ADP
bjos-8666337	164	39	head	head	NOUN
bjos-8666337	164	40	,	,	PUNCT
bjos-8666337	164	41	neck	neck	NOUN
bjos-8666337	164	42	and	and	CCONJ
bjos-8666337	164	43	genitals	genital	NOUN
bjos-8666337	164	44	.	.	PUNCT
bjos-8666337	165	1	vaccine	vaccine	NOUN
bjos-8666337	165	2	.	.	PUNCT
bjos-8666337	166	1	2021	2021	NUM
bjos-8666337	166	2	apr	apr	NOUN
bjos-8666337	166	3	22;39(17):2344	22;39(17):2344	NUM
bjos-8666337	166	4	-	-	SYM
bjos-8666337	166	5	2350	2350	NUM
bjos-8666337	166	6	.	.	PUNCT
bjos-8666337	167	1	doi	doi	NOUN
bjos-8666337	167	2	:	:	PUNCT
bjos-8666337	167	3	10.1016	10.1016	NUM
bjos-8666337	167	4	/	/	SYM
bjos-8666337	167	5	j.vaccine.2021.03.047	j.vaccine.2021.03.047	NOUN
bjos-8666337	167	6	.	.	PROPN
bjos-8666337	168	1	4	4	NUM
bjos-8666337	168	2	.	.	X
bjos-8666337	168	3	mcdermott	mcdermott	PROPN
bjos-8666337	168	4	jd	jd	PROPN
bjos-8666337	168	5	,	,	PUNCT
bjos-8666337	168	6	bowles	bowles	PROPN
bjos-8666337	168	7	dw	dw	PROPN
bjos-8666337	168	8	.	.	PROPN
bjos-8666337	169	1	epidemiology	epidemiology	NOUN
bjos-8666337	169	2	of	of	ADP
bjos-8666337	169	3	head	head	NOUN
bjos-8666337	169	4	and	and	CCONJ
bjos-8666337	169	5	neck	neck	VERB
bjos-8666337	169	6	squamous	squamous	ADJ
bjos-8666337	169	7	cell	cell	NOUN
bjos-8666337	169	8	carcinomas	carcinoma	NOUN
bjos-8666337	169	9	:	:	PUNCT
bjos-8666337	169	10	impact	impact	NOUN
bjos-8666337	169	11	on	on	ADP
bjos-8666337	169	12	staging	staging	NOUN
bjos-8666337	169	13	and	and	CCONJ
bjos-8666337	169	14	prevention	prevention	NOUN
bjos-8666337	169	15	strategies	strategy	NOUN
bjos-8666337	169	16	.	.	PUNCT
bjos-8666337	170	1	curr	curr	PROPN
bjos-8666337	170	2	treat	treat	PROPN
bjos-8666337	170	3	options	option	NOUN
bjos-8666337	170	4	oncol	oncol	ADJ
bjos-8666337	170	5	.	.	PUNCT
bjos-8666337	171	1	2019;20(5):1	2019;20(5):1	NUM
bjos-8666337	171	2	-	-	SYM
bjos-8666337	171	3	13	13	NUM
bjos-8666337	171	4	.	.	PUNCT
bjos-8666337	172	1	doi	doi	NOUN
bjos-8666337	172	2	:	:	PUNCT
bjos-8666337	172	3	10.1007	10.1007	NUM
bjos-8666337	172	4	/	/	SYM
bjos-8666337	172	5	s11864	s11864	PROPN
bjos-8666337	172	6	-	-	PUNCT
bjos-8666337	172	7	019	019	NUM
bjos-8666337	172	8	-	-	PUNCT
bjos-8666337	172	9	0650	0650	NUM
bjos-8666337	172	10	-	-	PUNCT
bjos-8666337	172	11	5	5	NUM
bjos-8666337	172	12	.	.	NOUN
bjos-8666337	172	13	5	5	NUM
bjos-8666337	172	14	.	.	X
bjos-8666337	172	15	boscolo	boscolo	NOUN
bjos-8666337	172	16	-	-	PUNCT
bjos-8666337	172	17	rizzo	rizzo	PROPN
bjos-8666337	172	18	p	p	PROPN
bjos-8666337	172	19	,	,	PUNCT
bjos-8666337	172	20	zorzi	zorzi	NOUN
bjos-8666337	172	21	m	m	PROPN
bjos-8666337	172	22	,	,	PUNCT
bjos-8666337	172	23	del	del	X
bjos-8666337	172	24	mistro	mistro	VERB
bjos-8666337	172	25	a	a	PRON
bjos-8666337	172	26	,	,	PUNCT
bjos-8666337	172	27	da	da	PROPN
bjos-8666337	172	28	mosto	mosto	PROPN
bjos-8666337	172	29	mc	mc	PROPN
bjos-8666337	172	30	,	,	PUNCT
bjos-8666337	172	31	tirelli	tirelli	PROPN
bjos-8666337	172	32	g	g	PROPN
bjos-8666337	172	33	,	,	PUNCT
bjos-8666337	172	34	buzzoni	buzzoni	PROPN
bjos-8666337	172	35	c	c	NOUN
bjos-8666337	172	36	,	,	PUNCT
bjos-8666337	172	37	et	et	PROPN
bjos-8666337	172	38	al	al	PROPN
bjos-8666337	172	39	.	.	PUNCT
bjos-8666337	173	1	the	the	DET
bjos-8666337	173	2	evolution	evolution	NOUN
bjos-8666337	173	3	of	of	ADP
bjos-8666337	173	4	the	the	DET
bjos-8666337	173	5	epidemiological	epidemiological	ADJ
bjos-8666337	173	6	landscape	landscape	NOUN
bjos-8666337	173	7	of	of	ADP
bjos-8666337	173	8	head	head	NOUN
bjos-8666337	173	9	and	and	CCONJ
bjos-8666337	173	10	neck	neck	NOUN
bjos-8666337	173	11	cancer	cancer	NOUN
bjos-8666337	173	12	in	in	ADP
bjos-8666337	173	13	italy	italy	PROPN
bjos-8666337	173	14	:	:	PUNCT
bjos-8666337	173	15	is	be	AUX
bjos-8666337	173	16	there	there	PRON
bjos-8666337	173	17	evidence	evidence	NOUN
bjos-8666337	173	18	for	for	ADP
bjos-8666337	173	19	an	an	DET
bjos-8666337	173	20	increase	increase	NOUN
bjos-8666337	173	21	in	in	ADP
bjos-8666337	173	22	the	the	DET
bjos-8666337	173	23	incidence	incidence	NOUN
bjos-8666337	173	24	of	of	ADP
bjos-8666337	173	25	potentially	potentially	ADV
bjos-8666337	173	26	hpv	hpv	NOUN
bjos-8666337	173	27	-	-	PUNCT
bjos-8666337	173	28	related	relate	VERB
bjos-8666337	173	29	carcinomas	carcinoma	NOUN
bjos-8666337	173	30	?	?	PUNCT
bjos-8666337	174	1	plos	plos	PROPN
bjos-8666337	174	2	one	one	NUM
bjos-8666337	174	3	.	.	PUNCT
bjos-8666337	175	1	2018;13(2):e0192621	2018;13(2):e0192621	NUM
bjos-8666337	175	2	.	.	PUNCT
bjos-8666337	175	3	doi	doi	NOUN
bjos-8666337	175	4	:	:	PUNCT
bjos-8666337	175	5	10.1371	10.1371	NUM
bjos-8666337	175	6	/	/	SYM
bjos-8666337	175	7	journal.pone.0192621	journal.pone.0192621	PROPN
bjos-8666337	175	8	.	.	PROPN
bjos-8666337	175	9	6	6	NUM
bjos-8666337	175	10	.	.	NOUN
bjos-8666337	175	11	kofler	kofler	PROPN
bjos-8666337	175	12	b	b	PROPN
bjos-8666337	175	13	,	,	PUNCT
bjos-8666337	175	14	laimer	laimer	PROPN
bjos-8666337	175	15	j	j	PROPN
bjos-8666337	175	16	,	,	PUNCT
bjos-8666337	175	17	bruckmoser	bruckmoser	NOUN
bjos-8666337	175	18	e	e	NOUN
bjos-8666337	175	19	,	,	PUNCT
bjos-8666337	175	20	steinbichler	steinbichler	NOUN
bjos-8666337	175	21	tb	tb	NOUN
bjos-8666337	175	22	,	,	PUNCT
bjos-8666337	175	23	runge	runge	VERB
bjos-8666337	175	24	a	a	DET
bjos-8666337	175	25	,	,	PUNCT
bjos-8666337	175	26	schartinger	schartinger	ADJ
bjos-8666337	175	27	vh	vh	PROPN
bjos-8666337	175	28	,	,	PUNCT
bjos-8666337	175	29	et	et	PROPN
bjos-8666337	175	30	al	al	PROPN
bjos-8666337	175	31	.	.	PUNCT
bjos-8666337	176	1	the	the	DET
bjos-8666337	176	2	role	role	NOUN
bjos-8666337	176	3	of	of	ADP
bjos-8666337	176	4	hpv	hpv	NOUN
bjos-8666337	176	5	and	and	CCONJ
bjos-8666337	176	6	non	non	ADJ
bjos-8666337	176	7	-	-	ADJ
bjos-8666337	176	8	hpv	hpv	ADJ
bjos-8666337	176	9	sexually	sexually	ADV
bjos-8666337	176	10	transmitted	transmit	VERB
bjos-8666337	176	11	infections	infection	NOUN
bjos-8666337	176	12	in	in	ADP
bjos-8666337	176	13	patients	patient	NOUN
bjos-8666337	176	14	with	with	ADP
bjos-8666337	176	15	oropharyngeal	oropharyngeal	ADJ
bjos-8666337	176	16	carcinoma	carcinoma	NOUN
bjos-8666337	176	17	:	:	PUNCT
bjos-8666337	176	18	a	a	DET
bjos-8666337	176	19	case	case	NOUN
bjos-8666337	176	20	control	control	NOUN
bjos-8666337	176	21	study	study	NOUN
bjos-8666337	176	22	.	.	PUNCT
bjos-8666337	177	1	cancers	cancer	NOUN
bjos-8666337	177	2	(	(	PUNCT
bjos-8666337	177	3	basel	basel	PROPN
bjos-8666337	177	4	)	)	PUNCT
bjos-8666337	177	5	.	.	PUNCT
bjos-8666337	178	1	2020;12(5):1192	2020;12(5):1192	X
bjos-8666337	178	2	.	.	PUNCT
bjos-8666337	179	1	doi	doi	NOUN
bjos-8666337	179	2	:	:	PUNCT
bjos-8666337	179	3	10.3390	10.3390	NUM
bjos-8666337	179	4	/	/	SYM
bjos-8666337	179	5	cancers12051192	cancers12051192	NOUN
bjos-8666337	179	6	.	.	PUNCT
bjos-8666337	180	1	7	7	NUM
bjos-8666337	180	2	.	.	X
bjos-8666337	180	3	augustin	augustin	PROPN
bjos-8666337	180	4	jg	jg	PROPN
bjos-8666337	180	5	,	,	PUNCT
bjos-8666337	180	6	lepine	lepine	PROPN
bjos-8666337	180	7	c	c	PROPN
bjos-8666337	180	8	,	,	PUNCT
bjos-8666337	180	9	morini	morini	PROPN
bjos-8666337	180	10	a	a	X
bjos-8666337	180	11	,	,	PUNCT
bjos-8666337	180	12	brunet	brunet	NOUN
bjos-8666337	180	13	a	a	NOUN
bjos-8666337	180	14	,	,	PUNCT
bjos-8666337	180	15	veyer	veyer	NOUN
bjos-8666337	180	16	d	d	PROPN
bjos-8666337	180	17	,	,	PUNCT
bjos-8666337	180	18	brochard	brochard	NOUN
bjos-8666337	180	19	c	c	AUX
bjos-8666337	180	20	,	,	PUNCT
bjos-8666337	180	21	et	et	PROPN
bjos-8666337	180	22	al	al	PROPN
bjos-8666337	180	23	.	.	PROPN
bjos-8666337	180	24	hpv	hpv	PROPN
bjos-8666337	180	25	detection	detection	NOUN
bjos-8666337	180	26	in	in	ADP
bjos-8666337	180	27	head	head	NOUN
bjos-8666337	180	28	and	and	CCONJ
bjos-8666337	180	29	neck	neck	VERB
bjos-8666337	180	30	squamous	squamous	ADJ
bjos-8666337	180	31	cell	cell	NOUN
bjos-8666337	180	32	carcinomas	carcinoma	NOUN
bjos-8666337	180	33	:	:	PUNCT
bjos-8666337	180	34	what	what	PRON
bjos-8666337	180	35	is	be	AUX
bjos-8666337	180	36	the	the	DET
bjos-8666337	180	37	issue	issue	NOUN
bjos-8666337	180	38	?	?	PUNCT
bjos-8666337	181	1	front	front	ADJ
bjos-8666337	181	2	oncol	oncol	ADJ
bjos-8666337	181	3	.	.	PUNCT
bjos-8666337	182	1	2020	2020	NUM
bjos-8666337	182	2	sep	sep	PROPN
bjos-8666337	182	3	15;10:1751	15;10:1751	NUM
bjos-8666337	182	4	.	.	PUNCT
bjos-8666337	183	1	doi	doi	NOUN
bjos-8666337	183	2	:	:	PUNCT
bjos-8666337	183	3	10.3389	10.3389	NUM
bjos-8666337	183	4	/	/	SYM
bjos-8666337	183	5	fonc.2020.01751	fonc.2020.01751	NOUN
bjos-8666337	183	6	.	.	PUNCT
bjos-8666337	184	1	8	8	NUM
bjos-8666337	184	2	.	.	PUNCT
bjos-8666337	185	1	rodriguez	rodriguez	PROPN
bjos-8666337	185	2	j	j	PROPN
bjos-8666337	185	3	,	,	PUNCT
bjos-8666337	185	4	herrero	herrero	PROPN
bjos-8666337	185	5	a	a	PROPN
bjos-8666337	185	6	,	,	PUNCT
bjos-8666337	185	7	li	li	PROPN
bjos-8666337	185	8	s	s	PROPN
bjos-8666337	185	9	,	,	PUNCT
bjos-8666337	185	10	rauch	rauch	VERB
bjos-8666337	185	11	n	n	SYM
bjos-8666337	185	12	,	,	PUNCT
bjos-8666337	185	13	quintanilla	quintanilla	VERB
bjos-8666337	185	14	a	a	PRON
bjos-8666337	185	15	,	,	PUNCT
bjos-8666337	185	16	wynne	wynne	PROPN
bjos-8666337	185	17	k	k	PROPN
bjos-8666337	185	18	,	,	PUNCT
bjos-8666337	185	19	et	et	PROPN
bjos-8666337	185	20	al	al	PROPN
bjos-8666337	185	21	.	.	PUNCT
bjos-8666337	185	22	phd3	phd3	PROPN
bjos-8666337	185	23	regulates	regulate	VERB
bjos-8666337	185	24	p53	p53	NOUN
bjos-8666337	185	25	protein	protein	NOUN
bjos-8666337	185	26	stability	stability	NOUN
bjos-8666337	185	27	by	by	ADP
bjos-8666337	185	28	hydroxylating	hydroxylate	VERB
bjos-8666337	185	29	proline	proline	NOUN
bjos-8666337	185	30	359	359	NUM
bjos-8666337	185	31	.	.	PUNCT
bjos-8666337	186	1	cell	cell	PROPN
bjos-8666337	186	2	rep	rep	PROPN
bjos-8666337	186	3	.	.	PROPN
bjos-8666337	186	4	2018	2018	NUM
bjos-8666337	186	5	jul	jul	PROPN
bjos-8666337	186	6	31;24(5):1316	31;24(5):1316	NUM
bjos-8666337	186	7	-	-	SYM
bjos-8666337	186	8	29	29	NUM
bjos-8666337	186	9	.	.	PUNCT
bjos-8666337	187	1	doi	doi	NOUN
bjos-8666337	187	2	:	:	PUNCT
bjos-8666337	187	3	10.1016	10.1016	NUM
bjos-8666337	187	4	/	/	SYM
bjos-8666337	187	5	j.celrep.2018.06.108	j.celrep.2018.06.108	PROPN
bjos-8666337	187	6	.	.	PUNCT
bjos-8666337	188	1	9	9	X
bjos-8666337	188	2	.	.	PUNCT
bjos-8666337	188	3	kobayashi	kobayashi	PROPN
bjos-8666337	188	4	k	k	PROPN
bjos-8666337	188	5	,	,	PUNCT
bjos-8666337	188	6	hisamatsu	hisamatsu	PROPN
bjos-8666337	188	7	k	k	PROPN
bjos-8666337	188	8	,	,	PUNCT
bjos-8666337	188	9	suzui	suzui	PROPN
bjos-8666337	188	10	n	n	PRON
bjos-8666337	188	11	,	,	PUNCT
bjos-8666337	188	12	hara	hara	PROPN
bjos-8666337	188	13	a	a	PRON
bjos-8666337	188	14	,	,	PUNCT
bjos-8666337	188	15	tomita	tomita	X
bjos-8666337	188	16	h.miyazaki	h.miyazaki	NOUN
bjos-8666337	188	17	t.	t.	VERB
bjos-8666337	188	18	a	a	DET
bjos-8666337	188	19	review	review	NOUN
bjos-8666337	188	20	of	of	ADP
bjos-8666337	188	21	hpv	hpv	NOUN
bjos-8666337	188	22	-	-	PUNCT
bjos-8666337	188	23	related	relate	VERB
bjos-8666337	188	24	head	head	NOUN
bjos-8666337	188	25	and	and	CCONJ
bjos-8666337	188	26	neck	neck	NOUN
bjos-8666337	188	27	cancer	cancer	NOUN
bjos-8666337	188	28	.	.	PUNCT
bjos-8666337	189	1	journal	journal	NOUN
bjos-8666337	189	2	of	of	ADP
bjos-8666337	189	3	clinical	clinical	ADJ
bjos-8666337	189	4	medicine	medicine	NOUN
bjos-8666337	189	5	.	.	PUNCT
bjos-8666337	190	1	2018;7(9):241	2018;7(9):241	X
bjos-8666337	190	2	.	.	PUNCT
bjos-8666337	190	3	doi:10.3390	doi:10.3390	PROPN
bjos-8666337	190	4	/	/	SYM
bjos-8666337	190	5	jcm7090241	jcm7090241	PROPN
bjos-8666337	190	6	.	.	PUNCT
bjos-8666337	191	1	10	10	NUM
bjos-8666337	191	2	koopaie	koopaie	PROPN
bjos-8666337	191	3	et	et	PROPN
bjos-8666337	191	4	al	al	PROPN
bjos-8666337	191	5	.	.	PROPN
bjos-8666337	191	6	braz	braz	PROPN
bjos-8666337	191	7	j	j	PROPN
bjos-8666337	191	8	oral	oral	PROPN
bjos-8666337	191	9	sci	sci	PROPN
bjos-8666337	191	10	.	.	PUNCT
bjos-8666337	192	1	2022;21	2022;21	NUM
bjos-8666337	192	2	:	:	PUNCT
bjos-8666337	192	3	e226337	e226337	NOUN
bjos-8666337	192	4	10	10	NUM
bjos-8666337	192	5	.	.	PUNCT
bjos-8666337	193	1	kermani	kermani	PROPN
bjos-8666337	193	2	ia	ia	PROPN
bjos-8666337	193	3	,	,	PUNCT
bjos-8666337	193	4	seifi	seifi	NOUN
bjos-8666337	193	5	s	s	PROPN
bjos-8666337	193	6	,	,	PUNCT
bjos-8666337	193	7	dolatkhah	dolatkhah	ADJ
bjos-8666337	193	8	r	r	NOUN
bjos-8666337	193	9	,	,	PUNCT
bjos-8666337	193	10	sakhinia	sakhinia	PROPN
bjos-8666337	193	11	e	e	PROPN
bjos-8666337	193	12	,	,	PUNCT
bjos-8666337	193	13	dastgiri	dastgiri	PROPN
bjos-8666337	193	14	s	s	PROPN
bjos-8666337	193	15	,	,	PUNCT
bjos-8666337	193	16	ebrahimi	ebrahimi	PROPN
bjos-8666337	193	17	a	a	X
bjos-8666337	193	18	,	,	PUNCT
bjos-8666337	193	19	et	et	PROPN
bjos-8666337	193	20	al	al	PROPN
bjos-8666337	193	21	.	.	PUNCT
bjos-8666337	193	22	human	human	ADJ
bjos-8666337	193	23	papilloma	papilloma	PROPN
bjos-8666337	193	24	virus	virus	NOUN
bjos-8666337	193	25	in	in	ADP
bjos-8666337	193	26	head	head	NOUN
bjos-8666337	193	27	and	and	CCONJ
bjos-8666337	193	28	neck	neck	VERB
bjos-8666337	193	29	squamous	squamous	ADJ
bjos-8666337	193	30	cell	cell	NOUN
bjos-8666337	193	31	cancer	cancer	NOUN
bjos-8666337	193	32	.	.	PUNCT
bjos-8666337	194	1	iranian	iranian	ADJ
bjos-8666337	194	2	journal	journal	PROPN
bjos-8666337	194	3	of	of	ADP
bjos-8666337	194	4	cancer	cancer	NOUN
bjos-8666337	194	5	prevention	prevention	NOUN
bjos-8666337	194	6	.	.	PUNCT
bjos-8666337	195	1	2012;5(1):21	2012;5(1):21	X
bjos-8666337	195	2	.	.	X
bjos-8666337	195	3	doi	doi	NOUN
bjos-8666337	195	4	:	:	PUNCT
bjos-8666337	195	5	10.1200	10.1200	NUM
bjos-8666337	195	6	/	/	SYM
bjos-8666337	195	7	jco.2011.29.15_suppl.e16011	jco.2011.29.15_suppl.e16011	NOUN
bjos-8666337	195	8	.	.	PUNCT
bjos-8666337	196	1	11	11	NUM
bjos-8666337	196	2	.	.	PUNCT
bjos-8666337	196	3	seifi	seifi	NOUN
bjos-8666337	196	4	s	s	PROPN
bjos-8666337	196	5	,	,	PUNCT
bjos-8666337	196	6	kermani	kermani	PROPN
bjos-8666337	196	7	ia	ia	PROPN
bjos-8666337	196	8	,	,	PUNCT
bjos-8666337	196	9	dolatkhah	dolatkhah	ADJ
bjos-8666337	196	10	r	r	NOUN
bjos-8666337	196	11	,	,	PUNCT
bjos-8666337	196	12	kermani	kermani	NOUN
bjos-8666337	196	13	aa	aa	PROPN
bjos-8666337	196	14	,	,	PUNCT
bjos-8666337	196	15	sakhinia	sakhinia	PROPN
bjos-8666337	196	16	e	e	PROPN
bjos-8666337	196	17	,	,	PUNCT
bjos-8666337	196	18	asgarzadeh	asgarzadeh	NOUN
bjos-8666337	196	19	m	m	PROPN
bjos-8666337	196	20	,	,	PUNCT
bjos-8666337	196	21	et	et	PROPN
bjos-8666337	196	22	al	al	PROPN
bjos-8666337	196	23	.	.	PUNCT
bjos-8666337	197	1	prevalence	prevalence	NOUN
bjos-8666337	197	2	of	of	ADP
bjos-8666337	197	3	oral	oral	ADJ
bjos-8666337	197	4	human	human	ADJ
bjos-8666337	197	5	papilloma	papilloma	NOUN
bjos-8666337	197	6	virus	virus	NOUN
bjos-8666337	197	7	in	in	ADP
bjos-8666337	197	8	healthy	healthy	ADJ
bjos-8666337	197	9	individuals	individual	NOUN
bjos-8666337	197	10	in	in	ADP
bjos-8666337	197	11	east	east	PROPN
bjos-8666337	197	12	azerbaijan	azerbaijan	PROPN
bjos-8666337	197	13	province	province	PROPN
bjos-8666337	197	14	of	of	ADP
bjos-8666337	197	15	iran	iran	PROPN
bjos-8666337	197	16	.	.	PUNCT
bjos-8666337	198	1	iran	iran	PROPN
bjos-8666337	198	2	j	j	PROPN
bjos-8666337	198	3	public	public	ADJ
bjos-8666337	198	4	health	health	NOUN
bjos-8666337	198	5	.	.	PUNCT
bjos-8666337	199	1	2013;42(1):79	2013;42(1):79	NUM
bjos-8666337	199	2	-	-	SYM
bjos-8666337	199	3	85	85	NUM
bjos-8666337	199	4	.	.	PUNCT
bjos-8666337	199	5	12	12	NUM
bjos-8666337	199	6	.	.	PUNCT
bjos-8666337	200	1	siebers	sieber	NOUN
bjos-8666337	200	2	t	t	PROPN
bjos-8666337	200	3	,	,	PUNCT
bjos-8666337	200	4	merkx	merkx	PROPN
bjos-8666337	200	5	m	m	PROPN
bjos-8666337	200	6	,	,	PUNCT
bjos-8666337	200	7	slootweg	slootweg	VERB
bjos-8666337	200	8	p	p	PRON
bjos-8666337	200	9	,	,	PUNCT
bjos-8666337	200	10	melchers	melchers	PROPN
bjos-8666337	200	11	w	w	PROPN
bjos-8666337	200	12	,	,	PUNCT
bjos-8666337	200	13	van	van	PROPN
bjos-8666337	200	14	cleef	cleef	PROPN
bjos-8666337	200	15	p	p	PROPN
bjos-8666337	200	16	,	,	PUNCT
bjos-8666337	200	17	de	de	X
bjos-8666337	200	18	wilde	wilde	PROPN
bjos-8666337	201	1	p.	p.	NOUN
bjos-8666337	202	1	no	no	DET
bjos-8666337	202	2	high	high	ADJ
bjos-8666337	202	3	-	-	PUNCT
bjos-8666337	202	4	risk	risk	NOUN
bjos-8666337	202	5	hpv	hpv	NOUN
bjos-8666337	202	6	detected	detect	VERB
bjos-8666337	202	7	in	in	ADP
bjos-8666337	202	8	scc	scc	NOUN
bjos-8666337	202	9	of	of	ADP
bjos-8666337	202	10	the	the	DET
bjos-8666337	202	11	oral	oral	ADJ
bjos-8666337	202	12	tongue	tongue	NOUN
bjos-8666337	202	13	in	in	ADP
bjos-8666337	202	14	the	the	DET
bjos-8666337	202	15	absolute	absolute	ADJ
bjos-8666337	202	16	absence	absence	NOUN
bjos-8666337	202	17	of	of	ADP
bjos-8666337	202	18	tobacco	tobacco	NOUN
bjos-8666337	202	19	and	and	CCONJ
bjos-8666337	202	20	alcohol	alcohol	NOUN
bjos-8666337	202	21	—	—	PUNCT
bjos-8666337	202	22	a	a	DET
bjos-8666337	202	23	case	case	NOUN
bjos-8666337	202	24	study	study	NOUN
bjos-8666337	202	25	of	of	ADP
bjos-8666337	202	26	seven	seven	NUM
bjos-8666337	202	27	patients	patient	NOUN
bjos-8666337	202	28	.	.	PUNCT
bjos-8666337	203	1	oral	oral	ADJ
bjos-8666337	203	2	maxillofac	maxillofac	NOUN
bjos-8666337	203	3	surg	surg	NOUN
bjos-8666337	203	4	.	.	PUNCT
bjos-8666337	204	1	2008	2008	NUM
bjos-8666337	205	1	dec;12(4):185	dec;12(4):185	NOUN
bjos-8666337	205	2	-	-	PUNCT
bjos-8666337	205	3	8	8	NUM
bjos-8666337	205	4	.	.	PUNCT
bjos-8666337	206	1	doi	doi	NOUN
bjos-8666337	206	2	:	:	PUNCT
bjos-8666337	206	3	10.1007	10.1007	NUM
bjos-8666337	206	4	/	/	SYM
bjos-8666337	206	5	s10006	s10006	NOUN
bjos-8666337	206	6	-	-	NOUN
bjos-8666337	206	7	008	008	NUM
bjos-8666337	206	8	-	-	PUNCT
bjos-8666337	206	9	0131	0131	NUM
bjos-8666337	206	10	-	-	PUNCT
bjos-8666337	206	11	7	7	NUM
bjos-8666337	206	12	.	.	NOUN
bjos-8666337	206	13	13	13	NUM
bjos-8666337	206	14	.	.	PUNCT
bjos-8666337	207	1	wood	wood	NOUN
bjos-8666337	207	2	zc	zc	PROPN
bjos-8666337	207	3	,	,	PUNCT
bjos-8666337	207	4	bain	bain	PROPN
bjos-8666337	207	5	cj	cj	PROPN
bjos-8666337	207	6	,	,	PUNCT
bjos-8666337	207	7	smith	smith	PROPN
bjos-8666337	207	8	dd	dd	PROPN
bjos-8666337	207	9	,	,	PUNCT
bjos-8666337	207	10	whiteman	whiteman	PROPN
bjos-8666337	207	11	dc.antonsson	dc.antonsson	PROPN
bjos-8666337	207	12	a.	a.	PROPN
bjos-8666337	207	13	oral	oral	PROPN
bjos-8666337	207	14	human	human	ADJ
bjos-8666337	207	15	papillomavirus	papillomavirus	NOUN
bjos-8666337	207	16	infection	infection	NOUN
bjos-8666337	207	17	incidence	incidence	NOUN
bjos-8666337	207	18	and	and	CCONJ
bjos-8666337	207	19	clearance	clearance	NOUN
bjos-8666337	207	20	:	:	PUNCT
bjos-8666337	207	21	a	a	DET
bjos-8666337	207	22	systematic	systematic	ADJ
bjos-8666337	207	23	review	review	NOUN
bjos-8666337	207	24	of	of	ADP
bjos-8666337	207	25	the	the	DET
bjos-8666337	207	26	literature	literature	NOUN
bjos-8666337	207	27	.	.	PUNCT
bjos-8666337	208	1	j	j	PROPN
bjos-8666337	208	2	gen	gen	PROPN
bjos-8666337	208	3	virol	virol	NOUN
bjos-8666337	208	4	.	.	PUNCT
bjos-8666337	209	1	2017	2017	NUM
bjos-8666337	209	2	apr;98(4):519	apr;98(4):519	NOUN
bjos-8666337	209	3	-	-	SYM
bjos-8666337	209	4	26	26	NUM
bjos-8666337	209	5	.	.	PUNCT
bjos-8666337	210	1	doi	doi	NOUN
bjos-8666337	210	2	:	:	PUNCT
bjos-8666337	210	3	10.1099	10.1099	NUM
bjos-8666337	210	4	/	/	SYM
bjos-8666337	210	5	jgv.0.000727	jgv.0.000727	NOUN
bjos-8666337	210	6	.	.	PUNCT
bjos-8666337	211	1	14	14	NUM
bjos-8666337	211	2	.	.	PUNCT
bjos-8666337	212	1	delavarian	delavarian	PROPN
bjos-8666337	212	2	z	z	PROPN
bjos-8666337	212	3	,	,	PUNCT
bjos-8666337	212	4	pakfetrat	pakfetrat	NOUN
bjos-8666337	212	5	a	a	NOUN
bjos-8666337	212	6	,	,	PUNCT
bjos-8666337	212	7	falaki	falaki	PROPN
bjos-8666337	212	8	f	f	PROPN
bjos-8666337	212	9	,	,	PUNCT
bjos-8666337	212	10	pazouki	pazouki	PROPN
bjos-8666337	212	11	m.pazouki	m.pazouki	X
bjos-8666337	212	12	n.	n.	NOUN
bjos-8666337	213	1	the	the	DET
bjos-8666337	213	2	role	role	NOUN
bjos-8666337	213	3	of	of	ADP
bjos-8666337	213	4	viruses	virus	NOUN
bjos-8666337	213	5	in	in	ADP
bjos-8666337	213	6	oral	oral	ADJ
bjos-8666337	213	7	squamous	squamous	ADJ
bjos-8666337	213	8	cell	cell	NOUN
bjos-8666337	213	9	carcinoma	carcinoma	NOUN
bjos-8666337	213	10	in	in	ADP
bjos-8666337	213	11	young	young	ADJ
bjos-8666337	213	12	patients	patient	NOUN
bjos-8666337	213	13	in	in	ADP
bjos-8666337	213	14	khorasan	khorasan	PROPN
bjos-8666337	213	15	(	(	PUNCT
bjos-8666337	213	16	northeast	northeast	ADV
bjos-8666337	213	17	of	of	ADP
bjos-8666337	213	18	iran	iran	PROPN
bjos-8666337	213	19	)	)	PUNCT
bjos-8666337	213	20	.	.	PUNCT
bjos-8666337	214	1	j	j	PROPN
bjos-8666337	214	2	appl	appl	PROPN
bjos-8666337	214	3	sci	sci	PROPN
bjos-8666337	214	4	.	.	PUNCT
bjos-8666337	214	5	2010;10(11):981	2010;10(11):981	X
bjos-8666337	214	6	-	-	SYM
bjos-8666337	214	7	5	5	NUM
bjos-8666337	214	8	.	.	PUNCT
bjos-8666337	214	9	doi	doi	NOUN
bjos-8666337	214	10	:	:	PUNCT
bjos-8666337	214	11	10.3923	10.3923	NUM
bjos-8666337	214	12	/	/	SYM
bjos-8666337	214	13	jas.2010.981.985	jas.2010.981.985	NOUN
bjos-8666337	214	14	.	.	PUNCT
bjos-8666337	215	1	15	15	NUM
bjos-8666337	215	2	.	.	PUNCT
bjos-8666337	215	3	sisk	sisk	PROPN
bjos-8666337	215	4	ea	ea	PROPN
bjos-8666337	215	5	,	,	PUNCT
bjos-8666337	215	6	soltys	soltys	PROPN
bjos-8666337	215	7	sg	sg	PROPN
bjos-8666337	215	8	,	,	PUNCT
bjos-8666337	215	9	zhu	zhu	PROPN
bjos-8666337	215	10	s	s	PROPN
bjos-8666337	215	11	,	,	PUNCT
bjos-8666337	215	12	fisher	fisher	PROPN
bjos-8666337	215	13	sg	sg	PROPN
bjos-8666337	215	14	,	,	PUNCT
bjos-8666337	215	15	carey	carey	PROPN
bjos-8666337	215	16	te.bradford	te.bradford	PROPN
bjos-8666337	215	17	cr	cr	PROPN
bjos-8666337	215	18	.	.	PUNCT
bjos-8666337	216	1	human	human	ADJ
bjos-8666337	216	2	papillomavirus	papillomavirus	NOUN
bjos-8666337	216	3	and	and	CCONJ
bjos-8666337	216	4	p53	p53	NOUN
bjos-8666337	216	5	mutational	mutational	ADJ
bjos-8666337	216	6	status	status	NOUN
bjos-8666337	216	7	as	as	ADP
bjos-8666337	216	8	prognostic	prognostic	ADJ
bjos-8666337	216	9	factors	factor	NOUN
bjos-8666337	216	10	in	in	ADP
bjos-8666337	216	11	head	head	NOUN
bjos-8666337	216	12	and	and	CCONJ
bjos-8666337	216	13	neck	neck	NOUN
bjos-8666337	216	14	carcinoma	carcinoma	NOUN
bjos-8666337	216	15	.	.	PUNCT
bjos-8666337	217	1	head	head	NOUN
bjos-8666337	217	2	&	&	CCONJ
bjos-8666337	217	3	neck	neck	PROPN
bjos-8666337	217	4	:	:	PUNCT
bjos-8666337	217	5	journal	journal	NOUN
bjos-8666337	217	6	for	for	ADP
bjos-8666337	217	7	the	the	DET
bjos-8666337	217	8	sciences	science	NOUN
bjos-8666337	217	9	and	and	CCONJ
bjos-8666337	217	10	specialties	specialty	NOUN
bjos-8666337	217	11	of	of	ADP
bjos-8666337	217	12	the	the	DET
bjos-8666337	217	13	head	head	NOUN
bjos-8666337	217	14	and	and	CCONJ
bjos-8666337	217	15	neck	neck	NOUN
bjos-8666337	217	16	.	.	PUNCT
bjos-8666337	218	1	2002;24(9):841	2002;24(9):841	NUM
bjos-8666337	218	2	-	-	SYM
bjos-8666337	218	3	49	49	NUM
bjos-8666337	218	4	.	.	PUNCT
bjos-8666337	219	1	16	16	NUM
bjos-8666337	219	2	.	.	PUNCT
bjos-8666337	220	1	jalilvand	jalilvand	PROPN
bjos-8666337	220	2	s	s	PROPN
bjos-8666337	220	3	,	,	PUNCT
bjos-8666337	220	4	shoja	shoja	PROPN
bjos-8666337	220	5	z.hamkar	z.hamkar	PROPN
bjos-8666337	220	6	r.	r.	PROPN
bjos-8666337	220	7	human	human	PROPN
bjos-8666337	220	8	papillomavirus	papillomavirus	PROPN
bjos-8666337	220	9	burden	burden	NOUN
bjos-8666337	220	10	in	in	ADP
bjos-8666337	220	11	different	different	ADJ
bjos-8666337	220	12	cancers	cancer	NOUN
bjos-8666337	220	13	in	in	ADP
bjos-8666337	220	14	iran	iran	PROPN
bjos-8666337	220	15	:	:	PUNCT
bjos-8666337	220	16	a	a	DET
bjos-8666337	220	17	systematic	systematic	ADJ
bjos-8666337	220	18	assessment	assessment	NOUN
bjos-8666337	220	19	.	.	PUNCT
bjos-8666337	221	1	asian	asian	PROPN
bjos-8666337	221	2	pac	pac	PROPN
bjos-8666337	221	3	j	j	PROPN
bjos-8666337	221	4	cancer	cancer	NOUN
bjos-8666337	221	5	prev	prev	X
bjos-8666337	221	6	.	.	PUNCT
bjos-8666337	222	1	2014;15(17):7029	2014;15(17):7029	NUM
bjos-8666337	222	2	-	-	SYM
bjos-8666337	222	3	35	35	NUM
bjos-8666337	222	4	.	.	PUNCT
bjos-8666337	223	1	17	17	NUM
bjos-8666337	223	2	.	.	PUNCT
bjos-8666337	223	3	kreimer	kreimer	PROPN
bjos-8666337	223	4	ar	ar	PROPN
bjos-8666337	223	5	,	,	PUNCT
bjos-8666337	223	6	johansson	johansson	PROPN
bjos-8666337	223	7	m	m	PROPN
bjos-8666337	223	8	,	,	PUNCT
bjos-8666337	223	9	waterboer	waterboer	PROPN
bjos-8666337	223	10	t	t	PROPN
bjos-8666337	223	11	,	,	PUNCT
bjos-8666337	223	12	kaaks	kaaks	PROPN
bjos-8666337	223	13	r	r	PROPN
bjos-8666337	223	14	,	,	PUNCT
bjos-8666337	223	15	chang	chang	PROPN
bjos-8666337	223	16	-	-	PUNCT
bjos-8666337	223	17	claude	claude	PROPN
bjos-8666337	223	18	j	j	PROPN
bjos-8666337	223	19	,	,	PUNCT
bjos-8666337	223	20	drogen	drogen	PROPN
bjos-8666337	223	21	d	d	PROPN
bjos-8666337	223	22	,	,	PUNCT
bjos-8666337	223	23	et	et	PROPN
bjos-8666337	223	24	al	al	PROPN
bjos-8666337	223	25	.	.	PUNCT
bjos-8666337	223	26	evaluation	evaluation	NOUN
bjos-8666337	223	27	of	of	ADP
bjos-8666337	223	28	human	human	ADJ
bjos-8666337	223	29	papillomavirus	papillomavirus	NOUN
bjos-8666337	223	30	antibodies	antibodie	VERB
bjos-8666337	223	31	and	and	CCONJ
bjos-8666337	223	32	risk	risk	NOUN
bjos-8666337	223	33	of	of	ADP
bjos-8666337	223	34	subsequent	subsequent	ADJ
bjos-8666337	223	35	head	head	NOUN
bjos-8666337	223	36	and	and	CCONJ
bjos-8666337	223	37	neck	neck	NOUN
bjos-8666337	223	38	cancer	cancer	NOUN
bjos-8666337	223	39	.	.	PUNCT
bjos-8666337	224	1	j	j	PROPN
bjos-8666337	224	2	clin	clin	PROPN
bjos-8666337	224	3	oncol	oncol	PROPN
bjos-8666337	224	4	.	.	PUNCT
bjos-8666337	225	1	2013;31(21):2708	2013;31(21):2708	NUM
bjos-8666337	225	2	.	.	PROPN
bjos-8666337	225	3	18	18	NUM
bjos-8666337	225	4	.	.	PUNCT
bjos-8666337	225	5	aghaeipour	aghaeipour	PROPN
bjos-8666337	225	6	f	f	NOUN
bjos-8666337	225	7	,	,	PUNCT
bjos-8666337	225	8	salehiniya	salehiniya	ADV
bjos-8666337	225	9	h.abbaszadeh	h.abbaszadeh	ADJ
bjos-8666337	225	10	h.	h.	NOUN
bjos-8666337	225	11	prevalence	prevalence	NOUN
bjos-8666337	225	12	of	of	ADP
bjos-8666337	225	13	human	human	ADJ
bjos-8666337	225	14	papillomavirus	papillomavirus	NOUN
bjos-8666337	225	15	(	(	PUNCT
bjos-8666337	225	16	hpv	hpv	NOUN
bjos-8666337	225	17	)	)	PUNCT
bjos-8666337	225	18	in	in	ADP
bjos-8666337	225	19	oral	oral	ADJ
bjos-8666337	225	20	mucosal	mucosal	NOUN
bjos-8666337	225	21	lesions	lesion	NOUN
bjos-8666337	225	22	in	in	ADP
bjos-8666337	225	23	iran	iran	PROPN
bjos-8666337	225	24	:	:	PUNCT
bjos-8666337	225	25	a	a	DET
bjos-8666337	225	26	systematic	systematic	ADJ
bjos-8666337	225	27	review	review	NOUN
bjos-8666337	225	28	and	and	CCONJ
bjos-8666337	225	29	meta	meta	ADJ
bjos-8666337	225	30	-	-	PUNCT
bjos-8666337	225	31	analysis	analysis	NOUN
bjos-8666337	225	32	.	.	PUNCT
bjos-8666337	226	1	j	j	PROPN
bjos-8666337	226	2	med	med	PROPN
bjos-8666337	226	3	virol	virol	NOUN
bjos-8666337	226	4	.	.	PUNCT
bjos-8666337	227	1	2021;93(11):6089	2021;93(11):6089	NUM
bjos-8666337	227	2	-	-	SYM
bjos-8666337	227	3	99	99	NUM
bjos-8666337	227	4	.	.	NOUN
bjos-8666337	228	1	19	19	NUM
bjos-8666337	228	2	.	.	PUNCT
bjos-8666337	228	3	toh	toh	PROPN
bjos-8666337	228	4	zq	zq	PROPN
bjos-8666337	228	5	,	,	PUNCT
bjos-8666337	228	6	kosasih	kosasih	PROPN
bjos-8666337	228	7	j	j	PROPN
bjos-8666337	228	8	,	,	PUNCT
bjos-8666337	228	9	russell	russell	PROPN
bjos-8666337	228	10	fm	fm	PROPN
bjos-8666337	228	11	,	,	PUNCT
bjos-8666337	228	12	garland	garland	PROPN
bjos-8666337	228	13	sm	sm	PROPN
bjos-8666337	228	14	,	,	PUNCT
bjos-8666337	228	15	mulholland	mulholland	PROPN
bjos-8666337	228	16	ek.licciardi	ek.licciardi	PUNCT
bjos-8666337	228	17	pv	pv	PROPN
bjos-8666337	228	18	.	.	PUNCT
bjos-8666337	229	1	recombinant	recombinant	ADJ
bjos-8666337	229	2	human	human	ADJ
bjos-8666337	229	3	papillomavirus	papillomavirus	NOUN
bjos-8666337	229	4	nonavalent	nonavalent	ADJ
bjos-8666337	229	5	vaccine	vaccine	NOUN
bjos-8666337	229	6	in	in	ADP
bjos-8666337	229	7	the	the	DET
bjos-8666337	229	8	prevention	prevention	NOUN
bjos-8666337	229	9	of	of	ADP
bjos-8666337	229	10	cancers	cancer	NOUN
bjos-8666337	229	11	caused	cause	VERB
bjos-8666337	229	12	by	by	ADP
bjos-8666337	229	13	human	human	ADJ
bjos-8666337	229	14	papillomavirus	papillomavirus	NOUN
bjos-8666337	229	15	.	.	PUNCT
bjos-8666337	230	1	infection	infection	NOUN
bjos-8666337	230	2	and	and	CCONJ
bjos-8666337	230	3	drug	drug	NOUN
bjos-8666337	230	4	resistance	resistance	NOUN
bjos-8666337	230	5	.	.	PUNCT
bjos-8666337	231	1	2019;12:1951	2019;12:1951	NUM
bjos-8666337	231	2	.	.	PROPN
bjos-8666337	231	3	doi:10.2147	doi:10.2147	NOUN
bjos-8666337	231	4	/	/	SYM
bjos-8666337	231	5	idr.s178381	idr.s178381	PROPN
bjos-8666337	231	6	.	.	PUNCT